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Proverb

The universe
is m a d e up
of stories,
not of atoms.
(Muriel Rukeyser)

W e are the stuff of stars.
(Carl Sagan)
A m a n said to the Universe:
"Sir, I exist!"
"However," replied the Universe,
"The Fact has not created in m e
A sense of obligation."
(Stephen Crane).
I would be the rock
about which the water is
flowing; and I would
be the water flowing
about the rock.
And I a m both and neither
being flesh.
(Charles Reznikoff)
A m a n smiles by himself in the dark
perhaps because he can see in the dark
perhaps because he can see the dark.
(Yannis Ritsos)

"One of the greatest things in the world
is to train ourselves to see beauty
in the commonplace."
(Charles Webster Hawthorne,
American realist painter)
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Abstract

Powerful n e w techniques in m a s s spectrometry (MS) provide an
unprecedented opportunity to develop methods that facilitate protein
characterization. This thesis utilizes matrix-assisted laser desorption/ionization
and electrospray Ionization MS to explore protein structure. Starting at the
'primary' level of protein structure, an approach is developed to aid in the
characterization of posttranslational modifications and processing of mature
gene products. The approach involves the elution of picomole amounts of whole
proteins from SDS-PAGE gels in a form suitable for MS analysis. Application of
the elution method to the obesity factor leptin led to the characterization of the
endogenous form of leptin in obese humans.
A biochemical procedure is developed that permits 'higher' order
structural features of proteins to be probed. The method uses limited proteolysis

to distinguish regions within a target protein that are solvent exposed and flexible
from those that are solvent inaccessible or conformationally rigid. The DNAbinding protein Max was investigated by the procedure and several structural
features were determined. The structural study of Max was extended in an
investigation of the effects of N-terminal phosphorylation. Limited proteolysis

was found to be of great utility in the determination of the 'precise' boundaries of
protein folding domains. This method of 'domain elucidation' is explored fully
and applied to proteins of unknown structure, including the Drosophila TAF

1

42/62 protein complex. Limited proteolysis/MS experiments permitted a rapid
design of a compact construct of the TAF complex, crystals of which X-ray
diffracted to 1.4 A resolution.
MALDI-mass spectrometric methods were absolutely crucial to every step
of the described research. However, before the methods could be effectively
applied, it proved necessary to develop new and practical MS sampling handling
procedures.

2

Chapter 1 — Introduction

What is 'protein characterization?' I asked this question before choosing
these words for the thesis tittle. Is characterization the same as analysis (an
alternate title)? Not really. The terms 'characterize' and 'analyze' have distinctly
different definitions. Analyze, according to Webster's Third Edition, means to
"ascertain the components of or separate into component parts" whereas
characterize means "to describe the essential character or quality of." The
former is mechanical, the latter is intimate. Accordingly, protein analysis refers
simply to protein separation whereas protein characterization refers to the
measuring of more intrinsic properties of proteins, such as molecular mass,
amino acid modifications and structure.
I begin the thesis with a discussion of methodologies that are the

traditional 'tools of the trade' in protein analysis and characterization. Therein, I
introduce the 'new player', mass spectrometry (MS) —a highly developed
'mechanical' methodology that can render 'intimate' details about a molecule.
For proteins, new mass spectrometric techniques can measure accurate
molecular mass, identify modifications of peptide residues, and provide structural
information. Finally, I present the concept of structural characterization via
proteolysis, a traditional biochemical method whose utility, when combined with
mass spectrometry, is greatly enhanced.

3

1.1 Protein Analysis
For biologists, the tool of choice to analyze proteins has been
polyacrylamide gel electrophoresis (PAGE). The most common forms of PAGE
are SDS (sodium dodecyl sulfate)-PAGE, isoelectric focusing (lEF), and
nondenaturing PAGE. In SDS-PAGE, proteins are separated spatially in onedimension, essentially according to their molecular masses. In lEF proteins are
spatially separated in one-dimension through a pH gradient according to their

isoelectric points or net charge. In two-dimensional PAGE, lEF is run in the first
dimension, followed by SDS-PAGE in the second dimension. The resolving
power of 2-D gels is unsurpassed, particularly in separating complex mixtures of
proteins from whole-cell lysates. In nondenaturing gels, electrophoresis is
performed under native conditions, important when the enzymatic activity or
structure of a protein or protein complex needs to be maintained during
separation.

1.2 Protein Characterization by Traditional Methods
To characterize proteins, PAGE methods are insufficient by themselves.
Molecular mass estimations by SDS-PAGE are often no better than 5-10%
accurate and many times grossly inaccurate. The isoelectric point, an intrinsic

property of the protein, is by itself of little value. However, if an antibody aga
a target protein is available. Western electroblotting methods are useful to
recognize the presence of the protein on the gel.
4

Classical methods for characterizing proteins include amino acid analysis
and N-terminal sequencing. In amino acid analysis, a single, purified protein is
subjected to strong acid at elevated temperatures to hydrolyze all peptide bonds
and release the individual amino acid residues. Elution through an ionexchanger identifies and quantifies the different amino acid residues. However,
amino acid analysis provides no information about protein sequence, is prone to
errors and requires a considerable amount of protein (>10 |ig).
Protein sequencing has been made possible by the powerful, classical
method of N-terminal (Edman) sequencing. Edman sequencing requires the
prior steps of protein separation, usually one- or two-dimensional gels, and
electroblotting. However, a substantial portion of intact intracellular eukaryotic
proteins are 'blocked' at their N-terminus, usually with acetyl groups.
N-terminally block proteins cannot be directly sequenced. An alternate strategy
involves enzymatic digestion of the protein on the blotting membrane or in the
gel, elution of the resulting peptide digest fragments for reverse-phase HPLC
separation. The HPLC-separated fragments can be delivered to an automated
sequencer for identification using Edman chemistry. Despite automation, Edman
sequencing methods are time consuming and expensive. More significantly,
success rates fall drastically when analyzing low picomole amounts of protein. In
addition, although Edman sequencing can locate a covalently modified residue,
the Edman method cannot normally determine the exact identity of the
modification. Nonetheless, in the 'pre-genome era', Edman sequencing has

5

been the method of choice for providing sequence information enabling the
design of cDNA probes for gene cloning.

1.3 Protein Characterization by Mass spectrometry
From a biologist's perspective, mass spectrometry is a methodology that
seems to have appeared 'out of the blue.' However there is a long history that
speaks of the efforts and advancements to bridge the biological community with
mass spectrometry. I survey some of that history in the following section,
providing some perspective and appreciation to the 'pioneers' of the field.

Mass Spectrometry
Simply put, a mass spectrometer measures the molecular mass of a
molecule, accurately and better than any other methodology. All mass
spectrometers consist of three principal components: an ion source, mass
analyzer and detector (Figure 1.1). Development of the mass analyzer and ion

source have had the most impact on mass spectrometry, particularly in biological
applications.

1.3.1 Mass Analyzer
Early in the development of mass spectrometry, attention was focused

principally on the mass analyzer. In the early 1900s electric and magnetic field
were used to separate positively charged 'rays' onto a photographic plate. The
rays were generated by an electrical discharge. Aston developed the first mass
6
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Figure 1.1 The elements of mass spectrometry
The essential elements of mass spectrometry are sample
volatilization and ionization, followed by mass analysis and
ion detection. The resulting mass spectrum is a plot of
relative ion intensity vs. the mass-to-charge ratio.
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spectrograph in 1919 (he coined the term). A photoplate w a s used to collect the
separated rays that were later identified to be charged atoms (i.e., ions). The
mass spectrograph represented a substantial breakthrough since it provided
accurate mass-to-charge (m/z) ratios of ions and a rapid means to determine
isotopic abundances of many of the elements.
In 1922 Dempster introduced the first 'single focusing' magnetic mass
spectrometer, equipped with an electrometer detector. It soon became apparent
that improvements in mass resolution were necessary, especially to satisfy the
growing needs of the rapidly developing field of synthetic organic chemistry.
Fulfilling the need was the double-focusing mass spectrometer, advanced during
the 1930s and 40s. Double-focusing instruments were equipped with electric as
well as magnetic sectors grouped in various arrangements and coupled together
with mechanical slits. The double-focusing instrument provided angular as well
as energy focusing of an ion beam, the combination of which produced
resolutions exceeding 10,000. Double-focusing instruments are still used today,
and though expensive, routinely provide high mass accuracy and resolution
measurements of small to intermediate organic molecules (M^ <2000).
Another Important group of mass analyzers, developed by Wolfgang Paul
in the 1950s, was the relatively inexpensive quadrupole ion filter and the
quadrupole ion trap. A much more expensive and high-performance analyzer is
the Fourier transform ion cyclotron resonance mass spectrometer (FT-ICR/MS or
FT-MS), introduced by Comisarow and Marshall in the 1970s. FT-MS offers very
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high resolution (exceeding 10^ at m/z 100) and high sensitivity. Finally, the least
expensive analyzer (and conceptually the easiest to understand) is the time-offlight (TOF) mass spectrometer, developed into a practical device by Wiley and
McLaren during the late 1950s. A majority of the research presented in this
thesis was performed on a TOF mass spectrometer. The TOF mass

spectrometer consists of a long 'field-free' flight path (typically 0.5-2 m) through
which ions traverse in vacuo to the detector. Using fast electronics, transit times
of the ions through the field-free drift region are accurately measured of all ions
impinging on the detector. The result is a 'time-of-flight' (TOF) spectrum. The

m/z of an ion is directly proportional to the square of its flight time, thus the TOF
data is easily converted into mass-to-charge data. The TOF mass spectrometer
offers low to moderate resolution, high transmission and, in principal, an
unlimited m/z range.

1.3.2 Electron Impact Ionization
Without a volatilization/ionization source, the mass analyzer is just a
heavy and expensive papen/veight. On early commercial MS instruments,
ionization was commonly performed by bombarding a gaseous sample with --70
eV electrons, a process that results in removal of an electron from the sample
atom or molecule (i.e., electron ionization, El). Involatile samples must be

vaporized prior to ionization, so that El is limited to molecules of low polarity an
molecular weights. For biological samples, small and relatively non-polar
molecules (e.g., fatty acids and steroids) can be analyzed by El. Chemical
9

derivatization methods have been extensively developed to increase the volatility
of polar compounds. A significant advancement resulted from coupling of the
eluant output of a gas chromatograph to the ion source of the mass
spectrometer (i.e., GC/MS). The practice of GC/MS has evolved into a large
field whose activities extend to forensic, environmental, and chemical sciences.
The Olympic Games is a good example of where GC/MS is applied to test
participating athletes for Illegal use of anabolic steroids and other drugs
(Longman, 1996).
Despite the many early efforts to facilitate volatilization. El is a high
energy process, producing radical ion species that tend to undergo significant
gas-phase fragmentation. Thus, the signal from an intact 'parent' ion is normally
weak or not detected when using El, particularly for compounds with M^ > 400
Da. However, most molecule ions exhibit a unique pattern of fragmentation,
driven mainly by gas-phase radical ion chemistry. Elaborate rules governing the
gas-phase fragmentation of small organic ions, pioneered by McLafferty and
others, have been enumerated and are still being actively studied (McLafferty
and Turecek, 1993). The fragmentation rules have permitted structural
elucidation by MS of an enormous number of organic molecules, especially
natural products. Today, the El fragmentation pattern of an 'unknown'
compound can be submitted to search large databases of El mass spectra using

pattern matching retrieval algorithms to facilitate identification or classificatio
the compound.
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1.3.3 Chemical Ionization
Chemical ionization (CI), developed by Field and Munson in 1966
(Munson and Field, 1966) represented a major breakthrough in ionization
methods. CI is a lower energy ('softer') process than El —much less
fragmentation is observed. Thus CI provides a facile means to measure the
masses of intact, moderately volatile molecules. Usually a protonated or
deprotonated species is detected in CI. For electronegative compounds,
electron capture CI has proven to be a particularly sensitive method of MS
analysis. CI has also bolstered the use of high resolution MS instruments for
determining elemental composition of organic molecules by measuring masses
to an accuracy better than 0.01 mass units. CI was soon thereafter adopted by
instrument manufacturers and became, along with El, a standard mode of
ionization. The combination of gas-phase fragmentation patterns (from EI-MS)
along with an accurate molecular mass (from CI-MS) has become a powerful
means of analyzing organic molecules.

1.3.4 Early Desorption Ionization Methods
To begin to make a significant impact on the analysis of intractable
biological molecules, a breakthrough in volatilization procedures was needed. It
came with the development of desorption methods —field desorption , pioneered
by Beckey and Schulten (Beckey and Schulten, 1975) and plasma desorption,
discovered by Macfarlane and Torgerson (Torgerson et al., 1974).

11

In field desorption

(FDMS),

ionization of the sample

precedes

volatilization. FDMS was a softer ionization method than El and showed promise

for qualitative analysis of picogram amounts of drugs and drug metabolites, small

sugars and other very polar molecules that failed to yield a parent ion by El or C
However, FDMS never really developed 'legs' because of sample preparation
and operational difficulties associated with the method. FDMS soon became
over shadowed by more facile and powerful desorption methods, one of which
was plasma desorption (Torgerson et al., 1974).
In plasma desorption (PDMS) the sample is directly deposited onto a thin
metal surface. The reverse side of the surface is bombarded by MeV fission
fragments that originate from spontaneous decay of ^"Cf nuclei mounted close
to the surface. The bombardment causes sample molecule ionization and
volatilization. Mass analysis is by TOF-MS since ion production is pulsed, based
on the random decay of ^^^Cf nuclei. Intact parent and fragment ions are
observed in PDMS. Despite technical complexities (e.g., data collection
sometimes can take hours for each sample), plasma desorption was adopted by
several groups around the world (including Field and Chait at Rockefeller
University). PDMS was much softer than EI-MS and has proven to be a rather

powerful tool in analyzing peptides (Chait, 1989) and other intractable molecules
such as synthetic porphyrins (Lindsey et al., 1992). Small molecules with
masses up to 24 kDa could be analyzed with this method, albeit with some
difficulty. Commercialization of PDMS lagged other methods, however, so
PDMS was never universally adopted by the greater mass spectrometry
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community. Dyed-in-the-wool sector-type mass spectrometrists were reluctant to
embrace the non-sophisticated pulsed ion source of PDMS and the low
resolution time-of-flight mass analyzer.

1.3.5 Fast-Atom Bombardment Ionization
Desorption technology gradually led to the developed of new atom and
lon bombardment methods. In the late 1970s Benninghoven and others
introduced secondary ion mass spectrometry (SIMS), a method that provided a
means to study the molecular composition of solid surfaces. A major
breakthrough came with Fast Atom Bombardment (FAB) pioneered by Barber
(Barber et al., 1981). FAB is a liquid SIMS method in which the analyte is
dissolved in a low-volatility matrix such as glycerol. The analyte/matrix mixture
bombarded in vacuo by keV energy heavy atoms or ions (e.g., Xe or Cs*).
Desorption and ionization of the analyte molecules from the liquid surface
produces a continuous, stable beam of ions that is suitable for analysis by
scanning sector instruments. FAB provided a means to analyze otherwise
intractable small and medium-sized polar molecules such as nucleotides, sugars
and peptides with greater reproducibility and ease than field desorption
techniques. FAB is a moderately low energy process producing parent ions
(protonated or deprotonated) of peptides with masses usually up to 6 kDa and in
some reports up to 25 kDa. The method was universally embraced by the MS
community and was quickly commercialized.
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Following historical trends, the notion of structural determination using
FAB-MS took hold. In particular, peptide (and oligosaccharide) sequencing and
the characterization of posttranslational modifications were actively explored.
PDMS of peptides was already shown by several groups to provide sequence
information due to a significant degree of fragmentation associated with the
method. Peptide sequencing by FAB-MS required the use of tandem MS.
Tandem MS, first conceptualized by McLafferty in the 1960s and then developed
by McLafferty, Biemann and others, offered a means to selectively analyze
components of a mixture using two mass spectrometers joined in series. In the
first mass spectrometer, an ion is mass selected, energetically 'activated' by
collisions with an inert gas and subsequently allowed to undergo unimolecular
dissociation, the product ions of which are analyzed by the second mass
spectrometer. Fortuitously, gas-phase peptide ions fragment primarily along the
peptide backbone, providing a means to sequence the peptide. Through
extensive research, the gas-phase fragmentation of peptide ions was found to be
a complex function of the mode of ionization, collision energy, and the peptide
sequence. Groups headed by Biemann, Cooks, Hunt, Yost & Enke, and others
developed tandem MS instrumentation for sequencing peptide ions generated by
FAB-MS. Despite its widespread appeal, however, FAB-MS offers only

moderate sensitivity (barely subnanomole) and the sensitivity sharply falls off fo
large (> 2 kDa) peptides. In addition, the mass analysis of large peptides
requires expensive (> $ 200,000) and intricate magnetic sector instruments. In
order to compete with existing N-terminal Edman sequencing methods, the MS
14

sensitivities provided by existing ionization methods required about a thousandfold improvement. This came with two concurrent ionization breakthroughs in
mass spectrometry —matrix-assisted laser desorption/ionization (MALDI) and
electrospray ionization (ESI). MALDI and ESI revolutionized biological MS,
catapulting mass range accessibility, sample sensitivity, mass accuracy, and
turn-around times to unprecedented levels. They are the main players in
biological mass spectrometry today.

1.3.6 Matrix-Assisted Laser Desorption/ionization (MALDI)
MALDI-MS was introduced by Hillenkamp and Karas in 1988 (Karas and
Hillenkamp, 1988). Figure 1.2 shows a simplified schematic of the MALDI-TOF
instrument designed and constructed by Chait and Beavis at Rockefeller
University (Beavis and Chait, 1989). The 'magic' in MALDI occurs between the
laser and the sample. A laser beam directed at 'bare' protein deposited on the
probe surface would result in charring of the sample and no signal from intact
protein. Hillenkamp and Karas originated the idea to embed the protein in a
solid organic matrix. (A second group developed an alternative laser desorption
method that made use of a viscous liquid matrix, but due to poor sensitivities,
was never adopted (Tanaka et al., 1988).) For MALDI-MS, the solid matrix is a
small, inert organic molecule, the crystals of which are capable of absorbing
laser light followed by sublimation. The crystals are grown from solutions
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IVIALDI-MS
matrix-assisted laser desorption
(time-of-flight) m a s s spectrometry
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(355nm)
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Figure 1.2 The basic components

of

MALDI-TOF-MS.

The essential elements of MALDI-TOF-MS consisting of a sample probe,
laser, time-of-flight analyzer, and detector (not to scale).
(1) A pulsed laser beam is focussed on the matrix-sample co-crystals
(deposited on a probe that is placed in vacuo at high voltage). (2) Molecules
are desorbed by the laser into the gas phase. Ionization occurs producing
ions (circlular shapes) of differing mass-to-charge (m/z) ratios (denoted by
the circle size). (3) With each laser pulse and starting at the s a m e time, ions
accelerate out of the source into the 2 m flight tube. Transit time down the
flight tube is proportional to the square-root of m/z (lower m/z ions have
higher velocities, denoted by arrow lengths). (4) Ions strike the detector,
producing an electrical signal that is amplified and sent to the computer
where the precise flight time of all detected ions are stored as a time-of-flight
spectrum. Mass conversion of the data results in a mass spectrum.
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consisting of analyte (e.g., proteins or peptides) and the matrix dissolved in water
(usually acidified) along with a portion of miscible organic solvent. The matrix
must exhibit at least partial solubility in the solution. It is believed that cocrystallization of the analyte with the matrix is critical for the MALDI process. In
simple but elegant experiment, Beavis showed that protein incorporates into
sinapinic acid matrix crystals in a well defined manner (Beavis and Bridson,
1993).
The precise mechanism of the MALDI process remains a mystery. In
short, the matrix acts to ionize as well as transport analyte molecules into the
gas phase and to provide a 'cushion' against charring by the high energy laser.
In one possible scenario, the laser photon (normally a 5-10 nsec pulse) is
'absorbed' by the matrix, the result of which leads to sublimation (or ablation) of
matrix molecules forming a dense matrix plume. In this ablation event, analyte
molecules embedded in the matrix are entrained in the plume. Experiments
done in the Chait lab as well by others indicate that the matrix plume is highly
'forward' directing, suggesting that the plume may consist of a fast moving
supersonic jet of molecules. A large number of collisions within the jet would
lower the internal energies of the molecules in the plume and foster analyte
ionization, two events that ultimately permit the detection of intact analyte ions.
Hillenkamp and Karas originally used 266 nm UV light from an expensive
Neodymium/YAG laser and the matrix nicotinic acid. The MALDI mass spectra
of proteins run in nicotinic acid matrix exhibited poor resolution and extensive
matrix photochemically generated adduct peaks. Chait and Beavis discovered a
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group of cinnamic acid derivatives (such as sinapinic acid) that permitted the use
of longer wavelength photons (355 or 337 nm) generated from a Nd/YAG laser
or from a less expensive nitrogen laser. The cinnamic acid matrices yielded
improved resolution and much less matrix adduction (Beavis and Chait, 1990a).
Application of cinnamic acids matrices also revealed a great strength of MALDI
—the ability to analyze complex mixtures of polypeptides (Beavis and Chait,
1990b). The power of MALDI-MS towards biological applications became
immediately apparent with its high mass accuracy (0.01% for peptides),
sensitivity (subpicomole) and analysis speed (minutes) (Hillenkamp et al, 1991;
Chait and Kent, 1992; Beavis and Chait, 1996).
Despite the rapid growth of the MALDI-MS technique, there has been a
need to better understand and improve the sample preparation stage of the
analysis. In this regard, I undertook an extensive study of the influences of
various sample preparation parameters that significantly effected the MALDI-MS
of peptides and proteins (see chapter 2). The results of the matrix study directly
influenced all of my subsequent research, permitting the development of a
method to elute proteins from gels for high sensitivity MALDI-MS analysis

(chapter 3) and the optimization of protein digestion analysis for protein structura
studies (chapter 4) and domain elucidation (chapter 5).
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1.3.7 Electrospray Ionization (ESI)
Electrospray ionization (ESI) MS was the other 'revolution' in biological
MS analysis, sweeping through the MS community about the same time as
MALDI-MS. ESI-MS was innovated by Fenn and coworkers (Fenn et al., 1989).
The great appeal in ESI-MS is the ability to generate gas-phase peptide and
protein ions directly from solution, in a simple and highly reproducible way. ESIMS was also ideal for interfacing to the liquid chromatograph. For years, a major
challenge was the interfacing of liquid chromatography (LC) to the mass
spectrometer. Through the early 1980s, two methods showed some promise for
an LC/MS interface —continuous-flow FAB and thermospray. Both methods,
however, were beset with technical difficulties and were quickly supplanted by
the development of ESI-MS. With ESI, a practical LC/MS interface was finally
possible.
Figure 1.3 depicts the general features of ESI-MS. The idea of ESI is
rather simple. A solution containing analyte (such as protein) is infused through
a metallic hypodermic needle that is kept at a high electrical potential (M kV).
The solution emerges from the needle at ambient pressure as a mist of small,
highly charged droplets that contain the analyte. The droplets are entrained by a
gas flow into the vacuum of the mass spectrometer. On the original Rockefeller
electrospray design (Chowdhury et al., 1990), the flow is directed through a
heated 20 cm long, 0.5 mm i.d. stainless steel capillary tube. The heating assists
in droplet evaporation and ion formation. The exact mechanism of ion formation
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The essential elements of ESI-MS (not drawn to scale) consist of an analyte
dissolved in an appropriate solution, the electrospray, a heated capillary tube,
the skimmer, m a s s analyzer and detector.
A solution is infused through a fine needle that is placed at 4-5 kV. Under the
proper flow conditions, the solution emerging from the needle forms an
'electrospray' at the tip of the needle under atmospheric pressure. Guided by
an electric field, the spray is directed into a heated stainless steel capillary
tube. The spray droplets are entrained into a gas flow through the capillary
(due to the vacuum of the M S instrument). The heat of the capillary
evaporates and shrinks the droplets, eventually leaving individual analyte ions
of multiple charges and a few solvating water molecules. Passing through the
skimmer, the hydrated ions collide with residual gas. T h e collision energy is
controlled by the gap voltage. The collisions completely desolvate the ions
that are then focused into the m a s s spectrometer for analysis and detection.
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remains in dispute. O n e scenario envisions ion formation through a series of
'Coulombic explosions' occurring from the drop. Through evaporation, the highly
charged droplet shrinks to a critical size —the so called Raleigh limit— where
electrostatic repulsive forces exceed the surface forces keeping the drop
together. At this point, an asymmetric Coulombic explosion occurs from the
surface of the drop, releasing smaller droplets containing the analyte. Following
several cycles of evaporation and Coulombic explosions, the droplet will have
almost completely evaporated, leaving the analyte in a highly charged (i.e.,
protonated or cationized) state and surrounded by a small number of solvent
molecules. Exiting the heated capillary tube, the solvated analyte ion collides
with residual gas in the vacuum (now at -1 torr) in transit to the skimmer. The
skimmer is at the entrance of the mass analyzer. An adjustable electric field,
maintained between the exit of the capillary and the skimmer, controls the
collision energy. At low to moderate collision energies the analyte ion can be
completely desolvated (Chowdhury et al., 1990), whereas at higher energies the
analyte, if it is a peptide ion, is collisionally activated and made to undergo
fragmentation (Katta et al., 1991).

1.3.7.1 Observing Non-Covalent Interactions by ESI-MS
Normally a protein analyzed by ESI-MS is dissolved in an acidic solution
with a high amount of miscible organic solvent (i.e., largely denaturing
conditions). If the acid and organic solvent is omitted (i.e., a pure water solution)
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the native, folded state of the protein can be maintained in solution. Through
careful adjustments of the capillary temperature and skimmer potential it is
possible to observe non-covalent protein interactions in the gas phase (Katta
and Chait, 1991). This can be achieved if the desolvation thermal energy
(capillary temperature, Figure 1.3) and the skimmer (gap) voltage are sufficiently
reduced. One example of one of the earliest non-covalent complex observed in
the gas phase by ESI-MS was the heme-globin complex in native myoglobin
performed in the Chait lab (Katta and Chait, 1991). The study of non-covalent
interactions in the gas phase by ESI-MS (Smith and Light-Wahl, 1993) is being
undertaken by several groups including Robert Anderegg (protein-peptide), Brian
Chait (protein-ligand), Jack Henion (protein-ligand), Sheena Radford (proteinprotein) Richard Smith (protein-DNA complexes), and Ken Standing (protein
oligomeric complexes). (An excellent review of noncovalent interactions can be
found in Przybylski and Glocker, 1996.) The mass analyzer used by most

groups to study non-covalent interactions is the quadrupole ion filter, instruments
that tend to have a limited m/z range. Non-covalent complexes sprayed from pH
7 aqueous solutions are less charged than if they were sprayed from acidic
solutions (a pH at which non-covalent complexed tend to dissociate.) Low
charge (z) means high m/z values (e.g., m/z > 3000) so quadrupoles that only
scan up to say m/z 2400 cannot be used. Some quadrupole instruments scan
up to m/z 4000. As an alternate mass analyzer to the ion filter, Richard Smith
has used an FT-ICR MS device and Ken Standing has demonstrated excellent
results with a less expensive ESI-time-of-flight device.
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1.4 Structural Characterization of Proteins
A principal application of mass spectrometry in this thesis is focused on
the characterization of protein structure. The most powerful techniques available
today to study protein structure are the high-resolution methods of X-ray
crystallography and multidimensional nuclear magnetic resonance (NMR)

spectroscopy. X-ray crystallography has been particularly fruitful, since the early
heroic efforts of Max Perutz (hemoglobin) and John Kendrew (myoglobin). The
three dimensional structures of >1000 proteins have been now determined.
Simultaneous advances in the technologies of recombinant DNA cloning, DNA
synthesis, and the expression of foreign DNA in heterologous systems as well as
powerful x-ray sources, phase-determination strategies and powerful computers
have paved the way to the explosive growth in protein structure determination of
the 1990s (Eisenberg and Hill, 1989). Although the atomic resolution details of
protein structure provided by X-ray crystallography and NMR are unsurpassed,
there are a large number of other methods that have been used to obtain protein
structural information. These techniques are considered as 'low resolution'
approaches that include genetic (e.g., mutational), spectroscopic (e.g., circular
dichroism), chemical methods (e.g., chemical modification and
hydrogen/deuterium exchange) and biochemical methods (e.g., proteolysis).
The last method has played a prominent role throughout the research described
in this thesis.
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1.5 Proteolysis
Proteolysis is a phenomenon recognized from early times. The first
protease to be isolated was trypsin by Kuhne in 1890 from pancreatic extractions
(Mihaiyi, 1978). A better understanding of proteolysis at the molecular level
came only after the purification of proteases in the 1920s. In the 1930s
Linderstrom-Lang recognized that the peptide bond was hydrolyzed during
proteolysis (Linderstrom-Lang et al., 1938). By the end of the 1950s, the

concept of partial or 'limited proteolysis' evolved from a structural study of fibr
proteins (Harrington et al., 1959). The authors of this short study (one of whom
was Peter Von Hippel) cleverly foresaw a use of proteolytic enzymes as a way of
distinguishing 'ordered' and 'disordered' regions of proteins.
There are two categories of proteases based on their mode of cleavage.
Exoproteases cleave amino acid residues sequentially from the N-terminal
(aminopeptidases) or C-terminal (carboxypeptidases), whereas endoproteases
cleave the peptide bond between residues within a polypeptide chain. Cleavage
specificity of a protease varies from highly specific (e.g., endoprotease Lys-C

targets lysines) to broadly specific (e.g., subtilisin targets almost any amino aci
(Hames and Rickwood, 1989)
The active site of a protease is where substrate peptide bond hydrolysis
occurs. A great deal of effort has been devoted to understanding the precise
mechanism of hydrolysis (Hames and Rickwood, 1989). Important for the thesis
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research is the 'size' of the active site. In a seminal study, Schecter and Berger
employed biochemical means to probe the size of the active site of the protease
papain (Schechter and Berger, 1967). From their findings and guided by the
X-ray analysis of another enzyme, lysozyme, the authors proposed a general
model of the proteolytic enzyme-substrate complex (Figure 1.4) (Schechter and
Berger, 1967). The model suggested that the active site of papain protease
extends beyond the catalytic site (C in Figure 1.4) to include seven enzyme
subsites (S) that coordinate interaction between the enzyme and an extended
form of the substrate peptide (P) that includes six residues. The intermolecular
interactions were shown to increase enzyme-subtrate binding. More recent
experimental (Fontana, 1989) and modeling studies (Hubbard et al., 1994)
support the notion that a substantial amount of conformational flexibility of the
substrate is a prime determinant for limited proteolysis. In contrast, another
modeling study downplays the significance of substrate flexibility and suggests
that surface exposure of the polypeptide substrate is a better determinant for
predicting sites of limited proteolysis (Novotny and Bruccoleri, 1987). These
differences notwithstanding, a survey of the literature generally favors the notion
that a combination of surface exposure and polypeptide flexibility of the substrate

are highly correlated to the sites of limited proteolysis of proteins (Mihaiyi, 1978
Fontana, 1989).
When a protein is subjected to denaturing conditions, the protein unfolds,
exposing the polypeptide backbone to solution. Because many proteases will
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Figure 1.4

Protease-extended

substrate interactions.

Schematic representation of a possible papain protease-substrate
interaction.
The active site of papain protease is composed of seven subsites,S
located on and numbered from both sides of the catalytic site, C. The
'primed' sites are on the C-terminal side of the catalytic site. The
hexapeptide substrate positions, P, have the s a m e numbering as the
papain subsites they occupy. The arrow points to the target of
proteolytic activity in the substrate (P/P'i scissile peptide bond) by the
enzyme. The dotted lines imply general protease-substrate binding
interactions required for complex formation and efficient hydrolysis.
The length of the complex (25 A) is based on a fully extended substrate
peptide chain. (Adapted from Schechter and Berger, 1967.)
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remain folded and active under mild to moderate denaturing conditions ( H a m e s
and Rickwood, 1989), the target protein will eventually give way to complete
digestion by protease action. This form of digestion, usually referred to as
peptide mapping, has for years facilitated protein identification, cDNA probe
design, and protein sequence verification.
Conversely, subjecting a protein to proteolytic attack under nondenaturing (native) conditions greatly limits the activity of the protease. Under
non-denaturing conditions, the protein is folded, and relevant protein-protein
interactions are maintained. Polypeptide chain that is buried within the protein
structure (such as a globular domain) is inaccessible to proteolytic attack.
Residues that are exposed on the surface of the protein, however, may or may
not resist proteolytic hydrolysis. According to the models discussed above,
conformational flexibility of the polypeptide chain adjacent to the cleavage site is
an important determinant for proteolysis. Thus solvent exposed residues within
an a-helix or p-sheet should show resistance to proteolytic cleavage, whereas
residues within extended flexible loops are expected to be highly susceptible.
The factors discussed above form the basis for using proteases to probe
proteins for structure. There is a long history employing proteases as probes for
structure, from studying conformational changes, protein unfolding and refolding
events as well as for domain elucidation (Mihaiyi, 1978; Hames and Rickwood,
1989). A majority of these studies relied on SDS-PAGE and N-terminal
sequencing methods to analyze the digests. In this thesis, MS analysis is used
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instead. Because of the speed and mass accuracy of M S , a large number of
digests can be performed, revealing a deeper a more complete 'picture' of
proteolytic action on a protein.
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Chapter 2 — Experimental

This chapter details the materials and methods for MALDI-MS analysis
used throughout my thesis research. It continues with the presentation of two
studies concerning properties of the MALDI matrix and the matrix preparation
step, a fundamental stage in the MALDI-MS analysis of peptides and proteins.
Study I concerns the influence of matrix solution conditions on the MALDI-MS
analysis of peptides and proteins. Study II discusses special properties of the
matrix solution.

2.1 Materials
2.1.1 Proteins, Peptides and Oligonucleotides
Max, USF, Hairy, SREBP1, Mef 2C, TAFs 42/62, leptin, TBP, TFIIB, and
elF-4C recombinant proteins were provided by various members of the
laboratory of Stephen K. Burley (Rockefeller University) (see chapters 4 and 5
for sequences of selected proteins). Additional recombinant leptin samples also
came from the laboratory of Jeffrey M. Friedman. Synthetic DNA
oligonucteotides were from the Burley laboratory. Sequences of the proteins
and DNA oligonucleotides and details of their preparation are given in the
material sections found at the beginning of chapters 4 and 5. Dynorphins 1-11,
1-13, and 1-17 (mass calibrants) were provided by the Kreek laboratory. Bovine

29

cytochrome C, ubiquitin and equine myoglobin (protein controls and mass
calibrants) were from Sigma (St. Louis, MO).

2.1.2 Proteases
Sequencing grade endoproteases Arg-C (Clostripain; Clostridium
histolyticum), Glu-C (Staphylococcus aureus V8), Lys-C (Pseudomonas
aeruginosa); and modified trypsin (bovine pancreas) were purchased from
Promega (Madison, Wl). Sequencing grade endoproteases Glu-C, Asp-N
(Pseudomonas fragi) chymotrypsin (bovine pancreas), and subtilisin (Bacillus
subtilis) were obtained from Boehringer Mannheim (Indianapolis, IN). A second
form of sequencing grade Arg-C (mouse submaxillary gland) was purchased
from Sigma. Preparation, storage and specificities of the proteases are given in
Chapter 4.

2.1.3 MALDI Matrix and Matrix Solutions
The matrix used in a majority of the experiments to analyze peptides and
proteins by MALDI-MS was 4-hydroxy-a-cyanocinnamic acid (4HCCA) obtained
from Aldrich (Milwaukee, Wl). 4HCCA was used almost exclusively throughout
the studies because of its excellent sensitivity (Beavis et al, 1992; Chou, et al,
1994). In addition, I found that 4HCCA consistently yielded highly reproducible
results. The 4HCCA was purchased several years ago (lot #HX06228PV) and
was used without further purification. All other lots of 4HCCA from Aldrich or
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Sigma were found to contain high levels of sodium and potassium salts that can
be removed by recrystallization in water-methanol (1:1 v/v).
Other matrices employed were sinapinic (sinapic) acid (SA) (Aldrich) and
2,5-dihydroxy benzoic acid (DHB) (Sigma) that required no further purification.
SA was best for proteins and peptides >2 kDa. DHB was best for analyzing
phosphorylated peptides. Despite the popularity of DHB by some practitioners of
MALDI-MS, I found DHB difficult to use for peptide analysis. The MALDI-MS
signal, when using the DHB matrix, varied from spot-to-spot. I list some of my
observations: (1) The MALDI-MS of a mixture of peptides from an enzyme digest
gave ion peaks for the peptides whose relative intensities differed significantly
from one spot to another of the same analyte-DHB sample. (2) The use of DHB
matrix required much higher laser power than required for 4HCCA to observe
peptide signal —higher laser intensities give rise to broader peaks and lower
resolutions. (3) In contrast to 4HCCA, DHB crystals can neither be 'washed' nor
used in slow crystallization. MALDI-MS of oligonucleotides were usually
performed in 3-hydroxypyridine-2-carboxylic acid (3-HPA) (Lancaster, Windam,
NH). The water for the matrix and sample solution preparations was supplied by
a MilliQ UV Plus water purification system (Millipore, Bedford, MA). Formic acid
(100% HPLC grade) was from Sigma and trifluoroacetic acid (TFA;
HPLC/spectrograde) was from Pierce (Rockford, III). All other acids and organic
solvents were HPLC grade or better.
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2.1.4 Other Materials and Equipment
Cyanogen bromide was from Sigma. n-Octylglucoside was from
Boehringer Mannheim. Pre-weighed amounts of N-octylglucoside were
lyophilized into small Eppendorf tubes and stored desiccated at 4°C until
needed. When DTT and urea was required, solutions were prepared fresh.
Stock solutions of buffers and salts (analytical grade or better) were prepared
and stored at 4°C or RT, normally in 125 mL glass bottles or 20 mL borosilicate
glass scintillation vials (VWR) with plastic caps (avoid aluminum or paper lined
caps). Some buffers required fresh preparation such as ammonium bicarbonate.
Microtubes and pipet tips were of the highest quality. This is a particularly
important point when handling small volumes (few j^L) of sample and matrix
solutions. Mass spectrometry (ESI or MALDI) has a great ability to detect trace

quantities of impurities and contaminants that can interfere partially or completely
with the detection of the analyte. Two sizes of microtubes were used throughout
—0.65 mL polyallomer micro-centrifuge tube (PGS Scientifics, Gaithersburg,
MD) and 1.5 mL microtube (Starsedt, Newton, NC). Avoid the use of colored
microtubes; they appear to contain high levels of contaminants that interfere with
MALDI-MS. Three sizes of microtips (in racks) were used: 100-1000 \A(RT200) and 20-250 \xL (RT20) tips and 1-10 ^iL tips (Eppendorf brand, Fisher
Scientific). Less expensive 1-10 \x\- microtips are available (USA/Scientific
Plastics, Ocala, Fl)but are not as rugged as the Eppendorf brand.
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2.2 Methods
2.2.1 Proteolysis
A complete description of the proteolysis protocols is given in the methods
section of Chapter 4. All protein digests were conducted in 0.65 |iL
microcentrifuge tubes. Typically, 15-30 laL of a 30 faM sample of recombinant
protein in a solution containing buffer and salt was subjected to enzymatic digest
at 25-37°C without any agitation. Enzyme:protein ratios ranged from 1:20-1:100
(w/w). For MALDI-MS analysis, 0.5 ^iL aliquots of the digest solution were mixed
with 15 laL of MALDI matrix solution (see below) after a specified time of
digestion, ranging from 30 s to 2 days. The acidity of the matrix solution (pH < 3)
was sufficient to completely quench any further digestion.

2.2.2 Matrix Solution Preparation
Solutions of cinnamic acid derivatives (4HCCA, SA) were prepared
saturated. They were made at room temperature by adding the solid matrix to
organic solvent, followed by the addition of water and acid (as required).
Microcentrifuge tubes (1.5 mL) were used for the solution preparation. Each
mixture was thoroughly vortexed and centrifuged, leaving a clear, working matrix
solution. The solubility of 4HCCA was dependent on the solvent composition,
ranging from 5 mM (watermethanol, 2:1 v/v), 29 mM (formic
acid:water:isopropanol, 1:3:2 v/v/v) to 74 mM (wateracetonitrile, 1:1 v/v). The
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solubilities were estimated experimentally. Although formic acid can modify
polypeptides through formylation, I have found that matrix solutions which
contained formic acid at levels < 17 % by volume (such as the 1:3:2 v/v/v
solution mentioned above) did not give rise to formylation side reactions. SA
matrix was usually prepared (saturated) in 0.1% TFA:ACN (2:1 v/v) and had
about twice the solubility of 4HCCA dissolved in a solution consisting of the
same solvents. A matrix solution of 4HCCA could be used for up to a week,

although it is advisable to use a fresh preparation for critical work. Sinapinic ac
matrix solution should be prepared fresh each day. When used, DHB matrix
solutions were unsaturated. DHB was first prepared saturated in 0.1%
TFA/ACN, H2O/ACN or H2O /MeOH. The saturated DHB solution is then diluted
1:4 making the working (unsaturated) matrix solution. See elsewhere for more
details on using DHB as a matrix (Qin, 1996). All pH measurements of the
matrix solutions were performed at room temperature with a combination pH
microelectrode (model MI-415; Microelectrodes, Inc., Bedford, NH) and pH meter
(model PHM 95; Radiometer, Copenhagen). The pH was also measured, albeit
less accurately, with pH test strips (pH 0.0-6.0) (Sigma).

2.2.3 Matrix-Analyte Solution Preparation
The most extensively used matrix-sample preparation procedure I used
(for 4HCCA and SA) was the dried-drop method (Karas and Hillenkamp, 1988). I
also used slow (Xiang and Beavis, 1993) and rapid (Weinberger et al., 1993)
crystallization. The methods are shown in Figure 2.1 and discussed below.

34

Figure 2.1 MALDI-MS

matrix crystallization methods

Three methods of matrix crystallization for the matrix 4 H C C A are shown.
Initially, the analyte (protein, peptide or mixture) is dissolved into the matrix
solution in a small microcentrifuge tube. Three procedures can be used to obtain
analyte-matrix co-crystals for deposition on a probe tip for M A L D I - M S analysis
—^slow, dried-drop and rapid crystallization. See text for full details.

SLOW: The matrix-analyte solution is allowed to slowly (4-12 hr) evaporate
directly from the tube. Analyte-matrix co-crystals, formed in the solution during
the evaporation are retrieved and deposited on the probe for M A L D I - M S
analysis.

DRIED-DROP: The matrix-analyte solution is aliquoted onto the MALDI probe tip
and allowed to air evaporate (-4 min) to form a bed of crystals.

RAPID: The matrix-analyte solution is aliquoted onto the MALDI probe tip that is
immediately subjected to vacuum (< 30 millitorr).

The solution quickly

evaporates (-10-15 s) leaving a fine bed of matrix crystals.
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2.2.3.1 Dried-drop Crystallization (Karas and Hillenkamp, 1988): The drieddrop method of matrix crystallization was used throughout except where noted.
In the dried-drop method, a small volume (-1 jaL) of the analyte (e.g., peptide,
protein or enzymatic digest) is mixed with a small volume (-10-30 ^iL) of matrix
solution. Mixing (vortexing) should be performed in 0.65 mL microcentrifuge
tubes. The microtube must be of high quality, free of plasticizers and other
contaminants that can compromise high sensitivity MS measurements. Avoid

the use of colored microtubes. After thoroughly vortexing, a small aliquot (<1 |LIL)
of the matrix-analyte solution is deposited onto the MALDI-MS probe and
allowed to air evaporate (-4 min). Normally, a uniform layer of fine, granular
matrix crystals remain adhering to the probe. The crystals can be washed to
help remove involatile salt residues. Cold water (2-4 |iL) is placed over the
crystals for a few seconds and removed by vacuum suction. (The 4HCCA or SA
matrices are practically insoluble in pure cold water.) The microcrystalline
surface layer is ready for MALDI-MS analysis.

2.2.3.2 Slow Crystallization Method (Xiang and Beavis, 1993): Although quite
tolerant to the presence of involatile additives commonly found in biological
samples (e.g., salts and buffers), the dried-drop method often fails to produce
matrix crystals when the concentrations of additives are very high (i.e., typically
>0.25 M) or liquid additives (e.g., glycerol) exceed a few percent in the matrix
solution. To overcome the shortcomings of the dried-drop method, Beavis
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introduced slow crystallization (Figure 2.1) as an alternate method for obtaining
analyte-doped matrix crystals (Xiang and Beavis, 1993). In the slow
crystallization approach, approximately 15-30 |iL of the sample-matrix solution is
left at room temperature in the microcentrifuge tube. A small hole (~1 mm
diameter) is pierced through the cap of the tube permitting partial evaporation of
the matrix solution. After 4-12 h, a portion of the solution evaporates, leaving
small granular crystals of matrix adhering along the sides of the tube, submerged
in the remaining supernatant solution. I have slightly modified the protocol to
hasten crystallization. Instead of a small hole punched through the top of the
microtube, the tube is left fully open and vortexed for 1-4 hr on a Tomy shaker
(model MT-360, 36-sample microtube mixer; Tomy Tech, Palo Alto, CA).
Vortexing produces a suspension of fine matrix crystals, much finer than the
coarse crystals obtained using the original slow crystallization protocols (without
vortexing). After crystals have formed, the tube is centrifuged, the supernatant
removed, cold water is added and vortexed briefly to wash the crystals. The
washing/centrifuging steps are repeated 2-3 times. The crystals are scraped off

the walls of the tube with a small pipette tip and taken up in ~1 |iL of water that i
deposited directly onto the MALDI probe tip. Evaporation of the water leaves a
bed of matrix crystals adhering to the probe ready for MALDI-MS analysis.

2.2.3.3 Rapid Crystallization Method (Weinberger et al., 1993): An aliquot
(0.5 |iL) of the sample-matrix solution is deposited onto the MALDI probe tip
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which Is immediately introduced into a vacuum (-20-30 mtorr) that is maintained
by a mechanical rotary pump. The Speedvac (model SC110, Savant Inst. Co.,
Farmingdale, NY), used without centrifugation, is a convenient tool for this
protocol. Secure a clean aluminum MALDI probe tip to its holder. Place the
holder into the Speedvac, spot the matrix solution onto the probe tip and
immediately close the lid to the Speedvac and apply vacuum. Viewing through
the transparent cover of the Speedvac instrument, the evaporation was complete
within 10-15 s leaving a fine, powdery layer of matrix crystals. With evaporation
times much beyond 20 s, the effects attributed to rapid crystallization (discussed
in Study I) become less pronounced. Peptides and proteins analyzed using the
rapid crystallization method tend to exhibit extensive alkali cation adduction. The
adduction is reduced by rinsing the crystals on the probe 3-4 times with portions
(-5 jaL) of cold water.
Investigation of the matrix-analyte preparation and crystallization steps
developed into a major study, the results of which had significant impact on the
research described in my thesis. I devote two separate sections to these matrix
solution studies at the end of this chapter

2.2.4 Mass Spectrometry

2.2.4.1. MALDI-MS-lnstrumentation: MALDI-MS was performed on a linear
time-of-flight device constructed earlier at Rockefeller by Chait and Beavis
(Beavis and Chait, 1989; Beavis and Chait, 1990a; Beavis and Chait, 1990b).
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The bare essentials of the instrument consist of an ion source, a flight tube and a
ion detector (discussed in more detail in chapter 1 and Figure 1.2). The three
Chait and Beavis papers (above) describe the instrument in full detail. A good
source for practical information concerning MALDI-MS can be found in Beavis
and Chait (1996). Here I will discuss aspects of the instrument that were
particularly relevant for my thesis research.

2.2.4.2 The MALDI Probe: Sample introduction into the ion source was via a
sample probe. The probe was essentially a metal rod at the end of which was
secured a sample probe tip. Aliquots (0.5-1 fiL) of analyte-matrix solutions were
deposited onto the probe tip for the dried-drop and rapid crystallization methods.
Matrix crystals taken up in liquid were placed on the probe for the slow
crystallization method (see Figure 2.1). I accumulated in excess of eight
thousand spectra over a four year period, so the probe tip design had a
significant impact on speed and ease of data collection. For example, MALDIMS measurements made before Dec, 1994 were performed using a single-stage
stainless steel sample probe tip (~2 mm diameter), whereas all subsequent
measurements were made using a 10-position aluminum multiple probe tip. The
ability to perform MALDI analysis on up to ten samples per introduction into the
ion source with the multiple tip proved to be an invaluable experimental feature.
The multiple probe design was based on contributions from all members of the
laboratory. The probe assembly and probe tips were constructed by John
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Doherty, supervisor of the Rockefeller University Instrument Shop.

A large

number of the aluminum sample probe tips were fabricated at low cost, allowing
storage of selected samples for re-analysis, if necessary.
A note concerning the multiple probe tips. Cleaning of the tips (using
gloves) is as follows. Rinse tip with acetone and methanol (from wash bottles),
then sand the surface of the tip, face down, with 4/0 grade emery paper
(Gamzon Bros., Inc., 21 W. 46th Street, NYC) wetted with isopropanol. Rinse
with acetone/MeOH, repeat sanding, rinse again and wipe with Kimwipe. DO
NOT USE WATER FOR CLEANING THE PROBE! (Water-cleaning of the probe
results in MALDI mass spectral peaks with extensive copper adduction,
especially if the matrix solution is 4HCCA + TFA/ACN or H20/ACN)). Dab a bit
of Apiezon high vacuum grease "L" (Manchester, England) onto the clean, dry
tip surface, wipe across whole surface and rub off to leave a ultrathin layer of
grease. The grease is necessary to prevent excess spreading of certain
solvents having low surface tensions, particularly formic acid and isopropanol.
The grease doesn't produce problematic background peaks in MALDI-MS at the
pmol sensitivity level. In lieu of the grease, the probe tip can be rubbed hard
across a piece of Teflon a few times. A thin layer of Teflon coats the surface.
However, I find copper adduction peaks (especially using water/acetonitrile
matrix solution) more prevalent in the MALDI spectra run from Teflon-coated
than from the grease-coated tips. (I am grateful to Dr. Ivan Haller of the
Rockefeller Mass Spectrometry group for suggesting the Teflon-coating Idea.)
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2.2.4.3. General Instrument Conditions: A prepared probe tip w a s inserted
into the ion source and allowed to reach high vacuum. Background pressure
within the instrument, measured by an ion gauge located below the source,
normally reached better than 5 x 10'^ torr. A Neodymium:YAG laser (Lumonics
Inc., Ontario, Canada) was set to deliver 355 nm wavelength pulses
(approximately 10 ns duration) onto the sample at a rate of 2.5 Hz. Each laser
shot produced a full mass spectrum. The spectra presented in this thesis
represent averages of 100-200 laser shots. Averaging improved the signal-tonoise ratios and sampling statistics. The ion acceleration potential was +30 kV
and the flight tube length was 2 m. An electrostatic particle guide mounted
within the flight tube was used to compensate ion beam divergence and maintain
good sensitivity levels when analyzing proteins, lon detection and signal
amplification was through a conversion microchannel plate detector-discrete
dynode multiplier assembly (Beavis and Chait, 1991). The multiplier voltage
ranged between 3.5-4 kV; the higher voltages are appropriate for proteins and
high sensitivity measurements.

2.2.4.4. Data Collection. Signal from the electron multiplier was amplified and
sent to the data collection system. For MALDI spectra collected before Aug.,
1995, the amplified signal from single laser shots was visually monitored with a
digital oscilloscope (model 7200A, LeCroy Corporation, Chestnut Ridge, NY).
Simultaneously, the signal was digitized by a transient recorder (LeCroy, model
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TR8828D) and stored as time-of-flight data on a Vax 4000 workstation (Digital
Equipment Corporation, Woburn, MA). The data was viewed and manipulated
using the program APPLE written by Ronald Beavis and modified by Wenzhu
Zhang and David Fenyo. For MALDI spectra collected after Aug. 1, 1995, the
digital oscilloscope was a Model 9350M, (LeCroy) and the mass spectra were
collected on a Pentium PC using the program AQUIRE in a Windows (3.1, 95 or
NT) environment. The collected spectra were viewed on the PC using the
program M/Z, which is publicly available on the World Wide Web (URL
http://mcphar04.med.nyu.edu/software/contents.htm). Both AQUIRE and M/Z
were written by Ronald Beavis and were quite powerful and simple to use. Like
the multiple probe, the AQUIRE and M/Z programs greatly facilitated my
research. Spectra collected on the VAX is also readable by the program M/Z.
Mass spectra run on M/Z can be conveniently converted into 'metafiles' for
import into Microsoft Powerpoint graphics program. All 8000+ spectra are

digitally stored (archived) on a single 1.2 Gbyte Verbatim Optical Disk (Club Mac

Irvine, CA). Access to the files (spectra, papers, etc.) stored on the Optical Dis
is through the Silicon Graphics computer (SGI) using protocols written by Ruud
Steenvorden. Files can be transferred between computers on the internet via
FTP. In the future, all of my files will also be stored on a recordable CD.

2.2.4.5 Mass Calibration: Raw data collected from the MALDI instrument
(either on the VAX or PC) was in the form of time-of-flight data. The TOF data
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was mass converted either by external calibration or by using internal ion peaks
of known mass — o n the V A X using the A P P L E program or on the P C using M/Z.

2.3 Study I: Influence of Matrix Solution Conditions on the
M A L D I - M S Analysis of Peptides and Proteins.

The matrix-analyte preparation step required an extensive investigation in
order to optimize the M A L D I - M S analysis of the complex peptide mixtures
produced by enzymatic digests of proteins. The results of this study impacted
greatly on m y research. I devote the rest of this chapter to detailing this study
(Cohen and Chait, 1996).

2.3.1 Background
There are many factors that influence the quality of MALDI mass spectra.
Because M A L D I - M S is a relatively new technique, many of these factors have
been little explored. For example, it is generally accepted that the matrix solvent
composition and sample-matrix preparation procedures greatly influence the
MALDI-MS response. To date, a number of different sample-matrix preparation
methods have been developed, such as the dried-drop (Karas and Hillenkamp,
1988) and slow crystallization procedure (Xiang and Beavis, 1993) (discussed
above and shown in Figure 2.1). Slow crystallization represented a significant
improvement over the dried-drop method in the tolerance of M A L D I to high levels
of involatile additives (Xiang and Beavis, 1993). In addition, I have observed
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other features of slow crystallization that proved to be important for the matrixsolution study (described below) as well as for the development of methods to
analyze whole proteins from gels using MALDI-MS (Chapter 3). More recent
studies have demonstrated the uses of a polycrystalline thin film of matrix as a
useful preparation procedure (Vorm et al., 1994; Xiang and Beavis, 1994).
There are other factors such as the choice of matrix (Chou et al., 1994; Gusev et
al., 1995) and matrix additives (Billed and Stults, 1993; Gusev et al., 1995) that
have been claimed to significantly influence the MALDI-MS response of peptides
and proteins. The additives consist of simple sugars such as fucose. I've had
little success in obtaining any positive results using the matrix additive fucose.
Despite over five years of development of MALDI-MS, an understanding of the
influences of other factors such as the matrix solvent composition on the quality
of the MALDI spectra have been lacking —much of the knowledge of these
factors has been anecdotal. To this end, I undertook a detailed investigation of
the matrix 4HCCA. Dramatic mass discrimination effects in the MALDI-MS
response of peptides, proteins and their mixtures were observed. The
discrimination effects are greatly influenced by the composition of the
sample-matrix solution, the solution pH, and the time scales used for growing the
sample-matrix co-crystals. My findings provided guidance to optimize samplematrix preparation procedures, permitting successful analysis of the majority of
components in complex mixtures of peptides and proteins.
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2.3.2 Results
2.3.2.1 Effects of the Matrix Solution Composition
I have found striking effects of the matrix solution composition on the
MALDI-MS of peptide and protein mixtures. An example of these effects is
illustrated in Figure 2.2, which compares mass spectra of a mixture consisting of
peptides and proteins prepared in three different 4HCCA matrix solutions using
the dried-drop method (Karas and Hillenkamp, 1988) (see Method section). The
mixture of peptides was prepared by partial V8 digestion of b/HLH/Z Max (10.8
kDa) (Cohen et al, 1995). b/HLH/Z Max is the DNA binding domain of the Max
proto-oncogenic transcription factor (Prendergast et al, 1991; Blackwood and
Eisenman, 1991) (see Chapter 4). Figure 2.2a shows the mass spectrum of the

digest obtained from a matrix solution consisting of 1:3:2 (v/v/v) mixture of formi
acid:water:isopropanol (pH 1.3) saturated with 4HCCA. I refer to this formulation
as FWI. The FWI matrix solution was originally developed by Klaus Schneider in
the Chait laboratory (Martin de Llano et al., 1993) and has been used with
considerable success by myself and others in the laboratory for protein analysis.
Figure 2.2b shows the results obtained from a saturated 4HCCA solution made
with a 2:1 (v/v) mixture of 0.1% trifluoroacetic acid:acetonitrile (TFA/ACN) with
pH 2.0. The TFA/ACN matrix solution formulation is commonly used for peptide
and protein analysis by many practitioners of MALDI-MS (Beavis and Chait,
1990a). A comparison of Figures 2.2a-b shows that the MALDI response from
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Figure 2.2 MALDI-MS

of peptide mixture using different matrix solutions.

Comparison of the positive ion M A L D I mass spectra of the partial V 8 digest of
b/HLH/Z M a x obtained from three different 4 H C C A matrix solutions using the
dried-drop method.

The matrix solution compositions consist of (a) formic

acid:water:isopropanol (1:3:2 v/v/v); (b) 0.1% trifluoroacetic acid:acetonitrile (2:1
v/v); and (c) wateracetonitrile (2:1 v/v). Both partial and complete digest
fragments are observed. Peaks that are marked 1+, 2+, and 3+ designate
singly, doubly, and triply protonated undigested Max. Peaks arising from singly
protonated fragments are marked by stars (*); multiply protonated fragments are
denoted by crosses (+). The sequences of the fragment ions are given in
Figures 4.5b,c.
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the sample prepared in the FWI solution favors the appearance of high mass
components (>6 kDa) compared to the response from that prepared in the
TFA/ACN solution. The third spectrum (Figure 2.2c) was obtained from a
saturated 4HCCA solution consisting of a 2:1 (v/v) mixture of water:acetonitrile
(pH 2.5), where the acidity derives from the moderately acidic 4HCCA matrix
(PKA ~4 in water). This latter preparation yields a spectrum dominated by low
mass (<2 kDa) but devoid of high mass peaks (>6 kDa). I have analyzed partial
digests of many other proteins including cytochrome C, TAFs 42/62, USF, and
leptin using the three 4HCCA matrix preparations described above and have
found mass discrimination effects similar to those presented in Figure 2.2
The differences in the MALDI response in Figure 2.2 can be attributed to
factors relating to the matrix solution composition and pH. These effects were
further explored by examining the mass spectrometric response of the Max
digest using a large variety of matrix solution compositions (Table 2.1). The
acidities of these matrix solutions range from pH 1.1 (4HCCA/0.1N
HCI/acetonitrile) to pH 2.9 (4HCCA/water/methanol). The results listed in Table
2.1 follow the same trends observed in Figure 2.2, showing a strong correlation
between the matrix solution acidity and the MALDI-MS response to the different
components in the digest. Highly acidic matrix solutions (pH <1.8), regardless of
the identity of the added acid or organic solvent, showed weak or no signal for
peptides <2 kDa and mainly favored the appearance of components with
masses >2 kDa. In addition, matrix solutions that contained formic acid
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T A B L E 2.1 Effects of matrix solution composition and pH on the MALDIMS of a complex mixture of peptides^
ComDOsition of 4HCCA Solution

pH

Response^

0.1 NHCI/ACN(2:1)''

1.1

(1), I h

1 % T F A / A C N (2:1)

1.1

(1), 1, h

Formic acid / Water /ACN (1:3:2)

1.1

(i), i, h

Formic acid / Water / IPA (1:3:2)

1.3

(1), i, b

0.5% T F A / A C N (2:1)

1.4

(1), 1. h

Formic acid / Water M e O H (1:3:2)

1.6

(1), i, b

0.01NHCI/ACN(2:1)

1.9

1,1, h

Formic acid / Water / IPA (0.2:3:2)

2.0

1.1, h

0.1 % T F A / A C N (2:1)

2.0

U, h

0.1 % T F A / M e O H (2:1)

2.0

l,lh

0.1 % TFA/IPA (2:1)

2.1

1,1, h

2 M Acetic acid/ACN (2:1)

2.3

U,h

Water/ACN (1:1)

2.4^

1, i, (h)

Water/ACN (2:1)

2.5^

1, i. (h)

Water/IPA (2:1)

2.7^

1, i. (h)

Water/EtOH (2:1)

2.8^

1, i. (h)

Water/MeOH (2:1)

2.9^

1. i, (h)

a. Peptide mixture is a partial V 8 digest of b/HLH/Z M a x protein (see chapter 4).
b. The matrix solutions were prepared by volume.
c. Response refers to a measure of relative peptide intensity, estimated from the
m a s s spectra obtained for each matrix solution. T h e response is divided over
three m a s s ranges designated by the letters I = low (0.8 - 2 kDa); i =
intermediate (2 - 6 kDa); h = high ( 6 - 1 1 kDa). For each solution the three
m a s s ranges (I, i, or h) are assigned a response level — t h e underlined letter
in boldface designates the m a s s range exhibiting the strongest relative
response; letters in normal face indicate a moderate response and the letter in
parenthesis indicates a w e a k or no response.
d. T h e acidity of these solutions derives from the moderately acidic 4 H C C A
(PKA-4).
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and whose p H w a s <1.8 consistently yielded the strongest response to high
mass components. Matrix solutions with pH between 1.8-2.3 exhibited mass
spectrometric peaks that spanned the greatest latitude in mass range, although
tending to favor the low and intermediate over the high mass components. The
matrix solutions with pH >2.3 (i.e., no added acids), regardless of the identity of
the organic solvent, consistently showed few components above 6 kDa and
strongly favored the appearance of peptides below 2 kDa.

2.3.2.2 Effects of the Detergent n-Octylglucoside
I speculated that the above-described pH-dependent discrimination
effects (Figure 2.2 and Table 2.1) may arise from differences in polypeptide

solubility, and tested this hypothesis by monitoring the effects of the addition of
n-octylglucoside on the MALDI-MS response of the V8 digest of b/HLH/Z Max.
n-Octylglucoside is a non-ionic detergent that is known to aid in polypeptide and
protein solubilization (Baron and Thompson, 1975). It has been previously
shown that the presence of n-octylglucoside in the matrix solution enhances the
MALDI-MS response of a large peptides in digest mixtures (Vorm et al., 1993).
Figure 2.3 displays the MALDI spectra of the V8 digest of the Max protein. The
spectra were obtained from a 4HCCA/water:acetonitrile (2:1 v/v) matrix solution
in the absence (Figure 2.3a) and presence (Figure 2.3b) of 20 mM
n-octylglucoside. In the absence of detergent from the matrix solution, highmass discrimination effects are observed. In the presence of n-octylglucoside,
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Figure 2.3 Effects of detergent on MALDI-MS

of a protein digest.

Effects of n-octylglucoside on the MALDI mass spectra of a partial (2 min)
V 8 digest of b/HLH/Z Max. Spectra were obtained from a matrix solution
consisting of 4HCAA-water/acetonitrile (2:1 v/v) in the (a) absence or (b)
presence of 2 0 m M n-octylglucoside using the dried-drop method of
matrix crystallization. S e e Figure 2.2 caption for a full description of the
symbols.
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the high mass discrimination effects are significantly reduced. Virtually all of the
high mass polypeptides are 'restored' in the spectrum (Figure 2.3b), which
strikingly now closely resembles the spectrum obtained using the FWI matrix
solution (Figure 2.2a). These results suggest that the observed pH-dependent
matrix solution mass discrimination effects may be related to polypeptide
solubility.

2.3.2.3 Effects of Droplet Evaporation
I suspected that the evaporation of the droplet of matrix solution was
accompanied by a change in pH, an effect that may influence the incorporation
of analyte into the matrix crystals. Initial evaporation of the drop involves
preferential loss of organic solvent. As the organic solvent evaporates, the
solubility of the matrix, a moderately weak acid, falls sharply. A simple
relationship describing the matrix dissolution and dissociation in a solution of
water/acetonitrile is given in equation 1.

Crystallization Dissolution Dissociation
MH (s) + H2O/ACN ^ MH (aq) + H2O/ACN ^ M- (aq) + H3OVACN (1)

In equation 1 the matrix (M), with its acidic hydrogen, is denoted as MH.
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I performed a simple experiment to measure the p H of evaporating drops

of matrix solution. In this experiment, the pH of droplets of matrix solution (initia
volume, 5 i^L) was monitored as they were allowed to air evaporate at room
temperature. A glass microelectrode measured the pH. Results of the
experiment are given graphically in Figure 2.4, which shows droplet pH as a
function of time. The results indicate that matrix solutions prepared without
added acid (e.g., 4HCCA in H2O/ACN) experience an increase in pH as the
droplet evaporates. In contrast, Figure 2.4 shows that matrix solutions with
added acids (e.g., 4HCCA in FWI or TFA/ACN) experience a decrease in pH
with droplet evaporation. I rationalize these results as follows. In the absence of
added acid, the matrix is the dominant source of H3O* in the droplet (Eq. 1). As
organic solvent evaporates, Eq. 1 is driven towards the left (i.e., matrix
crystallization) resulting in the removal of H3O* from solution and pH elevation.
In contrast, the presence of added (strong) acids ensures a high concentration of
H^0\ As organic solvent evaporates and Eq. 1 is driven towards the left, the
strong acids remaining in the droplet maintain the supply of H3O* ions. The H3O*
ions concentrate in the shrinking droplet, leading to the decline in pH.
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time (minutes)

Figure 2.4 pH profile of an evaporating drop of matrix solution.
The pH profile of evaporating drops (5 |xL initial volume; RT) of
three different matrix solutions (saturated with the matrix 4 H C C A )
monitored by a pH microelectrode. The matrix solutions consisted
of the following solvents: water/ACN (2:1 v/v) (diamond symbols);
0.1 % T F A / A C N (2:1 v/v) (square); and formic acid/
water/isopropanol (FWI) (1:3:2 v/v/v) (triangle). Evaporation w a s
nearly complete by -6 min for the water/ACN and 14 min for the
other two matrix solutions.
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2.3.2.4 Effects of the Rate of Matrix Crystal Growth
In addition to the matrix solvent composition, and pH changes during
droplet evaporation, I have found that an important element of the sample-matrix
preparation procedure is the rate at which matrix crystallization occurs. The
most commonly used strategy to grow analyte-doped matrix crystals involves
variations of the dried-drop method, a procedure that usually depends on a
moderately quick (minutes) and complete evaporation of a small drop (-1 |LIL) of
analyte-containing matrix solution (Karas and Hillenkamp, 1988). A second
approach in growing matrix crystals is slow matrix crystallization (Xiang and
Beavis, 1993), a method in which a moderate volume of matrix solution (--15 |iL)
is allowed to slowly (hours) and partially evaporate, a process that is
accompanied by matrix crystal formation within the remaining matrix solution. A
third approach involves a rapid (seconds) and complete evaporation of a small

drop of matrix solution (~1 )LIL) to obtain matrix crystals (Weinberger et al., 1993).
Using the three matrix preparation methods, I explored the effect on the
MALDI-MS response when utilizing the three different time scales described
above to grow analyte-doped matrix crystals. An example is given in Figure 2.5,
which compares MALDI spectra of a peptide mixture using the slow, dried-drop
and rapid crystallization methods for two different matrix solution compositions.
The peptide mixture derives from a complete V8 digest of b/HLH/Z Max. The
complete digest of Max produces principally six peptide fragments, labeled 1 - 6
in Figure 2.5. The mass spectra in Figures 2.5a-c were obtained from a sample-

54

matrix solution m a d e from the 4HCCA/formic acid:water:isopropanol (1:3:2 v/v/v)
(FWI) formulation, while spectra in Figures 2.5d-f were obtained from a samplematrix solution made from 4HCCA/water:acetonitrile (2:1 v/v). The spectrum in
Figure 2.5a, obtained from the FWI matrix solution using slow crystallization,
shows exclusively high mass peptide fragments 5 and 6 and is dominated by the
latter. No traces of fragments 1-4 appear in the spectrum. The spectrum in
Figure 2.5b, obtained from the same FWI solution using the dried-drop method,
also only shows fragments 5 and 6. In stark contrast, the spectrum in Figure
2.5c, obtained from the FWI solution using the rapid crystallization technique,
shows all six fragments, a strong indication that rapid matrix crystallization can
'overcome' the low mass discrimination effects observed from either slow
crystallization (Figure 2.5a) or the dried-drop methods (Figure 2.5b).
Results using the 4HCCA/water-acetonitrile matrix solution (Figures
2.5d-f) reveal characteristics similar to those observed with FWI. The spectrum
in Figure 2.5d, obtained using slow crystallization, shows only the two high mass
fragments 5 and 6 (cf. Figure 2.5a) whereas the spectrum in Figure 2.5a,
obtained from the dried-drop method, shows all 6 fragments. The spectrum in
Figure 2.5f, obtained from rapid crystallization, exhibits all six fragments and is
dominated by the lower mass fragments 1-4.
The results illustrated in Figure 2.5 indicate that the rates of matrix crystal
growth have striking effects on the MALDI-MS response of different mass
components in a polypeptide mixture. I have performed similar experiments with

55

Formic Acid-Water-IPA

Water-ACN

' d '
Slow

'I
3

JL_
e

4

Dried
Drop

iilu I
3

C

Rapid
12
6

5
2000

3000

m/z

L
2000

5

6

3000

m/z

Figure 2.5 Effects of the rate of matrix crystal growth on the
of a protein digest.

MALDI-MS

Positive ion spectra of the complete V 8 digest of b/HLH/Z M a x obtained from
two matrix solutions: (a-c) 4HCCA-formic acid/water/isopropanol (1:3:2 v/v/v)
and (d-f) 4HCCA-water/acetonitrile (2:1 v/v). Results using three rates of
matrix crystallization are illustrated: top panels (a,d), slow crystallization;
middle panels (d,e), dried-drop; and bottom panels (c,f) rapid crystallization. A
complete V 8 digestion of M a x results in six fragments that appear in the
spectra as singly protonated peptides (labeled 1-6).
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other polypeptides including a synthetic peptide ladder and enzymatic digestions
of human leptin. The results from these experiments mirror the findings
illustrated in Figure 2.5.

2.3.2.5 Mass Discrimination Effects between Proteins
I have shown that there are appreciable MALDI-MS mass discrimination
effects from complex mixtures of peptides and proteins (Figures 2.2-2.5). The
components of these mixtures ranged in mass from 0.8 to 11 kDa. I have also
observed strong mass discrimination effects between small proteins whose mass
differ from each other by < 1 kD. An example of this phenomenon is illustrated in
Figure 2.5, which compares spectra run under various conditions of a protein
that consists of two non-covalently interacting subunits with molecular masses
9.0 kDa and 9.9 kDa. These subunits are recombinant, truncated forms of the
Drosophila proteins TAF62 (p62) and TAF42 (p42), factors that have been
implicated in activated transcription (Kokubo et al., 1994) (also see chapter 5).
The proteins share similar amino acid composition: the number of positively
charged residues in p42 & p62 are 14 & 14, respectively; negatively charged
residues 13 & 11; polar uncharged residues: 21 & 22; non-polar residues: 38 &
36. The pi (isoelectric point) values were also estimated (Sillero and Ribeiro,
1989) p42, pl=6.5 and p62, pl=9.9.
Figure 2.6 compares the MALDI response of the proteins using two matrix
crystallization methods run in three different matrix solution preparations. Figure
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2.6a-c shows results of the dried-drop method, while Figures 2.6d-f shows
results using the slow crystallization procedure. The three preparations consist
of 4HCCA in formic acid:water:isopropanol (1:3:2 v/v/v; FWI) (Figures 2.6a & d);
0.1% TFA:acetonitrile (2:1 v/v; TFA-ACN) (Figures 2.6b & e); and TFA-ACN with
8 mM n-octylglucoside (Figures 2.6c & f). The spectra reveal dramatic
discrimination effects that are influenced by the matrix solution composition and
the rates of growth of the matrix crystals. The spectrum obtained from the FWI
matrix solution and the dried-drop method (Figure 2.6a) shows results that
approach the 1:1 stoichiometry expected for the p42 and p62 subunits of the
protein. In contrast, the spectrum obtained from the TFA-ACN matrix solution
using the dried-drop method (Figure 2.6b) shows a strong signal from p62 and a
weak signal for p42. The addition of n-octylglucoside to the TFA-ACN matrix
solution restores the response of p42 (Figure 2.6c) to levels similar to that
observed with FWI (Figure 2.6a). I contrast the dried-drop results (Figure 2.6a-c)
with the findings using slow crystallization (Figures 2.6d-f). Again, discrimination
effects are observed between the two proteins, but surprisingly in reversed order
compared to the dried-drop method (compare Figure 2.6a with d and b with e).
The addition of n-octylglucoside in the TFA matrix solution again restores the
response of the discriminated subunit—this time p62 (Figure 2.6f).
I have observed discrimination effects using other 4HCCA matrix solution
compositions (such as those listed in Table 2.1) between p42 and p62 as well as
for other proteins (e.g.. Max, TATA binding protein and TFIIB). In general, for
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Figure 2.6 Mass discrimination effects between proteins in MALDI-MS.
Mass discrimination effects between truncated forms of the proteins T A F 42
and TAF 62 (labeled as p42 and p62 in the spectra). MALDI mass spectra
were obtained using the dried-drop method (left column) or the slow
crystallization method (right column). Spectra were obtained from three
4 H C C A matrix solutions: top panels (a,d), formic acid/water/isopropanol (1:3:2
v/v/v); middle panels (d,e), 0.1% TFA/ACN (2:1 v/v); and bottom panels (c,f),
0.1% TFA/ACN (2:1 v/v) with 8 m M n-octylglucoside (NOG). Only a portion of
the spectra that display the singly protonated proteins is shown.
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mixtures of proteins of comparable masses that exhibit a propensity towards the

discrimination effects illustrated in Figure 2.6, I find that: (1) matrix solutions that
are prepared with formic acid and whose pH is < 1.8 are particularly effective in
yielding MALDI spectra that more closely reflect the true stoichiometries of the
proteins in solution; (2) matrix solutions containing TFA, acetic acid or HCl
exhibit a tendency towards mass discrimination between the proteins; and (3) a
moderate level of n-octylglucoside in the matrix solution can often reduce the
mass discrimination effects.

2.3.3 Discussion
I have demonstrated that MALDI-MS analysis of complex mixtures of
polypeptides (using the matrix 4HCCA) is accompanied by strong mass
discrimination effects that are related to the sample-matrix preparation
procedures. These effects are highly dependent on the rates at which the
sample-matrix co-crystals are grown —slow, rapid or intermediate (dried-drop).

2.3.3.1 Slow Matrix Crystallization (hours)
The slow crystallization procedure favors the appearance of high mass
components of complex mixtures, regardless of the matrix solution composition
and pH (see Figures 2.5a & d). I hypothesize that during matrix crystallization,
polypeptide components partition between the growing matrix crystal lattice and
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the bulk solution. The tendency to partition between the crystal and the solution
suggests a resemblance to the partitioning of polypeptides between a reversephase column and the solution phase in reverse-phase liquid chromatography.
This idea is based upon a detailed physico-chemical investigation of the matrix
sinapinic acid (a cinnamic acid derivative) undertaken by Beavis and Bridson
(Beavis and Bridson, 1993). In this study the authors showed that polypeptides
were attaching to the (103) face of the growing matrix crystal, a surface that was
determined to be non-polar. They thus believed that 'hydrophobic' interactions
could be a significant mode of polypeptide attachment to the matrix crystal.
Borrowing from the concepts of reverse-phase liquid chromatography, the
propensity of a polypeptide to adhere to the matrix crystal lattice would be a
function of the mass of the peptide, a relationship that is consistent with our
findings that show crystallization strongly discriminates against the incorporation
of low mass components of mixtures.

2.3.3.2 Rapid Matrix Crystallization (seconds)
The rapid crystallization method favors the appearance of low mass
peptides, regardless of the composition or pH of the matrix solution (Figures 2.5c

& f). I believe that under rapid crystallization conditions, there is insufficient time
for extensive partitioning of peptide components between the growing matrix
crystal and the solution phase (as postulated for slow crystallization). Under
these circumstances both low and high mass components in solution quickly
become 'captured' in the matrix crystals, a phenomenon that would be largely
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independent of the matrix solution composition and pH. Spectra obtained from
rapid crystallization of complex mixtures of peptides show a relatively stronger
response for low mass than for high mass peptide components. The difference
in response between high and low mass peptides probably reflect a greater
MALDI-MS sensitivity for the low mass peptides.

2.3.3.3 Dried-drop Matrix Crystallization (minutes)
Unlike the findings observed from the slow and rapid crystallization
methods, the dried-drop method exhibits strong pH- and composition-dependent
mass discrimination effects (Figures 2.2, 2.3, 2.5b & e and Table 2.1). I cannot
fully rationalize these results. Although the microscopic events within a small
drying drop of matrix solution have not been well characterized, a number of
phenomena are likely to be important. (1) The organic solvent is expected to
volatilize quickly from a drying drop of matrix solution, hastening matrix
crystallization and leaving the solution enriched in the aqueous phase. (2) The
pH of the droplet changes during its evaporation (Figure 2.4). (3) Related to (1)
and (2) above are polypeptide solubility and a partitioning between the solution
and matrix crystal phases. The results using n-octylglucoside suggest that
polypeptide solubility may play an important role in the discrimination effects,
especially from matrix solutions with pH > 2.3 (Figure 2.3). In addition, peptide
solubility may be the reason for the particular benefits of using formic acid in the
matrix solution, since formic acid is known for its strong polypeptide solvating
properties (Heukeshoven and Dernick, 1982). (4) It is not clear why highly
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acidic matrix solutions (pH < 1.8), regardless of the identity of the acid, would
cause discrimination against the low mass peptides (cf. Figures 2.5b & e). The
low mass discrimination may reflect a partitioning phenomenon as described for
slow crystallization. In this scheme, low mass peptides would favor remaining in
the acidic matrix solution instead of partitioning into the growing matrix lattice. It
is also not clear how the changing pH of the drying drop would affect the
partitioning events.
There are other factors that influence the MALDI-MS response, including
peptide polarity and basicity (Liao and Allison, 1994). I and others have found
that highly acidic peptides often yield poor or no response by MALDI-MS (Juhasz
and Biemann, 1994). The matrix solution discrimination effects that I have
characterized are observed irrespective of these other factors.
I include a note pertaining to the interpretation of my findings as it
concerns quantitation and relative vs. absolute intensity of mass spectral peaks.
First, my data interpretation has been based on the premise that the matrix
preparation procedures affect mainly the extent to which an analyte incorporates
into the matrix and on the assumption that such incorporation does not
significantly effect the laser desorption and ionization properties of the analyte.
Second, accurate quantitation of peptides and proteins by MALDI-MS is often
quite difficult, highly dependent on the laser fluence levels and the nature of the
polypeptide (unpubl. results and Tang et al., 1993). In all of my experiments the
laser fluence was set slightly above the desorption/ionization threshold and
varied only marginally between each sample. I have reduced the dependence
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on quantitation and on the need for absolute sensitivity measurements by relying
on comparative analyses of the mass spectra of samples consisting of the same
components and interpreting the data based on changes in the relative peak
heights. Any small variation in laser fluence did not greatly affect the relative
intensities.

2.4 STUDY II: Special Properties of the 4HCCA/FWI Matrix Solution

2.4.1 Effects of Additives on the MALDI-MS of Proteins
There are special attributes concerning the 4HCCA/FWI matrix solution in
addition to those discussed in the previous section. (1) 4HCCA/FWI was a
rather 'robust' matrix. In the face of elevated levels of involatile additives, FWI
out-performed the TFA/ACN matrix combination for protein analysis. An
example is seen in Figure 2.7 which shows the MALDI-MS of a recombinant form
of the eukaryotic initiation factor 4E (elF-4E) binding protein (a.k.a. the small
RNA cap-binding protein) (22.1 kDa). The protein sample contains polyethylene
glycol (PEG) 4000, a commonly employed precipitating agent used in protein
crystallization trials. The concentration of PEG in the matrix solution, after
addition of protein, was about 2% by volume. The MALDI-MS results using the
dried-drop method of matrix crystallization (Figures 2.7a-b) are quite striking.
The TFA/ACN matrix solution spectrum (Figure 2.7a) is dominated by PEG
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Figure 2.7 Effects of polyethylene glycol on MALDI-MS of proteins.
MALDI-MS of a recombinant form of the small R N A cap binding protein
(22.1 kDa). The matrix solvent composition and crystallization procedures
effect the MALDI-MS response of the protein. The matrix solutions contain
- 2 % (by volume) polyethylene (PEG) 4000. 4 H C C A matrix solution and
crystallization methods are: (a) 0.1% TFA/ACN (2:1 v/v) by the dried-drop
method; (b) Formic acid/water/isopropanol (FWI) 1:3:2 (v/v/v) by the dried
drop method and (c) FWI by the slow crystallization method. P E G polymer
(P) appears as a broad distribution of peaks (inset in a) centered at m/z 4358.
Individual peaks within the polymer cluster are separated by 44 Da (C2H4O).
The protein appears as a singly (1+) and multiply charged species (2+-5+).
65

polymer peaks and hardly shows any protein signal. In contrast, the FWI matrix
solution shows a reduction in the signal from the PEG, but now with strong signal
from the elF-4E protein (Figure 2.7b). Slow crystallization (Xiang and Beavis,
1993) from the FWI matrix solution improves the signal-to-noise even further
(Figure 2.7c). (Slow crystallization will be discussed more extensively in chapter
3.)
The 'robustness' of the 4HCCA/FWI matrix combination has proven to be
quite beneficial in many situations, most significantly in the analysis of protein
crystals used for high resolution X-ray crystallographic structural studies. I have
use MALDI-MS to determine protein homogeneity, degradation products, and
stoichiometry (for multi-component structures) of the mother liquor as well as the
protein crystals for a number structural studies. The mother liquor or the protein
crystals were directly dissolved into MALDI matrix solution. Polymeric additives
such as PEG are normally present in the mother liquor as well as the protein
crystals, so 4HCCA/FWI is the best choice of matrix solution (see Figure 2.7). I
have applied this approach to several protein crystallization projects including the
TBP-TFIIB-DNA ternary complex (Nikolav/Burely) (Nikolov et al, 1995), TAF
42/62 (Xie/Burley) (Xie et al, 1996) and the elF-4C protein
(Marcotrigiano/Burley).

2.4.2 Effects of DNA on the MALDI-MS of Proteins.
4HCCA/FWI has particularly interesting properties when analyzing protein
samples that contain DNA oliogonucleotides (oligos). I highlight these findings
66

here. (1) 4 H C C A gives a better protein MALDI response than sinapic acid in the
presence of oliogs. regardless of the matrix solution composition. (2) FWI as a
solvent system is superior than TFA/ACN to observe protein signal in the
presence of oligos. (3) The presence of DNA oligos. tends to degrade the
protein MALDI signal (positive ion MALDI) in a fashion that is dependent on the
oligo. size and concentration —DNA oligos. longer than -20 base pairs and an
oligo:protein ratio (molar) greater than -four begin to adversely affect the MALDI
response from the protein. (4) Protein/DNA oligo. mixtures run in 4HCCA/FWI
(or SA/FWI) give rise to protein-DNA adduct peaks that are completely absent
when the same mixture is run using a TFA/CAN solvent system. The adduct
peaks have a distinct 'shape' that can serve as a unique signature for the
presence of DNA. (Normally, MALDI analysis of DNA oligos. is performed with
non-cinnamic acid derivative matrices run in the negative ion mode, a
combination that is unsuitable for protein analysis.) An example of the proteinDNA adduction is given in Figure 2.8 that compares the MALDI spectra of
b/HLH/Z Max and a 14-mer double-stranded DNA oligonucleotide run in 4HCCA
matrix with either TFA/ACN or FWI. The oligo. sequence is
5'-AGGTCACGTGACCT-3' and the protein:ssDNA mole ratio is 1:4. The spectra
from both matrix solutions show the presence of the Max protein. However, the
spectrum from the FWI matrix solution (Figure 2.8/RIGHT) exhibits a series of
small peaks that correlate to Max-DNA adduct ions. Close inspection of these
adduct peaks reveals an interesting asymmetry —the high-mass side of the
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Figure 2.8 Protein-DNA adduction by MALDI-MS.
MALDI-MS of b/HLH/Z Max and a 14-mer D N A oligonucleotide using 4 H C C A
as the matrix. Spectra obtained from two different matrix solutions are shown:
LEFT C O L U M N : 0.1% TFA/ACN (2:1 v/v) and RIGHT C O L U M N : formic
acid/water/isopropanol (FWI) (1:3:2 v/v/v). TOP panels show the complete
mass spectra from the two matrix solutions. Two regions in each spectrum at
the TOP (labeled a and b) are shown expanded in the MIDDLE and BOTTOM
panels. Max monomer is labeled M, oligomers are 2-4M and all peaks are
singly charge unless noted otherwise. The Max-DNA adduct peaks are absent
in TFA/ACN (LEFT) spectrum but strongly apparent in FWI spectrum (RIGHT).
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peaks show a steep slope while the low mass side show significant 'tailing'. The
low-mass side of protein peaks normally show a sharp slope. The tailing may be
seen in Figure 2.8 for the FWI preparation may reflect gas-phase decomposition
of the DNA in the adduct ion occurring just after ion formation following laser
desorption but before emerging from the acceleration region of the ion source.
Facile DNA fragmentation in the gas phase has been shown to occur in the
linear TOF instrument, particularly at the guanosine residues of DNA oligos.
(Schneider and Chait, 1993) for negative ion MALDI using cinnamic acid
derivative matrices. The four guanosine residues in the 14-mer oligo. used for
Figure 2.8 (see sequence above) could account for extensive gas-phase
fragmentation. If the guanosine fragmentation hypothesis is correct, my results
suggest that the gas-phase protein-DNA interaction is rather strong. However, it
remains unclear why the Max-DNA adducts appear when using FWI but not with
TFA/ACN (Figure 2.8). From a practical perspective, the protein-DNA adduct
peak 'signature' was useful for the TBP-TFIIB-DNA ternary complex
crystallization project (Nikolov et al., 1995). MALDI-MS quickly determined
candidate crystals that contained all three components of the complex,
information that was highly valuable in expediting completion of the project.

2.4.3 Effects of Redissolving the Matrix-Analyte Crystal
A final example of the benefits of using 4HCCA/FWI matrix solution is
shown in Figure 2.9. The MALDI-MS of an endoprotease Asp-N digest of
b/HLH/Z Max is performed in three ways. The spectrum in Figure 2.9a was from
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Figure 2.9 Effects of redissolving the matrix crystals of a protein digest.
MALDI-MS of a complete endo Asp-N digest of b/HLH/Z Max using 4 H C C A
matrix and dried-drop matrix crystallization. Spectrum of the digest in (a) was
obtained using a matrix solution consisting of formic acid/water/isopropanol
(1:3:2 by volume). Note the low-mass discrimination. In (b) the matrix solution
was water/ACN (2:1 v/v). More low mass peaks appear. In (c) the matrix
crystals used to obtain the spectrum in (a) were redissolved in ~1 ^L of
water/ACN (1:1 v/v) and allowed to recystallize directly on the probe. The
AspN digest peaks of Max are labeled according to their sequence.

70

4 H C C A / F W I and in Figure 2.9b from a 4 H C C A - H 2 O / A C N matrix solution using
the dried-drop method of matrix crystallization. The pH-dependent discrimination
effects (discussed previously) between the low and high mass peptides are
clearly apparent —FWI favors high mass whereas H2O/ACN favors low mass
peptides. In Figure 2.9c, the spectrum was from the same dried-drop matrix
crystals used to obtain Figure 2.9a except that the matrix crystals were
redissolved and recrystallized directly on the probe tip with 1 ^iL of
water/acetonitrile (1:1 v/v). Low mass peptides are now clearly observed in
Figure 2.9c.

2.5 Conclusions
A major strength of MALDI mass spectrometry is its facility for analyzing
complex mixtures of peptides and proteins. I have demonstrated that the choice
of the matrix solvent system and the rate of matrix crystal growth add a certain
'chromatographic-like' dimension to the sample-matrix preparation, and that to
take full advantage of the power of MALDI, careful attention must be paid to the
sample-matrix preparation procedures. Having extensively investigated these
effects, I suggest here some general guidelines for matrix solution preparation
(using the matrix 4HCCA and the dried-drop method) (1) The analysis of
proteins and high mass peptides ( > 3 kDa) is best performed using matrix
solutions that include formic acid and have a pH < 1.8. (2) The analysis of small
peptides ( < 3 kDa) is best carried out using matrix solutions that do not have
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added acids. (3) For a complex mixture of peptides and proteins, a single matrix
solution ( pH ~2) can be used (such as TFA/ACN). However, to obtain a more
complete coverage of components in the mixture, it is advisable to run the
mixture separately in the two matrix solutions suggested in (1) and (2) above.
(4) The presence of formic acid (such as in FWI) lends particularly useful
features for analyzing protein samples with oligonucleotides or high levels of
involatile additives. (5) Overall, optimizing the MALDI-MS signal is somewhat
sample-dependent, requiring a fine tuning of the matrix solvent composition and
matrix crystallization protocols.
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Chapter 3 — Mass Spectrometry of Whole Proteins
Eluted from SDS-PAGE Gels

3.1 Introduction
Gel electrophoresis plays a significant role in biological research (Hames
and Rickwood, 1990). The notable strength of gel electrophoresis is its ability to
provide separation of mixtures of large biomolecules at high resolving powers in
a relatively timely and inexpensive manner. Isoelectric focusing (lEF) and
sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels,
used individually (1-D gels) or in combination (2-D gels), are powerful
electrophoretic methods that provide microscale analyses of complex mixtures of
proteins. However, the information concerning a particular protein 'spot' on a gel

is limited. lEF reveals the relative acidity or basicity (i.e., pi) of a protein where
SDS-PAGE provides an 'apparent' molecular mass of the protein. Mass
accuracy by SDS-PAGE, however, is no better than 5% and more often than not
is grossly lower.
Matrix-assisted laser desorption/ionization (MALDI) (MS) and electrospray
ionization (ESI) MS can provide rapid, sensitive, and accurate analysis of
proteins. Mass accuracies are usually better than 0.1 % (Beavis and Chait,
1990b; Chait and Kent, 1992), representing at least a 50-fold improvement over
the mass accuracy of SDS-PAGE. Thus, the coupling of SDS-PAGE (protein
separation) and mass spectrometry (mass accuracy) is a potentially powerful

73

analytical combination.

For example, the interfacing of one- and two-

dimensional polyacrylamide gel EF with MS is experiencing a surge of activity in
the areas of protein identification, using database searching algorithms (Qin et
al., 1996b; Wilm et al., 1996b; Yates III et al., 1996b), and in characterization of
posttranslational modifications of proteins (reviewed in Burlingame et al., 1996).
These applications employ various types of gel separation and mass
spectrometric techniques that depend on in-situ chemical or proteolytic digestion

of the protein of interest followed by elution of the resulting peptide fragments for
MS analysis.
Techniques are also being developed for the MS analysis of whole
proteins from gels. However, retrieving large polypeptides and proteins from
gels is inherently more difficult than recovering small and moderately sized
peptides. In addition, with the use of SDS-PAGE, the presence of SDS
detergent and protein visualization dye (e.g., Coomassie Brilliant Blue) severely
compromises mass spectrometric response to proteins (S. L. Cohen,
unpublished results; Strupat et al., 1994; Loo et al., 1996a). A variety of
methods have been introduced to overcome these limitations and permit MS
analysis of whole proteins from gels. One strategy uses electroblotting and
electroelution techniques. For example, plasma desorption-MS (Klarskov and
Roepstorff, 1993), UV-MALDI-MS (Vestling and Fenselau, 1994) or IR-MALDIMS (Strupat et al., 1994) can be directly run on proteins that have been
electroblotted onto polymeric membranes. UV-MALDI-MS has also been applied
to electroblotted proteins recovered from a dissolvable nitrocellulose membrane
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(Liang et al., 1996), and ESI-MS analysis of proteins electroeluted from S D S PAGE gels (leMaire et al, 1993; Nakayama et al, 1996; Schuhmacher et al,
1996). A more recent approach applies UV-MALDI-MS to the analysis of
proteins directly from ultrathin polyacrylamide gels (Loo et al., 1996a).
I developed an alternative strategy to mass spectrometrically analyze
whole proteins from gels, a strategy that evolved principally from the MADLI
matrix studies described in chapter 2. The method consists of three
components: the use of conventional SDS-PAGE gels, reversible negative
staining procedures, and passive elution of proteins from the gel followed by
MALDI- or ESI-MS analysis. For high sensitivity applications, the method is
restricted to MALDI-MS and involves the use of slow matrix crystallization (Xiang
and Beavis, 1993). This strategy offers the ability to analyze soluble proteins
from gels down to the low picomole level (1-10 pmol), providing a powerful
means for characterizing endogenous forms of mature proteins separated by
SDS-PAGE (Cohen and Chait, 1997).

3.2 Materials
3.2.1 Proteins
Horse skeletal muscle myoglobin (+heme = 17,568 Da; 95-100% pure;
Sigma) was accurately weighed on a microbalance (Cahn 4400, Orion
Instruments, Boston, MA) and dissolved in aqueous 0.1 % TFA (pH 2) (Pierce,
Rockford, IL) to make a 50 i^M protein solution. Recombinant mouse leptin was
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provided by Dr. Jeffrey Friedman (Rockefeller University). The leptin consisted
of wild-type residues 22-167 with an amino-terminal methionine (16,134 Da)
(Zhang et al., 1994). The presence of a single intramolecular disulfide bond in
mouse leptin was determined by performing in-solution CNBr digestion as well
as enzymatic proteolysis (Halaas et al., 1995). The leptin concentration was 1
mg/mL (62 jiM; prepared in a standard phosphate-buffered saline solution, pH
7.4) and was determined spectrophotometrically using an extinction coefficient of
0.16 (mg-cm/mL)'^ (personal communication, Ketan Gajiwala, Rockefeller
University). For qualitative studies, a broad range protein mass marker mixture
(0.1-0.2 mg/mL each protein) was purchased from New England BioLabs
(Beverly, MA) and bovine transferrin and bovine carbonic anhydrase II were
obtained from Sigma.

3.3 Methods
3.3.1 Preparation of proteins for SDS-PAGE
Proteins were aliquoted into 0.65 mL micro-centrifuge tubes and
ammonium phosphate or acetate buffer was added to bring the volume to 10 \iL.
An equal amount (10 ^L) of Tris-Glycine sample buffer (2X concentrated)
(Novex, San Diego, CA) was added to each tube. The sample buffer contained
bromophenol blue to visualize the electrophoresis dye front. The protein/sample
buffer solutions were vortexed and centrifuged prior to loading onto the gel.
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3.3.2

SDS-PAGE

Gel electrophoresis was performed according to Laemmli (Laemmli,
1970). Gloves were worn at all times when handling the gels. Precast 14 %
Tris-Glycine gels (1 mm thick, 10 wells) (Novex) were used throughout, although
gels with other acrylamide concentrations, thickness and number of wells can be
used, depending on the desired molecular mass range, sample volumes, and
electrophoresis equipment available. However, only Tris-Glycine gels are
appropriate for the present application because the destaining process is based
on the Tris buffer system (Lee et al., 1987). Electrophoresis was carried out on
an Xcell II Mini-Cell device (Novex) at room temperature. The running buffer
was prepared from a 10X Tris-Glycine SDS solution (Novex). Following
assembly of the Mini-Cell with a fresh gel and addition of the running buffer, the
protein/sample-running buffer solutions (20 i^L; see above) were loaded into the
sample wells with the aid of gel loading tips (Novex). Electrophoresis was
carried out at 120 volts and an initial current of -32 mA using a PowerPac 1000
power supply (Bio-Rad; Hercules, CA), and was terminated when the dye front
reached close to the bottom of the gel. Typical run times were 1.5-2 h.

3.3.3 Gel Staining
Immediately following electrophoresis, the gel can be rinsed in water,
although I recommend against rinsing when handling low molecular mass
proteins (<20 kDa). Protein bands were visualized by soaking the entire gel in

77

Gel Excision and Destaining
gel slice

0.65 mL
microtube

SDS-PAGE Gel (Cu stained)

Gel Extraction Method A

Add
solvent

Retrieve &
lyophilize
supernatant

Close tube
Shake at
RT; 2-8 hr

\/ -®^VJ^
\y
''

Add matrix
solution to
redissolve

Vw
"

r

f

Retrieve
matrix sol.
for dried-drop

I

I

MALDI
probe

Gel Extraction Method B
5b)
Add
matrix
solution

Close tube
Shake at
RT;1-2h

V—-T-y

(6b)

.. m . ,, Open tube
to crystallize
v ^ ^
matrix (oooo)
0.5-1 h.

ffx

^

\\W//
^^yy

Qb-)
^'°^® ^ shake
up to 1 day.
Retrieve crystals
for MALDI-MS

1f

Centrifuge
& pipet
crystals onto
MALDI probe

Figure 3.1 Eluting whole proteins from SDS-PAGE gels for
mass spectrometric analysis.
The strategy is comprised of two parts. The first consists of gel
excising, destaining, and crushing (TOP R O W ) . The second
part consists of gel extraction, involving either passive elution of
the gel using an acidic solution (MIDDLE R O W , Gel Extraction
Method A ) or passive elution combined with a slow matrix
crystallization using a MALDI matrix solution ( B O T T O M R O W ,
Gel Extraction Method B). See text for a full description.
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45 |iL of copper staining solution (supplied 10X from Bio-Rad) for five minutes
with gentle rocking (Lee et al., 1987). Alternatively, zinc staining (Dzandu et al.,
1988) or imidazole-zinc staining (Ortiz et al., 1992) protocols can be used. After
staining, the gels were thoroughly rinsed In deionized water. Because copper
and zinc staining are negative stains, protein bands appear translucent and are
best viewed against a black background. Bands with as little as 17 ng (1 pmol)
of myoglobin or recombinant leptin were visualized by copper staining.

3.3.4 Gel Excising and Destaining (Figure 3.1)
Destaining was performed on individual gel slices containing a single
protein band as depicted in Figure 3.1 and each step is described as follows.

Step 1: Protein bands were excised from the stained gel with a clean, sharp
straight-edge razor. The gel slices were excised as close as possible to the
boundaries of the protein band. The resulting blue-tinted gel slices typically had
the dimensions 1-1.5 mm x 6-7 mm and were best handled with flat-end
tweezers. Protein extraction should be performed immediately after destaining.

If a delay is anticipated, it is best to leave the gel slices stained and stored moi
(but not soaking) at 4°C in a sealed microtube until needed.

Step 2: The destaining process completely removes the visualization stain as
well as the SDS detergent (Lee et al., 1987). Each gel slice was treated in a
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separate 1.5 m L

micro-centrifuge tube using standard

copper-destaining

protocols (Bio-Rad). Zinc-stained gels can also be destained using the same
protocols. Destaining was performed by a three-step soaking process using a
copper Tris-Glycine destain solution (Bio-Rad). The first soaking of the gel is
carried out in a solution consisting of 100 i^L destain buffer and 900 ^iL water.
The tube is sealed and vortexed (Tomy MT-360 36-sample microtube mixer;
Tomy Tech, Palo Alto, CA) for 5 minutes at room temperature. During the first
destaining period the solution turns pale translucent blue (for copper-stained
gels) and may become slightly foamy. The gel will retain a faint blue tint. The
second soaking is performed in fresh solution of 100 |aL destain and 900 ^L
water with 10 minutes of vortexing. At the end of the second soaking, the
destain solution and gel will be nearly colorless. The final soaking is performed
in a solution of 50 |iL destain and 950 i^L water with 5 minutes of vortexing. At
the end of the third soaking, the destain solution as well as the gel are clear.
The destained gel slice is rinsed in deionized water and is now ready for
extraction or in-gel digestion (see below).

Step 3: Prior to protein extraction, the gel slice is crushed. Before crushing, the
destained gel is gently blotted free of any excess water clinging to the gel with a
lint-free tissue, a step that facilitates crushing of the gel. With the aid of
tweezers, the gel slice is placed into a 0.65 mL microtube (PGC Scientifics,
Gaithersburg, MD). The microtube should be of high quality, free of plasticizers
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and contaminants that can compromise high sensitivity M S measurements. The
gel slice is manually crushed at the bottom of the microtube for a few seconds
with a sharp-pointed dental tool. Mechanical homogenization of the gel can be
used instead of the manual crushing, but I recommend against it since the
resulting small gel pieces tend to clog pipettor tips. Others have also noted that
homogenization introduces 'poisons' that severely impair mass spectrometric
protein analysis (personal communication. Bill Jordan). At this point, either of
two methods described below (Extraction Methods A or B) can be used to elute
the protein from the gel.

3.3.5 Extraction Method A (Figure 3.1, Steps 4a-8a)
This method of extraction elutes protein from the gel directly into an
aqueous solution and is best suited for gel loadings exceeding 25 pmol. Solution
compositions that I have examined for protein extraction include formic
acid/water/2-propanol (1:3:2 v/v/v) (FWI); formic acid/water (1:5 v/v);
water/2-propanol (2:1 v/v); and pure water. Optimal extraction efficiency
occurred with the FWI combination, whereas no extraction was observed with
pure water. The relative extraction efficiencies are based on a qualitative
assessment of the MALDI-MS signal-to-noise ratios. Other acids and watermiscible organic solvents (e.g., 0.1 % TFA and acetonitrile) can be used for
extraction.
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Step 4a: Sufficient extraction solution (--30-40 |aL) is added to the crushed gel to
completely cover the gel pieces.

Step 5a: The tube is closed and vigorously shaken or vortexed at room
temperature typically for a period of 2-8 hr. Although not essential for protein
elution, shaking/vortexing facilitates protein extraction. Generally, the greater the
protein loading or the smaller the protein, the shorter the vortexing time required
for extraction. The gel extraction times for the spectra in Figure 3.2 is 4 hr
whereby for Figure 3.3, it is 12 hr.

Step 6a: After the vortexing period, the microtube is centrifuged and the
supernatant is retrieved with a micropipettor equipped with a 1-10 |aL tip,
avoiding taking up any of the gel pieces. The crushed gel is washed once with
an equal volume of fresh extraction solution that is combined with the
supernatant.

Steps 7a and 8a: If the protein is to be analyzed by MALDI-MS, the extraction
solution is lyophilized and a MALDI matrix solution (2 nL for Figure 3.2 and 3.3)
is added to redissolve and retrieve the protein for MS analysis using the drieddrop method of matrix crystallization (see chapter 2). The matrix solution is FWI
saturated with 4-hydroxy-a-cyano-cinnamic acid (4HCCA) (Cohen and Chait,

82

1996). A calibrant protein, if required, can also be added to the solution at this
point.
If the protein is to be analyzed by ESI-MS, the extraction solution is
injected into a protein desalting cartridge (Michrom BioResources, Inc., Auburn,
CA) that is mounted to the ESI capillary inlet. (The desalting cartridge is
discussed in detail in chapter 2, Methods). The loaded cartridge is flushed
several times with a 2 % acetic acid wash solution. Following the washing, the
protein is eluted from the cartridge into the electrospray source with a solution
consisting of 7% acetonitrile/2.5% acetic acid at 6 i^L/min. ESI-MS was
performed on a TSQ-700 triple quadrupole (Finnigan Corp., San Jose, CA) using
standard ESI conditions for analyzing proteins (Mirza et al., 1995) (see chapter 5
"Methods" section for ESI conditions).

3.3.6 Extraction Method B (Figure 3.1, Steps 4b-8b)
This method of extraction elutes protein from gels directly into a MALDIMS matrix solution and is best suited for gel loadings below 25 pmol of protein or
for proteins that fail to passively elute using Extraction Method A (described
above). In Method B the matrix is allowed to undergo slow crystallization (Xiang
and Beavis, 1993) during the protein extraction period. The matrix used
throughout was 4HCCA, although sinapinic acid can also be used. The
moderately low solubility of these cinnamic acid derivatives in the matrix solution
is an important characteristic for efficient slow crystallization (Xiang and Beavis,
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1993).

The most frequently used matrix solution consisted of a saturated

solution of 4HCCA in FWI. Other solvent systems were also examined (e.g.,
0.1% TFA:acetonitrile, 2:1 v/v) (see Table 2.1 for suggestions). Gel extraction
with the matrix solution (Figure 3.1) is as follows:

Step 4b: After crushing the destained gel (see above), enough matrix solution
(-20-50 laL) is added to cover the gel pieces. A calibrant protein, if necessary,
can be added at this point to the solution.

Step 5b: The tube is closed and vigorously shaken or vortexed at room
temperature for 1-2 h.

Step 6b: Matrix crystallization is induced by leaving open the top of the
microtube (0.5-1 h) with vortexing. The matrix solution will become slightly
cloudy with a suspension of 4HCCA crystals. An aliquot (1 )aL) of the milky
supernatant can be immediately retrieved and deposited onto the MALDI probe
for MS analysis while the remaining sample is closed and left vortexing for
additional extraction. Avoid taking up any gel pieces while pipetting and avoid
crushing the matrix crystals once they are on the probe.

Steps 7b and 8b: If the MALDI-MS response is weak from matrix crystals that
were immediately retrieved following their formation, the signal may improve from
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crystals that have undergone a longer period (--4-24 h) of vortexing in the
gel/matrix suspension. During extended vortexing periods, the matrix crystals

may precipitate to the bottom as a fluffy yellow 'pellet', cling to the sides of th
microtube, and/or remain suspended in solution. Crystals can be retrieved from
any of these locations within the tube with a micropipettor for MALDI-MS
analysis. Also, during the vortexing period volume losses of the solution due to
evaporation and aliquot sampling will occur. To offset the volume losses, small
amounts (5-10 ^iL) of matrix-free extraction solution (i.e., formic acid-water-lPA

1:3:2, v/v/v) or just acidified water (i.e., formic acid/water, 1:5 v/v) can be adde
to keep the gel pieces completely submerged in solution. For the results

presented in the thesis, vortexing times were: 4 h (Figure 3.9), 6 h (Figure 3.6), 8
h (Figure 3.8) to 12-19 h (Figure 3.7).

3.3.7 In-Gel Digests
Gel slices for digestion were destained and crushed as described above
(steps 1-3, Figure 3.1). Trypsin digest: To the crushed gel was added 60 |LIL of
10 mM ammonium acetate buffer (pH 7) (enough to at least completely
submerge the gel pieces) and 250 ng of trypsin. The tube was closed and
vortexed 4 h at room temperature. Two approaches (I or II) were used to map
the digest. In the first method (I), the gel and supernatant together were
lyophilized to dryness after which 40 |LIL of matrix solution (4HCCA/FWI) was
added to rehydrate the gel pieces. Gel extraction Method B was followed to
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obtain matrix crystals for M A L D I - M S analysis. Alternatively, in the second
method (II) the original digest supernatant was retrieved and retained. The gel
pieces were extracted once with 40 ^L of 0.1% TFA/ACN (1:1 v/v) and once with
40 ^L of pure acetonitrile. The two extracts were combined with the digest
supernatant and lyophilized to dryness. The lyophilized digest was redissolved
with matrix solution (2-3 ^iL) followed by the dried-drop method to obtain matrix
crystals. The lyophilized digest can also be redissolved in 5-10 |LIL of 0.1%
TFA/ACN (1:1 v/v), 1 |aL of which was combined with an equal volume of matrix
solution for dried-drop matrix crystallization (Qin, 1996). Cyanogen Bromide
Digest: To the crushed gel was added 50 i^L of 0.1 N HCl and a small crystal of
CNBr. The tube was left shaking in the dark at room temperature for 12 h.
Following the digestion, the supernatant was retrieved and the gel pieces
retained. The supernatant was lyophilized and redissolved in 3 faL of
4HCCA/FWI matrix solution for dried-drop MALDI-MS. To the retained gel
pieces was added 4HCCA/FWI matrix solution. Gel extraction Method B was
followed to obtain matrix crystals for MALDI-MS analysis.

3.3.8 MALDI-MS
The dried-drop method of matrix crystallization (see chapter 2) (Karas and
Hillenkamp, 1988) were used to obtain the spectra in Figures 3.2 and 3.3a Slow
crystallization (Xiang and Beavis, 1993) (as described in chapter 2,
'Experimental') was used to obtain the spectrum in Figure 3.3b.
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3.4 Results
3.4.1 Eluting Whole Proteins from SDS-PAGE Gels.
My strategy for eluting whole proteins from SDS-PAGE gels is presented
in Figure 3.1. Full details of the procedures are given in the Methods section
above. The approach starts with an SDS-PAGE gel on which proteins have
been resolved. Protein bands are visualized with a reversible negative stain
such as copper (Lee et al., 1987) or zinc (Dzandu et al., 1988; Ortiz et al., 1992)
staining. The bands are excised from the gel and destained. The destaining
procedure completely removes the stain and SDS detergent. The gel is then
crushed and the protein extracted by one of the protocols I term Extraction
Methods A and B. I have found that for gel loadings > 25 pmol of protein, the
protein passively elutes directly into a simple extraction solution (Extraction
Method A). For gel loadings < 25 pmol of protein, the inclusion of a MALDI

matrix in the extraction solution is important to ensure high sensitivity (Extractio
Method B).

3.4.2 Extraction Method A: Elution of Whole Proteins from Gels for
MS Analysis
This method involves a passive elution of the protein into solution.

Following extraction, the solution is retrieved from the gel pieces and lyophilized.
Saturated matrix solution is added to the lyophilized protein and MALDI-MS is
performed on the matrix crystals prepared by the dried-drop method. Figure 3.2
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Figure 3.2 MALDI-MS of proteins eluted from SDS-PAGE
using gel Extraction Method A.

gels

The extraction solution was formic acid/water/2-propanol (1:3:2 v/v/v)
MALDI spectra of three gel loadings are shown: (a) 25 pmol equine
myoglobin (peaks are apomyoglobin, M, = 16,951); (b) 25 pmol, and
(c) 6 pmol of recombinant mouse leptin (M^ = 16,134). The small
peaks labeled with an asterisk are low-level impurities.
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shows MALDI m a s s spectra of equine myoglobin and recombinant m o u s e leptin
extracted by Method A. The spectra in Figures 3.2a,b, obtained from the
extraction of gels loaded with 25 pmol of the two proteins, show excellent signalto-noise ratios, suggesting favorable protein extraction by Method A. However,
because accurate quantitation by MALDI-MS is difficult, I did not estimate the
recovery yields. MALDI mass spectra were also obtained for 50 pmol gel
loadings of bovine carbonic anhydrase II (29 kDa) and bovine transferrin (78
kDa) using Extraction Method A and are shown in Figure 3.3. As an alternative
to the MALDI-MS technique, ESI-MS can be used to analyze the extracted
protein. Good quality ESI mass spectra from the extraction of 50 pmol gel
loadings of recombinant leptin and myoglobin here obtained. The ESI-MS
spectrum of recombinant leptin is shown in Figure 3.4
The utility of Extraction Method A, however, is limited to gel loadings > 25
pmol. As observed in Figure 3.2c, the MALDI-MS signal significantly drops for

gel loadings approaching the 6 pmol level of leptin. A similar fall-off in sensitivity
is also observed with myoglobin (data not shown). I attributed the fall-off in
signal to a reduction in protein extraction recovery yields. To offset the poor
recovery yields from gels with low picomole loadings, I slightly modified the
passive extraction method. The modification makes use of MALDI-MS analysis
and exploits the power of slow matrix crystallization as described below.
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MALDI-MS
SDS-PAGE

of high mass proteins extracted from
gels by Extraction Method A.

(a) Bovine carbonic anhydrase II, BCA II, (29 kDa) and (b) bovine
transferrin (78 kDa). 50 pmol gel loadings. The B C A II spectrum is
dominated by the hydrolysis product ( :^ ) of acid cleavage at an
Asp/Pro bond. The acid hydrolysis occurred during gel extraction
with the strongly acidic extraction solution.
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from SDS-PAGE gel by Extraction Method A.
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mass of the leptin. Expected mass is 16,155 Da. The sodium
adduct peak is marked.
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3.4.3 Slow Crystallization of the MALDI

Matrix Greatly Enhances

MALDI-MS

Sensitivity.
MALDI-MS depends on growing analyte-doped matrix crystals. Several
methods of matrix crystallization are available (Beavis and Chait, 1996), the most
widely used of which is the dried-drop method (Karas and Hillenkamp, 1988)
(described in chapter 2). In the dried-drop method, proteins are dissolved in a
saturated MALDI matrix solution. Ideally, the protein concentration in the matrix
solution should be > 0.1 |LIM to ensure a good MALDI-MS response. Below 0.1
laM of protein in the matrix solution, there is a non-linear drop-off in the MALDIMS response (Figure 3.5a). Figure 3.5a shows the MALDI mass spectrum of
recombinant mouse leptin using the dried-drop method (1 |LIL of matrix solution
containing 0.01 )iM protein). No signal from the protein is observed. In striking
contrast, when slow crystallization (Xiang and Beavis, 1993) is used to produce

matrix crystals (30 laL of matrix solution containing 0.01 |iM protein), I observe a
moderately strong MS response (Figure 35b). A similar pattern of behavior is
seen from a matrix solution containing 0.01 ^iM equine myoglobin (data not
shown). Slow matrix crystallization thus provides a convenient means to
concentrate protein from the solution into the matrix, a property that can be
exploited to enhance MALDI-MS sensitivity. (One example of the MALDI signal
enhancement effect by slow crystallization has already been shown in Figure
2.7b-c).
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Slow crystallization greatly improves
the MALDI-MS response of proteins.

MALDI-MS of recombinant mouse leptin at a very low
concentration in the matrix solution (0.01 |iM). Using
(a) conventional dried-drop method, and (b) slow
crystallization method of MALDI-MS analysis.
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3.4.4 Extraction Method B: Eluting Whole Proteins from Gels
for High Sensitivity MALDI-MS Analysis
To achieve high sensitivity analysis of proteins originating from gels, I
combined passive gel elution (Extraction Method A) with slow matrix
crystallization. The result is a new approach to mass spectrometrically analyzing
proteins from gels (Figure 3.1, Extraction Method B). In Method B the eluting
solvent is a MALDI matrix solution. The matrix solution permits passive
extraction of the gel along with a nearly simultaneous slow crystallization of the
matrix. Under vortexing conditions, the matrix crystals remain finely dispersed in
solution with the gel pieces. Thus, protein that elutes from the gel has a chance
of co-crystallizing with the matrix. Figure 3.6 depicts MALDI mass spectra of
recombinant mouse leptin using Extraction Method B. The spectra show the
effects of decreasing gel loadings of leptin, from 25 pmol (Figure 3.6a) to 1 pmol
(Figure 3.6c). Extraction Method B maintains good sensitivity even at 1 pmol gel

loading of leptin, a level at which direct elution (Extraction Method A) completely
failed to give any MALDI-MS signal for the protein (Figure 3.2c). (See Cohen
and Chait, 1997, Fig. 4, for a photo of a Cu-stained gel with 25-1 pmol protein.)
The MALDI mass spectra of a selection of protein mass markers obtained
using Extraction Method B is shown in Figure 3.7. Based on the marker set
manufacturer's specification, the gel loadings were calculated at 200 ng for each
protein. This represents 14 pmol of lysozyme (14.3 kDa; Figure 3.7a), 7 pmol of
triosephosphate isomerase (26.6 kDa; Figure 3.7b) and 3 pmol of bovine serum
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Figure 3.6 MALDI-MS of recombinant human
copper-stained SDS-PAGE gels.

leptin from

MALDI-MS of recombinant mouse leptin (M =16,134) eluted from
SDS-PAGE gels using Extraction Method B. The MALDI matrix
solution used to extract the gel slices was formic acid/water/2propanol (1:3:2 v/v/v) saturated with 4HCCA. The gel loadings
represent (a) 25 pmol, (b) 9 pmol, and (c) 1 pmol of leptin.
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Figure 3.7 MALDI-MS
of molecular mass markers extracted from
copper-stained SDS-PAGE gels.
MALDI-MS of protein mass markers eluted from S D S - P A G E gels using
Extraction Method B. The markers are (a) chicken egg white lysozyme; (b)
triosephosphate isomerase; and (c) bovine serum albumin. The spectrum
In (a) also shows peaks (labeled by an asterisk) corresponding to the
marker protein aprotinin (6.5 kDa) that co-migrated and eluted along with
lysozyme. Masses above the 1+ pks. are derived from external calibration.
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albumin (66.4 kDa; Figure 3.7c). Figure 3.7a exhibits an additional set of peaks
whose mass correlates to the mass marker aprotinin (6.5 kDa), indicating that
aprotinin co-migrated with lysozyme on the SDS-PAGE gel.

3.4.5 Mass Accuracy
The MALDI mass spectra shown in Figures 3.2-3.7 are externally
calibrated. External calibration of proteins using the dried-drop method normally
yields mass accuracies in the simple linear time-of-flight mass spectrometer no
better than 0.1 %. With slow crystallization, other factors contribute to further
reduce mass accuracy. For example, slow crystallization tends to produce larger
and more heterogeneous matrix crystals than crystals formed by the dried-drop
method. Also, a complication of using Extraction Method B is the inadvertent
retrieval of microscopic gel pieces along with matrix crystals (Figure 3.1, step
8b). Large matrix crystals and the inclusion of gel pieces on the MALDI probe
may act to distort the electric field in the ion source. These effects lead to peak
broadening and centroid shifts that ultimately reduce the mass accuracy. The
use of internal calibrants leads to substantial improvements in mass accuracy.
With Extraction Method A, a protein of known molecular mass can be included in
the matrix solution prior to the dried-drop crystallization (Figure 3.1, step 7a).
Using Extraction Method B, the protein calibrant must be included before slow
crystallization of the matrix (Figure 3.1, step 4b). The amount of calibrant to be
added depends on the level of sensitivity and must be established on a trial-anderror basis.
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Figure 3.8 Internal calibration improves mass accuracy.
MALDI-MS of recombinant mouse leptin (calc. mass 16,134 Da)
eluted from S D S - P A G E gel using Extraction Method B with equine
myoglobin added as internal calibrant. Three repeat measurements
are shown. The 1+ and 2+ leptin peaks, bracketed by the 1+ & 2+
myoglobin (Myo) peaks, are labeled with their measured mass.
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found relatively good M S reproducibility. A s an example, separate extractions of
freshly prepared gel slices, containing 3-25 pmol loadings of recombinant mouse
leptin, were performed at different times over the four-month period. The
resulting MALDI mass spectra of the extracted gels using Method B yielded
similar signal-to-noise ratios consistent to those shown in Figures 3.6 and 3.8. I
finally note that in order to hasten the analysis of a large number of protein gel
bands, the gel destaining/extraction procedures can be scaled up by processing
the samples in a parallel manner.

3.5 Discussion
My approach to mass spectrometrically analyze whole proteins from SDSPAGE gels depends on passive elution methods. The most efficient and
frequently used passive gel elution employs buffer systems that normally contain
SDS detergent (Hager and Burgess, 1980). However, the presence of ionic
detergents, such as SDS, usually severely compromises MS response by both
ESI and MALDI techniques (Beavis and Chait, 1990a & b; Mock et al., 1992).
For example, I have observed that even 0.1 % of SDS in the matrix solution is
'lethal' for MALDI-MS analysis using 4HCCA matrix. Difficulty with SDS is
equally true for ESI-MS. Thus, it is imperative to eliminate SDS detergent.
When microgram quantities of protein are involved, detergent removal is
normally carried out by protein precipitation with organic solvents such as cold
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acetone (Hager and Burgess, 1980) or by ion pairing methods (Henderson et al.,
1979). However, the precipitation procedures are lengthy and usually become
inefficient for submicrogram quantities of protein.
Other approaches to eliminate detergent involve electroblotting proteins
onto membranes, but this step usually requires staining procedures that may
interfere with MS analysis. Of particular interest is the MALDI-MS of proteins
directly irom a membrane or from the gel itself. The use of infra-red (IR) MALDIMS is one such example. Proteins are blotted onto membranes, matrix is added,
allowed to dry and the entire membrane is placed into the mass spectrometer
(Strupat et al., 1994). An infra-red laser is set to 'scan' the gel and desorb
protein (ions) from the blotted gel bands for mass analysis. An IR laser is used
(instead of the conventional UV-MALDI laser) because of the greater penetration
depths (i.e., through the membrane) of IR compared with UV radiation. The field
of IR-MALDI is still in the developmental stages. A second example of a 'direct'
MALDI method involves the use of ultrathin SDS-PAGE gels (available from
Pharmacia) (Loo et al., 1996a) and conventional UV-MALDI-MS. In this method,
after resolving the proteins, the gel is soaked in a MALDI matrix solution and is
carefully dried. The entire gel is placed in the mass spectrometer and is
scanned by the UV-MALDI laser followed by mass analysis of desorbed protein
ions. The developers of this method claim 1 pmol sensitivity for myoglobin from
an ultrathin SDS-PAGE gel, although they give little evidence to support such an
assertion (Loo et al., 1996a). In addition, there are several difficulties associated
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with ultrathin gels. Because of their low sample loading capacities (-low fiL),
ultrathin gels are not widely used. The gel drying procedures are intricate and
the dried gels are very delicate to handle, difficulties that could jeopardize the
analysis of precious protein samples.
Part of my aim in this study was to develop a means to mass
spectrometrically analyze submicrogram (low picomole) amounts of whole
proteins loaded onto conventional gels with minimal sample handling. Reverse
staining procedures using transition metal salts provided the desirable qualities
to achieve my goal (Qin et al., 1996a). Copper staining of SDS-PAGE gels
shows moderately high sensitivities (-10 ng protein) (Lee et al., 1987 and BioRad, Bulletin No. 1820). More importantly, the copper destaining protocols are
simple and result in complete removal of the copper stain and SDS detergent
with minimal loss of protein, leaving the gel prepared for passive elution. An
earlier investigation of ESI-MS of whole proteins from gels employed copper
staining combined with an electroelution of the proteins (le Maire et al., 1993).
This study used preparative SDS-PAGE gels and protein quantities exceeded
200 pmol. Two recent studies have demonstrated ESI-MS of proteins
electroeluted from Coomassie Blue-stained (Schuhmacher et al, 1996) and
copper-stained gels (Nakayama et al., 1996). In the former study, large
quantities of protein (>300 pmol) were loaded onto the gels. In the latter study,

the authors claim low picomole sensitivities but fail to indicate their quantification
methods.
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I found that passive elution of destained gels using the solvent mixture
FWI (Extraction Method A) was sufficient to extract soluble proteins for MALDIor ESI-MS analysis for protein loadings > 25 pmol (-0.5 |ig of myoglobin or
leptin; Figure 3.2a,b). FWI was selected because of its excellent protein
solubilizing properties —demonstrated, for example, in reverse-phase HPLC of
proteins (Heukeshoven and Dernick, 1982). Extraction solutions of differing
compositions have been employed by others, including the mixture formic
acid/acetonitrile/2-propanol/water (FAPH) (50:25:15:10, by volume) (Feick and
Shiozawa, 1990). FAPH was noted particularly for its ability to elute hydrophobic
proteins, such as membrane proteins, with high efficiency. Typical recoveries of
hydrophilic (soluble) or hydrophobic (membrane) proteins (5-10 i^g loadings on
SDS-PAGE gels) using passive elution by FAPH was reported to exceed 90 %
using radioactively labeled polypeptides (Feick and Shiozawa, 1990). I
examined FAPH as an Extraction Method A eluant for gels containing 25 and 6
pmol of either recombinant mouse leptin or myoglobin and found MALDI-MS
signals comparable to those observed by eluting with FWI (i.e.. Figure 3.2).
Below the 25 pmol gel loading of soluble protein. Extraction Method A
showed a rapid non-linear decline in the mass spectrometric response (e.g..
Figure 3.2c). For Figure 3.2c, I attribute the disappearance of the MALDI-MS
signal to insignificant protein recovery from the gel at low picomole levels of gel
loading. The recovery losses are probably due to irreversible adsorption of
eluted protein onto the microtube and dispenser tip surfaces, loss mechanisms
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known

to dominate

for low

picomole

amounts

of protein

(personal

communication, Salvatore Sechi, Rockefeller University). To counter protein
losses at low picomole levels, I combined the passive elution procedure with a
second process —slow crystallization of the MALDI matrix (Xiang and Beavis,
1993).
Beavis initially described slow crystallization as a powerful strategy to
grow analyte-doped matrix crystals in the presence of high levels of involatile
additives, conditions that normally preclude matrix crystallization by the drieddrop method (Xiang and Beavis, 1993). I have observed an additional benefit of
slow crystallization —a significant improvement in the MALDI response of
proteins present in the matrix solution (especially when present in low amounts)
over that observed using the dried-drop method (compare spectra in Figure 3.5).
Thus, slow crystallization is a powerful means of concentrating protein into matrix
crystals, providing the rationale behind Extraction Method B —protein that elutes
from the gel has a high chance of being 'captured' by matrix crystals present in
the extraction solution.
There are several possible shortcomings with the method of elution and
MALDI-MS on picomole amounts of proteins from gels. Hydrophobic proteins or
very large proteins may resist passive elution. However, the use of different
solvent systems (e.g., FAPH, see Results section) (Feick and Shiozawa, 1990)
or the inclusion of certain non-ionic detergents (e.g., n-octylglucoside) may assist
in the elution. Also, as discussed previously, obtaining sufficient mass
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accuracies using Extraction Method B can be a significant concern because of
the heterogeneous matrix layer. Careful selection of internal calibrants and
repetitive measurements usually provide mass accuracies better then 0.1 %. It
is likely that the newly developed pulsed ion extraction methods for the MALDI
ion source (Brown and Lennon, 1995; Vestal et al., 1995; Whittal and Liang,
1995) will provide a means to 'correct' the deleterious effects of the
heterogeneous matrix layer. Preliminary evidence for improvement in mass
accuracies has been shown (Loo et al., 1996b).

3.6 MALDI-MS of Whole Proteins from Gels—^An Application
3.6.1 The characterization of native human leptin.

The present method of eluting picomole amounts of proteins from gels for
MS analysis has a particular application for the study of endogenous (native)
forms of proteins. This application is particularly relevant for eukaryotic proteins
that normally undergo extensive in vivo processing events following protein
translation (e.g., proteolytic cleavage, disulfide formation, phosphorylation, and
glycosylation). Characterizing posttranslational modifications is routinely
performed by evaluating proteolytic digests by MS peptide mapping. However,
peptide coverage of protein digestions by MS is frequently incomplete, a
situation that can lead to inconclusive results. Knowledge of the accurate
molecular mass of the intact protein along with information from digestions and
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peptide mapping can lead to more definitive results. This approach w a s used to
characterize endogenous human leptin, the recently cloned obesity factor
(Cohen etal., 1996).
The discovery of the obese (ob) gene by Jeffrey Friedman by positional
cloning methods has lead to new insights concerning the molecular mechanisms
underlying obesity (Zhang et al., 1994). Friedman originally showed that mice
homozygous for a mutant form of the ob gene exhibited profound heredity
obesity and non-insulin-dependent diabetes mellitus. The mutation in these mice
was mapped to an Arg-to-stop codon conversion in the middle of the open
reading frame of the gene. The wild-type ob gene product was predicted to be a
146 residue secreted protein (leptin) with a single disulfide bond (Zhang et al.,
1994). (In a later study, I used cyanogen bromide digestion and peptide
mapping by MALDI-MS to confirm the presence of the disulfide bridge in
bacterially and yeast expressed recombinant forms of leptin; see chapter 5
(Halaas et al., 1995).) The original mutation in ob mice was correlated to an
absence of ob RNA transcripts (Zhang et al., 1994) and to undetectable levels of
leptin in blood serum (Halaas et al., 1995). The protein is exclusively expressed
in adipose (fat) tissue and at the amino-acid sequence level, the mouse and
human forms of leptin are 84% identical, showing little sequence homology to
other known mammalian proteins.
Subsequently, Friedman and others demonstrated that daily injections of
bacterially expressed recombinant mouse leptin into obese mice, administered
over a two week period, caused a marked reduction in body weight, fat, and food
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intake and w a s accompanied by an increase in metabolic and physical activity
(Halaas et al., 1995; Pelleymounter et al., 1995; Devos et al., 1996). These
remarkable findings were particularly intriguing given that about a third of the
American population is afflicted by some form of obesity. However, puzzling
data has begun to emerge. For example, the weight-reducing effects of
injections of bacterially expressed recombinant leptin into wild-type mice required
relatively high levels of leptin (Halaas et al., 1995). The basis for the high
dosage requirements were not known. It was also eventually disclosed that
contrary to the findings from ob/ob mice, a majority of obese humans express
high levels of leptin in plasma and these levels are highly correlated to the body
mass index in both obese and lean human subjects (Maffei et al., 1995;
Considine et al., 1996). In addition, no coding sequence polymorphisms in the
ob gene from a pool of 105 obese human patients were detected (Maffei et al.,
1996). Ultimately, clinical human trials for administration of recombinant leptin
would be undertaken as treatment for obesity. Thus it became important to
address some of these puzzling findings concerning leptin.
One consideration was the protein itself. Using western blotting, leptin
from obese and lean humans as well as from bacterially expressed recombinant
protein eluted on SDS-PAGE with identical mobilities (apparent molecular mass
16 kDa.) The poor accuracy of SDS-PAGE, however, excluded the possibility of
detecting subtle mass differences (such as low molecular mass post-translational
modifications). The absence (or presence) of post-translational modifications
may give rise to forms of the protein with differing physiological activities.
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Application of m y gel extraction/MALDI-MS procedure would clarify the question
concerning protein modification. I showed earlier that 1-3 pmol of protein loaded
onto the gel was sufficient to acquire reasonably good MALDI-MS spectra (see,
for example. Figure 3.6c). Obtaining endogenous leptin in pmol quantities,
however, proved to be a challenge. The levels of leptin circulating in obese
mouse blood serum were estimated (by ELISA) to be in the order of 50 ng/mL (3
pmol/mL) and about four times less in lean mice (Maffei et al., 1995). Similar
leptin levels were also found in human blood serum. Jeff Halaas (biomedical
fellow/Friedman laboratory) attempted to isolate leptin from mouse serum by
immunoprecipitation (IP) using polyclonal antibodies. In the first trial, I ran
MALDI-MS directly on the leptin IP from the mouse serum (Figure 3.9a). The
spectrum is dominated by unidentifiable high-mass components with little
evidence for -16 kDa proteins. Assuming leptin was present in the IP, high
levels of the high-mass components could suppress the leptin MALDI signal. To
avoid such suppression problems, the next trial involved separation of the leptin
IP by SDS-PAGE and copper staining. The IP gel lanes ran poorly, however,
showing uneven streaks of copper staining in the low mass region. The poor
performance was attributed to large loading volumes that were needed to attain
pmol levels of endogenous leptin. Although no bands appeared for leptin in the
IP lane, gel slices were excised by 'bracketing' the IP lane with recombinant
leptin lanes. Gel extraction of the bracketed IP lane slice by Extraction Method B
yielded the MALDI spectrum shown in Figure 3.9b. The spectrum shows the
presence of several components including the intriguing peak at m/z -16,100.
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Figure 3.9 MALDI-MS
of immunoaffinity isolated
h u m a n leptin from blood serum.
(a) Unfractionated elutant from immunoaffinity column.
(b) Elution of S D S - P A G E gel of immunoaffinity precipitation
using gel Extraction Method B. T h e spectra s h o w externally
calibrated masses.
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(The spectrum w a s externally calibrated, so the mass accuracy w a s no better
than 0.1% and all attempts to calibrate internally failed.) The conclusions that I
drew from the several attempts to isolate native leptin were (1) a protein
separation step, such as SDS-PAGE or 2-D electrophoresis, must be performed
on the IP isolated fraction and (2) gel extraction should only be applied to
reasonably well defined copper stained bands.
Jeff Halaas and I eventually utilized the services of Amgen (Thousand
Oaks, CA), the pharmaceutical company that has made a financial commitment
to leptin. Researchers at Amgen were close to commencing clinical human trials
with recombinant leptin and were very interested in characterizing the
endogenous protein. Amgen had the capacity to isolate over ten times the
amount of leptin that could be isolated at Rockefeller. The isolation procedures
involved two stages of immunoaffinity chromatography performed on 50 mL of
serum that was pooled from three moderately obese human females.
Subsequently, the protein was eluted from a monoclonal antibody-affinity resin
and subjected to SDS-PAGE and zinc staining. The principal band, well
separated from contaminating and irrelevant proteins, showed the same mobility
as recombinant human leptin (apparent relative molecular mass 16 kDa). The
endogenous band was estimated to contain 250 ng (15 pmol) of leptin.
The gel bands were excised by Amgen and sent to me. I destained the
gels and performed Extraction Method B. The resulting MALDI spectra are
shown in Figure 3.10. When myoglobin was included as an internal calibrant,
the molecular mass for endogenous leptin was measured to be 16,026 ± 9, a
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value identical, within experimental error, to the molecular mass calculated from
the human ob cDNA sequence minus the putative 21 residue N-terminal signal
sequence, 16,024. For recombinant human leptin, the measured mass was
16,178 ± 10. The expected mass of recombinant protein was 16,155. The mass
discrepancy for the recombinant protein was perplexing. It may be attributed to
partial methionine oxidation (+16 Da), giving rise to a heterogeneous mixture
impossible to resolve by low-resolution MALDI-MS. However, there was little
Indication of methionine oxidation in a soluble sample of recombinant leptin (i.e.,
from a stock solution of the protein) when analyzed by ESI-MS, a method which
has can easily resolve oxidation peaks of a 16 kDa protein.
I further compared the proteins by performing in-gel digests with trypsin
followed by MALDI-MS peptide mapping using Extraction Method B. The results
of the digests are shown schematically in Figure 3.11. The peptide maps from
both proteins essentially superimpose, except for the N-terminal start methionine
residue present only in the recombinant protein. Cyanogen bromide digest (data
not shown) confirmed the presence of a C-terminal disulfide bridge in the
endogenous protein. Taken together, the MALDI-MS results unambiguously
showed that endogenous human leptin from obese humans has the wild-type
sequence with the predicted posttranslational processing (Cohen et al., 1996).
The characterization was completed in less than two days. As a follow up, it
would be interesting to characterize leptin isolated from lean humans. However,
such a study would require a scale-up of the IP protocols because of the 4-5 fold
lower levels of leptin in lean vs. obese subjects.
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Figure 3.10 MALDI-MS of human leptins
MALDI-MS of recombinant (top), and endogenous
(bottom) human leptin eluted from SDS-PAGE
gels using gel Extraction Method B . The labeled
masses were obtained from spectra that included
an interal calibrant. See text for details.
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Figure 3.11 Trypsin digestion of fiuman leptins.
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3.7 Conclusions
In addition to the characterization of endogenous proteins, I believe that
the gel extraction/MALDI-MS analysis procedure will be useful in the study of
disease states. Often, diseases result in dramatic changes in the expression
levels of certain proteins as monitored by 2-D gel electrophoresis. These
proteins can also appear on a 2-D gel in a complex manner, sometimes as
multiple 'bands' (a ladder of bands) In either the lEF or the SDS-PAGE
dimensions. I have recently applied the gel extraction/MALDI-MS procedure to
analyze a ladder of bands from a 2-D gel of hepatocyte proteins. The tissue was
from human infants suffering from neuronal ceroid-lipofuscinoses, a fatal
degenerative disease. The biologist involved with this project (Bill Jordan) had
spent over a year attempting to characterize the gel spots using non-MS
methods. Within 4 hours, gel extraction/MALDI-MS of these gel spots revealed a
molecular mass of the major protein and accurate (0.1%) estimations of the
mass differences between the proteins within the ladder.
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Chapter 4 — Proteolysis as a Probe for Protein Structure:
Max and Related Proteins

This chapter discusses the development of a biochemical method to
probe the structure of proteins using proteolysis and mass spectrometry. The
DNA-binding protein Max serves as a model protein. Application of the method
to phosphorylated Max and three proteins related to Max are presented.

4.1 Materials
4.1.1 Proteins
All HLH proteins were from Adrian Ferre-D'Amare (Burley Lab/Rockefeller
University). They were obtained by overexpression in Escherichia Coll and
purified as described previously (Ferre-D'Amare et al., 1993; Ferre-D'Amare,
1994). Sequences of the HLH constructs are given in Figure 4.1. Max: Two
recombinant forms of Max were studied. (1) The basic-helix-loop-helix-leucine
zipper (b/HLH/Z) Max construct (Max 22-113, 92 residues, calc. mass 10,826
Da) (Amati et al., 1993). Full length Max is 160 residues). (2) A C-terminaltruncated construct (MaxAC) that spanned the b/HLH/Z region (Max 22-113) with
the additional 11 N-terminal residues (Max 2-12) resulting in a 103 residue
construct, 12,045 Da. Upstream stimulatory factor (USF): The USF construct
sequence spanned the b/HLH/Z domain (USF 197-310 + N-terminal Met,
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sterol regulatory binding protein 1
b/HLH/Z S R E B P 1
(SREBP1 319-407 + N-term. Gly,
C404S)
90 residues, 10,074 Da

Max
b/HLH/Z Max (Max 22-113)
92 residues, 10,826 Da
21 30 40
I

I

I
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MaxAC
Max 2-12/22-113 (13-21 omitted)
103 residues, 12,045 Da
1 10 20
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Hairy
b/HLH Hairy
(Hairy 30-96, C50S)
90 residues, 10,074 Da
21 30 40
1
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KRRRARimSLNE LKT L "iLD
TvkHLQELQRQQAAMQ

Upstream stimulatory factor (USF)
b/HLH/Z U S F
(USF 197-310 +N-term. Met.
C229S & C248S)
115 residues, 13,423 Da
191 200 210

I
1
1
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Figure 4.1: HLH constructs
Numbering systems are based on
the wild-type sequences. Calculated
average molecular masses are
shown. b/HLH/Z regions are dot
underlined. Basic region is italicized;
loop residues are in bold; leucine
zipper is italicized. Acidic N-terminal
of MaxAC is doubly underlined.
Double underlined residues in U S F
& S R E B P 1 are not in wild-type
sequences.
Lower case letters
indicate wild-type residues that are
omitted in the constructs.

with Cys-to-Ser mutations C229S and C248S; 115 residues, 13,423 Da). Full
length USF is 310 residues. Hairy: Drosophila Hairy protein spanned the b/HLH
region (Hairy 30-96, C50S, 67 residues, 7890 Da). Full length Hairy is 337
residues. Sterol regulatory element binding protein 1 (SREBP1): SREBP1
spanned the b/HLH/Z domain (SREBP1 319-407+N-terminal Gly, C404S, 90
residues, 10,074 Da). Full length SREBP1 is 661 residues. All of the proteins
were normally stored in 10 % glycerol, 100 mM KCl, 10 mM HEPES-KOH (pH
7.5) buffer and kept frozen at -65 or -20°C until used. Concentrations of the
proteins were: b/HLH/Z Max, 3.6 mg/mL (333 ^iM); MaxAC, 1.5 mg/mL (123 i^M);
b/HLH/Z USF, 0.7 mg/mL (52 ^M); b/HLH/Z SREBP1, 3.4 mg/mL (337 ^M);
Hairy, 0.5 mg/mL (63 |aM).

4.1.2 DNA Oligonucleotides
DNA oligonucleotides (oliogos.) were prepared synthetically in the Burley
laboratory (Ferre-D'Amare et al., 1993; Ferre-D'Amare, 1994),
chromatographically purified, annealed and stored in 100 mM KCl, 1 mM MgCl2,

and kept at -20''C until used. A double-stranded, palindromic 14-mer oligo. wit
the sequence 5'-AGGTCACGTGACCT-3' (1.5 mM single strand concentration;
calculated mass, 4264 Da) was used for experiments involving Max, MaxAC,
USF, and Hairy. This oligo. contains the 6 bp recognition E-box sequence

(underlined in the sequence above) that is specific for high affinity DNA-bindi
(sDNA). Other E-box containing oligos. were the 18-mer
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5'-GTAGGTCACGTGACCTAC-3' palindrome (1.25 m M ss. cone; 5500 Da), and
the 16-mer 5'-TAGGCCACGTGACCGG-3' non-palindrome (0.63 mM of each
strand, 4908 Da (top strand) and 4858 Da (bottom strand with the
complementary sequence)). The sterol regulatory element (SRE) nonpalindromic 14-mer DNA oligo. had the sequence 5'-GTATCACCCCACTT-3' (0.6
mM of each strand; 4159 and 4369 Da). The 10 bp SRE is underlined. The
double-stranded 14-mer with the sequence 5'-AGCTATAAAAGGGC-3' (TATA
DNA) (1.5 mM each strand; 4322 & 4205 Da) served as the non-specific DNA
(nsDNA). Another nsDNA oligo. was NOT I linker (New England BioLabs) with
the palindromic sequence 5'-TTGCGGCCGCAA-3' (200 }aM; 3,647 Da).

4.1.3 Other Materials
Casein kinase II (CKII; 20 |aL, 10K units) was purchased in recombinant
form from New England BioLabs. The sample of CKII was divided into 0.7 \iL
aliquots into separate 0.65 mL microtubes and stored at -70°C until needed.

Dividing the sample avoids repetitive freeze-thaw cycles. The CKII concentration
was given as 0.7 mg/mL (~5 pmol/|LiL). The buffer for performing the CKII
phosphorylation was also supplied (10X) by New England BioLabs. The buffer
(IX) consisted of 20 mM Tris (pH 7.5), 50 mM KCl, and 10 mM MgCl2. ATP was
from Sigma. All other materials —proteases, buffers, MALDI matrix solutions—
are described in the Materials section of chapter 2.
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4.1.4 Proteases —Preparation, Storage and Specificities
Endo Glu-C, Arg-C, Asp-N, and Lys-C were kept as lyophilized powder at
4°C for up to a year. To a 50 i^g of sample of protease (typical amount
purchased from Promega or Boehringer Mannheim) was added 100 |JL of
distilled water. The solution was distributed in 10 ^iL aliquots into 0.65 mL
microtubes. When possible, the aliquoted samples were fast-frozen in liquid
nitrogen. They were immediately lyophilized in a Speed-Vac (no heat) and
stored under desiccant at 4°C. Trypsin and chymotrypsin were treated the same
way but using 1 mM HCl instead of water to reconstitute the enzyme. I found
that once resuspended in solution, the enzymes remained active for a few days
when stored at 4°C. Subtilisin preparation: 1-2 mg of subtilisin powder was
dissolved into buffer to make a 2 |^g/|LiL solution. The subtilisin buffer was 810
nL of 100 mM ammonium acetate (pH 7) + 210 |nL of 500 mM CaClj. The 2
|ig/|aL subtilisin solution was then diluted with the buffer solution 1:20 (v/v) to
make a 100 ng/j^L working solution of subtilisin which was stored at 4°C.
Subtilisin remains active for many days in these solutions. For critical work, it's
best to prepare a fresh solution of proteases. Read the inserts that usually
accompany the enzymes when they are shipped by the manufacturer. Two
practical and excellent references for proteolysis are Hames & Rickwood, 1989
and Keil, 1992. A good source for theory and applications of proteolytic
enzymology can be found in Mihaiyi, 1978.
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Activities & specificities of proteases: I found that all of the proteases
used in my studies showed good enzymatic activities when used in solutions of
pH 6 to 8. Here is list some of the 'gross' details of enzyme specificity. More
subtle details of specificity depend on many factors that are frequently substrate
dependent. Endo Glu-C (V8) targets primarily glutamate residues, regardless of
the buffer used, for most of the proteins that I've studied. Aspartic residues are
secondary targets of V8 that cleave only after many hours or days of incubation.
In a protein dependent manner, Endo Asp-N targets aspartate residues, but has
some moderate activity towards glutamate. Lys-C virtually always targets
lysines; trypsin targets exclusively lysine and arginine residues; Arg-C will
hydrolyze at arginine residues, although this enzyme (from either Promega or
Sigma) is not a good as Lys-C in its 'thoroughness' and tends to show a lot of
non-specific cleavages. Chymotrypsin targets tyrosine and tryptophan and less
avidly, phenylalanine. Over a longer period (several hours to days) chymotrypsin
begins to cleave at non-aromatic residues. Finally, subtilisin has the least
degree of specificity, cleaving after many types of residues.

4.2 Methods
4.2.1 MaxAC Phosphorylation
MaxAC was phosphorylated (when needed) with casein kinase II (CKII)
according to the procedures given by New England BioLabs. Normally 15-30 \x\-
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of 15-30 liM MaxAC, prepared in N E BioLabs buffer (see materials), w a s mixed
with ATP (to yield 200 |aM ATP) plus an aliquot (-0.7 ^L) of CKII.
Phosphorylation was performed at 30X and was usually complete in 1-2 hr.

4.2.2 Proteolytic Digestions
The stock solution of Max (or other HLH proteins) were thawed to room
temperature and diluted with a 50 mM ammonium phosphate pH 6.0 buffer that
included 1 mM Mg(0Ac)2. A pH of 6 was adequate for high enzymatic activity
towards any of the proteins (without DNA) for all six proteases used in this study.
Incidentally, pH 5.5 was used to prepare crystals in the original X-ray
crystallographic study of the Max-DNA complex (Ferre-D'Amare et al., 1993).
The final digest solution usually consisted of 30 |uL of 30 fiM protein (monomer
concentration). Smaller solution volumes as well as lower protein concentrations
can be used when less protein is available. For each proteolytic digest
experiment at least three 30 ^L preparations were made: (-) DNA, (+) sDNA and
(+) nsDNA. Duplex DNA was added to the solution in a ~1.5-fold molar excess
over HLH dimer. The solutions were allowed to incubate at room temperature for
ten minutes prior to the initiation of digestion. Digestion was started by the
addition of an aliquot of an aqueous solution of a specific protease. The ratio of
protease:protein ranged from 1:20 to 1:40 (w/w). The samples were hand
shaken BUT NOT VORTEXED. All digests were performed at 25°C, although
subtilisin and trypsin digests can be performed at lower temperatures. The time
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course M A L D I - M S peptide analyses were carried out in the following manner.
One half i^L aliquots of the digest solution were withdrawn and mixed with 15 [iL
of MALDI matrix solution (full details in Chapter 2) at the times 1, 2, 5, 15 min.; 1,
2, 4, 8 hr.; and 1, 2 day intervals following the start of digestion. The acidity of
the matrix solution (pH < 3) completely quenched any further digestion. MALDIMS was performed as described in Chapter 2.
A DOS computer program (PEPTIDE, written by David Fenyo) greatly
facilitated the proteolytic mapping assignments. Currently the utilities
"Proteinlnfo" and "PAWS" in the PROWL environment (URL http://chaitsgi.rockefeller.edu) are extremely useful for peptide mapping assignments and
searching for protein information. The Insight II program (Biosym Technologies,
San Diego, CA), run on an Indigo 2 workstation (Silicon Graphics, Mountain
View, CA), was used to create Figure 4.12. Coordinates of the b/HLH/Z MaxDNA X-ray crystallographic complex were supplied by Adrian Ferre-D'Amare.

4.3 Introduction — Max

Max is a small transcription factor (Prendergast et al., 1991; Blackwood
and Eisenman, 1991) important for the regulation of cell development,
proliferation, differentiation, and apoptosis. Max is a member of the basic/helixloop-helix/zipper (b/HLH/Z) family of DNA-binding proteins, a subset of the HLH
family of proteins (Murre et al., 1989) (>100 proteins) found in a broad range of
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species from Drosophila to human (Littlewood T D and Evan, 1994). Generally,
the HLH proteins form homodimers and heterodimer complexes with each other
that are competent for DNA binding. The DNA recognition sites for high affinity
binding of most HLH proteins are termed E-boxes, consisting of the six-base pair
palindromic sequences 5'-CACGTG-3' or 5'-CAGCTG-3'.
In vivo, Max homodimerizes with itself as well as heterodimerizes with the
proteins Mad and Mxil (Ayer et al., 1993; Zervos et al., 1993). Max is also the
obligate in vivo dimerization partner of the oncoprotein c-Myc (Blackwood et al.,
1992; Amati et al., 1993). c-myc is a highly studied oncogene that has been
implicated in many types of human cancers (Cole, 1986; Marcu et al., 1992).
The oncogenic activity of myc has been shown to arise from processes such
DNA amplification, chromosomal translocation, and point mutations, events that
lead to the disruption of tight transcriptional controls over the production and
frans-activation activity of the myc gene product, c-Myc (Marcu et al., 1992;
Rabbitts, 1994). There is growing evidence for the existence of a transcriptional
suppression network consisting of Myc, Max, Mad, and Mxil (Bernards, 1995).
In this network, c-Myc transactivation occurs through the Myc-Max heterodimer
binding to E-box consensus sites (CACGTG) in Myc-responsive promoters
(Blackwood et al., 1992; Kato et al., 1992; Amati et al., 1993). Max homodimers
also bind to these sites. However, since Max lacks a transactivation domain.
Max homodimers do not activate transcription, but rather repress E-box
containing promoters through competition with Myc-Max heterodimers and
possibly other HLH transcription factors (Kretzner et al., 1992; Prendergast et al.,
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MAD
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MAX

-RAOILDKATEYIQYMRRKNHTHOODIDDLKRONALLEOOVRALEKARSSAOLOT. {160)

cMYC

-KWILKKATAYILSVQAEEQKLISEEDLLRKRREQLKHKLEQLRNSCA(439)

MAD

-TLSLLTKAKLHIKKLEDCDRKAVHQIDQLQREQRHLKRQLEKLGIERIRMDSIG. {221)

USF

-KGGILSKACDYIQELRQSNHRLSEELQGLDQLQLDNDVLRQQVEDLKNKNLLLR. {310)

SREBPl

-KSAVLRKAIDYIRFLQHSNQKLKQENLSLRTAVHKSKSLKDLVSACGSGGNTDV. {661)

HAIRY

-KLEKADILEKTVKHLQELQRQQAAMQQAADPKIVNKFKAGFADCVNEVSRFPGI. {337)

IDl

-KVEILQHVIDYIRDLQLELNSESEVGTTGGRGLPVRAPLSTLNGEISALAAEAA. {176)

F I G U R E 4.2 Sequence

alignment of HLH proteins

Sequence alignment of the D N A binding domains of mammalian M a x with
b/HLH/Z proteins c-Myc, Mad, USF, and S R E B P l ; b/HLH protein Hairy; and H L H
protein Id. Boundaries of the basic, helix I, loop, helix II, and zipper regions are
denoted above the sequences.

Conserved (homologous) residues are

highlighted in bold and underlined for Max. The five heptad repeat residues of
the leucine zipper are doubly underlined. The helix-breaking proline residue in
the basic region of Hairy is underlined. Id does not have a basic region. The
N- and C-termini residues are numbered (in brackets) according to the complete
sequence of each protein. Except for c-Myc, the sequences continue to the
C-terminus residue of each protein, whose number is italicized.
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1992; Amati et al., 1993). Both M a d and Mxil also lack transactivation domains
and their heterodimerization with Max antagonizes the transformation effects of
c-Myc (Bernards, 1995). More recently, the Sin3 proteins were shown to interact
with Mad and strongly suppress c-Myc activation when recruited to form MaxMad-Sin3 DNA-bound ternary complexes (Ayer et al., 1995; Schreiber-Agus et
al., 1995).
Sequence alignment of the DNA-binding regions of various HLH proteins
is shown in Figure 4.2. The figure includes the b/HLH/Z proteins Max, c-Myc,
Mad, the upstream stimulatory factor (USF), the sterol regulatory element
binding protein 1 (SREBPl); the b/HLH protein Hairy, and the HLH protein Id.
USF (Sawadogo and Roeder, 1985) is a b/HLH/Z transcription factor that forms
homodimers; there is evidence for tetramerization of USF, a process that may
mediate DNA looping (Ferre-D'Amare et al., 1994). SREBPl is a fra/is-activator
for the low density lipoprotein (LDL) gene (Yokoyama et al., 1993; Wang et al.,
1994). Unlike most other b/HLH and b/HLH/Z proteins, SREBPl only weakly
recognizes the canonical 6 bp E-box motifs. Instead, SREBPl binds to a 10 bp
DNA sequence called the sterol regulatory element (SRE). The b/HLH protein
Hairy lacks a leucine zipper and has a helix-breaking proline residue within its
basic region. Finally, Id (inhibitor of DNA binding) shows no sequence homology
with other HLH proteins within the basic N-terminal region. Id is believed to
dimerize with specific b/HLH targets through the HLH dimerization interface.
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effectively inhibiting D N A binding and the transcriptional activity of the b/HLH
dimerization partner in a dominant negative manner (Benezra et al., 1990).
Fig 4.2 shows that the HLH proteins share high sequence homologies in
regions that allow them to interact with each other as well as to bind DNA
(Baxevanis and Vinson, 1993). Max was the first HLH protein whose threedimensional structure was determined and clearly revealed the nature of the
dimerization and DNA-binding interactions (Ferre-D'Amare et al., 1993). The
crystal structure, solved at 2.9 A by X-ray crystallography, showed that the Max
b/HLH/Z domain binds to its cognate DNA as a symmetric homodimer. Figure
4.3 shows a ribbon diagram of the b/HLH/Z Max-DNA complex from the X-ray
crystallographic study (Ferre-D'Amare et al., 1993). There are four features
deduced from the structure of the Max-DNA complex that are of consequence for
the present study. These are that (1) Max binds the major groove of E-box DNA
as a symmetric homodimer with its N-terminal alpha-helical basic regions,
grabbing the DNA in a 'scissors grip' fashion; (2) the HLH region folds into a
parallel, left-handed, four-helix bundle which is apposed to the DNA; (3) a

parallel coiled coil (i.e., a 'leucine zipper') extends immediately C-terminal to the
four-helix bundle; and (4) C-terminal to the zipper, the protein becomes random
coil. The structures of three other homodimeric b/HLH proteins —all bound to
their cognate DNA— have been determined by X-ray crystallography [b/HLH
USF (Ferre-D'Amare et al., 1994), E47 (Ellenberger et al., 1994), and MyoD (Ma
et al, 1994)], providing further structural information about the HLH proteins. In
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Figure 4.3

The b/HLH/Z Max-DNA

complex

A ribbon diagram of the X-ray crystallographic structure of the b/HLH/Z Max-DNA
complex (Ferre-D'Amare et al., 1993). The peptide backbones tracing the two
Max monomers are outlined as ribbons. The N-termini (residue 22) are at the
bottom, the C-termini (residue 107) are at the top. The coordinates of the last
residues (108-113) were not available because the X-ray crystallographic
electron density map indicated that these residues were random coil. The
4-helix bundle and leucine zipper tertiary structural elements are labeled. The

duplex DNA containing the E-box recognition site is outlined across the bottom o
the figure.
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Leucine
Zipper

addition to the crystallographic analyses, studies using genetic (i.e., mutational)
and biochemical techniques have provided insight into structural features that
control the dimerization, DNA-binding specificities and functions of Max and
other HLH proteins (reviewed in Littlewood and Evan, 1994).
To further elucidate the biochemical mode of action of Max and other
members of the biologically important helix-loop-helix family, it is necessary to
understand the relationship between the structures and functions of these
proteins in solution. However, little is known about the structure of the HLH
proteins in solution, although NMR spectroscopy has been used to study a
disulfide-linked dimer of a MyoD-bHLH peptide, which is inactive in DNA binding
(Starovasnik et al., 1992), and electron paramagnetic resonance spectroscopy
has been used to distinguish between alternate folding topologies of a MyoD
bHLH peptide (Anthony-Cahill et al., 1992). (Incidentally, no X-ray
crystallographic information is available on the structure of Max in the absence of
DNA due to a failure of crystallization of unbound protein.) Although
multidimensional NMR spectroscopy and mutational analyses are of pivotal utility
for solution studies of proteins, it remains desirable to develop additional
complementary biochemical approaches that can be applied with ease and
speed.
In this present study, I developed an approach that combines enzymatic
proteolysis with mass spectrometry to investigate the solution behavior of the
Max protein. The method involves performing time-course limited proteolytic
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digestions of the protein in both the absence and presence of D N A (Fig. 4.4).
Evaluation of the resultant proteolytic fragmentation patterns along with the rates
of digestion provides information about cleavage site accessibility and flexibility
of the protein in solution. Fundamental to this approach is the notion of
protection against proteolysis. Protection is conferred on regions of the protein
that are buried, are within a rigid structure, or are involved in protein-protein or
protein-DNA interactions. In contrast, regions of the protein that are solvent
accessible and flexible or unstructured will be less protected and therefore
susceptible to proteolytic cleavage (Fruton, 1975; Fontana, 1989; Hubbard et al.,
1994). An essential requirement of the method is a facile and accurate
identification of the proteolytic products. MALDI-MS serves this analytical need
well because of its superior ability for measuring the molecular masses of
mixtures of peptides and proteins (discussed in Chapter 2). Because of the
speed and mass accuracies associated with MALDI-MS, the progress of a large
number of enzymatic digestions and surveying a wide variety of solution
conditions can be achieved practically 'on the fly'.
This study of Max was partly retrospective because the b/HLH/Z MaxDNA X-ray crystallographic structure (Ferre-D'Amare et al., 1993) was available
for a comparative analysis. In the proteolysis study I addressed several specific
questions concerning b/HLH/Z Max. What are the structural characteristics of
Max in the absence of DNA? How does solution ionic strength affect the
structure of the protein? How does the presence of DNA alter the protein? How
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Figure 4.4 Proteolytic protection assay
A n illustration of the m a s s spectrometric proteolytic protection assay. The
figure compares m a s s spectrometric peptide m a p s obtained by enzymatic
proteolysis of a hypothetical DNA-binding protein, in the absence and presence
of D N A .

A thick black line traces the polypeptide backbone of the protein

containing three proteolytic cleavage sites. A: In the absence of D N A , the
protein is proteolyticaUy cleaved into four peptide fragments (a, b, c, and d). The
m a s s spectrum of the resulting digest shows four peaks with masses that can be
determined with sufficient accuracy to unambiguously identify the four peptide
fragments.

B: In the presence of D N A , one of the three potential sites of

proteolysis becomes protected following D N A binding. Under these conditions,
the protein is cleaved into three fragments (a, d, and b+c) that can be identified
in the m a s s spectrum. Because the site between b and c is protected against
proteolysis, a single peak, corresponding to the combined fragment b+c, appears
at higher mass. Comparison of the mass spectra provides information regarding
the DNA-binding region. The scheme illustrated is a simplification of the actual
requirements for cleavage. In addition to accessibility, there is also the necessity
that the cleavage sites be located within flexible segments of the protein, in order
to optimize interaction with the extended active site of the protease (Fruton,
1975; Hubbard etal., 1994).
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a b e d
proteolysis
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does the solution structure of the M a x - D N A complex compare to the structure
deduced from X-ray crystallography?

4.4 Results
Max protein (with and without DNA) was subjected to time-course
measurements of proteolysis employing six different endoproteases: Glu-C (V8),
Lys-C, Asp-N, trypsin, chymotrypsin and subtilisin. MALDI-MS was used to
follow the digestions and accurately map the sites of cleavage in the protein.

4.4.1 V8 Proteolysis of b/HLH/Z Max in the Absence of DNA
Figure 4.5 shows the time-course of a V8 digest of Max in the absence of
DNA. V8 protease targets primarily glutamate residues, of which b/HLH/Z Max
has five (see Figure 4.1). The digestions were performed at 25°C in 50 mM
ammonium phosphate buffer (pH 6) and at a low salt concentration (15 mM KCl).
The masses of the proteolytic fragments were determined with sufficient
accuracy to enable their unambiguous identification. In the absence of DNA, V8
protease digests Max very rapidly (Figure 4.5a-c). After just two minutes,
considerable cleavage is observed from all five glutamate residues (Figure 4.5b).
By one hour, the digestion is nearly complete (Figure 4.5c). These findings
demonstrate that, in the absence of DNA and at low salt, b/HLH/Z Max adopts a
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Figure 4.5 V8 digest of b/HLH/Z Max in the absence of DNA
MALDI mass spectra of the products of a time-course V8 proteolysis of
b/HLH/Z Max in the absence of DNA. Digests were performed in 1 5 m M KCl
at pH 6 buffer and 25°C. Three time points are shown, a: 0 s (before addition
of V8); b: 2 min of digestion; and c: 1 hr of digestion. Singly charged V 8
fragment ions are labeled with their sequences. Multiply charged fragment
peaks are marked with the pound symbol, #. Peaks labeled 1+ arise form the
singly protonated monomeric M a x protein. Peaks labeled 2+-4+ arise from
multiply protonated monomeric Max resulting from the MALDI process.
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form that is highly susceptible to V 8 proteolysis, correlating to a rather open and
flexible structure.

4.4.2 V8 Proteolysis in the Presence of Max-specific DNA
The presence of a 50% excess molar quantity (over protein) of a 14-mer
Max-specific DNA oligonucleotide (sDNA; see Materials) leads to a dramatic
decrease in the proteolytic susceptibility of the protein. Thus, after a two minute
period, Max exhibited no V8 digestion (compare Figure 4.6b to Figure 4.5b).
After one hour, only a hint of digestion has occurred and this from the C-terminal
(fragment 22-103, Figure 4.6c). Even following 48 hours of digestion, a
significant fraction of Max remains undigested (Figure 4.7). The fragmentation
that does occur by 48 hours falls into two categories. The first resembles the
complete digestion observed in the absence of DNA. The second arises from
highly selective partial proteolysis of Max to yield two C-terminally truncated
fragments, 22-103 and 22-96. These two fragments appear sequentially, first
22-103 (after one hour. Figure 4.6c) followed by 22-96 (after several hours,
Figure 4.7). The long persistence of intact protein and fragments 22-103 and
22-96 indicates that in the presence of sDNA, Max adopts a form that is highly
protected against V8 proteolysis. In addition, fragments 22-96 and 22-103 retain
a high level of protection against further digestion, suggesting that these
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Figure 4.6 V8 digest of b/HLH/Z Max in the presence of E-box DNA
MALDI mass spectra of the products of a time-course V8 proteolysis of
b/HLH/Z Max in the presence of E-Box DNA. Digests were performed in
15mM KCl at pH 6 buffer and 25°C. Three time points are shown, a: 0 s
(before addition of V8); b: 2 min of digestion; and c: 1 hr of digestion. See
Figure 4.5 caption for full description of all labels and symbols.
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Figure 4.7 V8 digest (48 hr) of b/HLH/Z Max + E-box DNA.
TOP: MALDI mass spectrum of a 48 hr V8 digest of Max in the
presence of Max-specific (E-box) D N A . T w o peaks, 22-96 and
22-103 are the singly protonated V 8 digest fragments of the protein.
Peaks labeled with an asterisk represent complete V 8 digest
fragments.
B O T T O M : Linear diagram of the sequence of b/HLH/Z Max showing
the two V 8 cleavage sites in the DNA-bound form of the protein that
are accessible to protease (open arrows pointing to Glu96 and
Glu103) out of the five Glu residues accessible to V 8 in the unbound
form of Max (solid arrowheads).
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fragments remain tightly bound to D N A .

Results of the 48 hour partial V 8

proteolysis are summarized in the diagram at the bottom of Figure 4.7

4.4.3 V8 Proteolysis in the Presence of Non-specific DNA
Figure 4.8a shows a five minute V8 digest of Max performed in the
presence of a 14-mer non-specific DNA (nsDNA), which does not contain the
E-box Max recognition site (TATA DNA; see Materials). From Figures 4.8a and
4.5b, it is seen that the rate of digestion of Max has slowed in the presence of
nsDNA compared to that in the absence of DNA. The rate of digestion, however,
is considerably greater than that observed in the presence of sDNA (compare
Figures 4.8a and 4.6c). Figure 4.8a shows that after five minutes of digestion of
Max in the presence of nsDNA, two principal components dominate. The first is
undigested Max and the second is the fragment 33-113, which arises from a
cleavage in the N-terminal region of the protein. A minor amount of cleavage
from the C-terminal region is also seen (fragments 33-103, 22-96, and 22-103).
This pattern of fragmentation shows that in the presence of nsDNA, susceptibility
to V8 proteolysis follows the order N-terminal region » leucine zipper >
four-helix bundle. Following rapid cleavage of the N-terminal of the protein,
digestion of the remaining V8 sites is slower, requiring over four hours for
completion (data not shown). These results indicate that the presence of nsDNA
reduces the susceptibility of the helix-loop-helix-zipper regions of Max to V8
proteolysis, possibly through non-specific DNA interactions. In an attempt to
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Figure 4.8 V8 digest of b/HLH/Z Max with nsDNA

11
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or salt.

TOP: a, MALDI mass spectrum of a 5-min V8 digest of b/HLH/Z Max
performed in the presence of nsDNA (TATA DNA; see Materials). Digest
was carried out at 15 m M KCl. Cleavage at the N-terminal of Max gives rise
to the peptide 33-113. (For simplicity, only the high-mass portion of the
spectrum is shown); and b, MALDI mass spectrum of a 5-min V 8 digest of
b/HLH/Z Max in the absence of D N A but at 150 m M KCl. Note the similarity
of two the spectra. BOTTOIVI: Linear diagram summarizes the V 8 results.
Solid arrowhead indicate Glu residues. Dark arrow signifies most rapid
cleavage (min); open arrows signify slower cleavage (min-hrs).
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diminish such non-specific interactions, a V 8 digest of M a x (in the presence of
nsDNA) was carried out at 150 mM KCl (data not shown). The rates and
patterns of V8 cleavage of Max under these conditions were similar to those
obtained at 15 mM KCl. It should be recognized, however, that an elevated salt
level by itself promotes a tightening of the dimeric structure of the protein (see
below.)

4.4.4 Proteolysis and the Effects of Ionic Strength
Increasing the ionic strength had notable effects on the V8 proteolysis of
Max in the absence of DNA. Figure 4.8b shows a five minute V8 digest of Max
in 50 mM buffer and 150 mM KCl. Compared to the digestion carried out under
low salt conditions (15 mM KCl), the elevated ionic strength leads to a modest
reduction in the rates of proteolysis and a large change in the patterns of
fragmentation (compare Figure 4.8b and 4.5b). At elevated ionic strength,
digestion occurs primarily from the N-terminal and to a lesser extent from the
C-terminal regions of Max (Figure 4.8b). Even after one hour of digestion, there
remains a portion of high-mass peptides, fragments 33-96, 33-103 and 33-113
(data not shown). These findings indicate that physiological salt levels lead to a
considerable protection against proteolysis of the four-helix bundle. Two other
points are noteworthy. First, the pattern of proteolytic cleavage of Max,
measured at physiological salt levels (Figure 4.8b), is remarkably similar to the
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pattern obtained in the presence of n s D N A and low salt (Figure 4.8a). Second,
moderate ionic strengths (150 mM KCl) have little effect on either the rates or
patterns of proteolysis of Max in the presence of sDNA (data not shown).

4.4.5 Proteolysis of the Leucine Zipper
A sequential proteolytic removal of residues of the leucine zipper was
shown to occur during the V8 digestion of Max (Figs. 4.6a-c and 4.7). Similar
and even more striking effects on the leucine zipper were observed with the use
of trypsin and subtilisin. Subtilisin has the broadest specificity of all the
endoproteases used in this study. After just one minute, in the absence of DNA,
Max undergoes extensive digestion by subtilisin, leaving very little starting
protein intact (Figure 4.9a). By one hour, only small peptide fragments (<2500
Da) remain (data not shown). This outcome changes dramatically in the
presence of sDNA. At one minute of digestion, a highly selective cleavage has
occurred between residues 108 and 109 on a portion of the protein, although a
substantial proportion of Max (>50%) remains undigested (Figure 4.9b). After
four hours, digestion continues to occur exclusively from the C-terminal region in
a sequential manner (Figure 4.10a). Over the next two days, the fragmentation
progresses sequentially through the leucine zipper, in the N-terminal direction
until just three.fragments dominate, 22-77, 22-83 and 22-84 (Figure 4.10c). The
progression of cleavage abruptly stalls at residue 77, near the base of the
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Figure 4.9 Subtilisin digest (1 min) of b/HLH/Z

Max (-/+) DNA.

MALDI mass spectra of the subtilisin proteolysis of b/HLH/Z Max.
a: The 1-min subtilisin digest in the absence of D N A . Extensive
cleavage has occurred. The large number fragment peaks are not
labeled, b: The 1-min subtilisin proteolysis of M a x in the presence of
E-box DNA. Rapid cleavage at residue 108 is observed resulting in the
fragment 22-108.
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Figure 4.10 Subtilisin digest of b/HLH/Z Max (+) E-box DNA.
MALDI mass spectra of the subtilisin proteolysis of b/HLH/Z Max in
presence of E-box DNA. a, b, c: The 1-min, 4-hr, and 2-day subtilisin
proteolysis. Only the relevant high mass regions are shown. The
spectrum in a is shown complete in Figure 4.9b. Rapid cleavage at
residue 108 is followed by a slow, sequential cleavage through the
leucine zipper. Cleavage stalls at residue 77.
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leucine zipper and just above the four-helix bundle. This 'unzipping and stalling'
pattern also appears in the V8 digest results (Figures 4.6 and 4.7) and the
trypsin results (data not shown). For the trypsin digestion, the progression of
cleavage stalls at residue 75.

4.4.6 Additional Proteases
In a manner similar to the above-described experiments with V8, subtilisin
and trypsin. Max was also extensively studied with endo Asp-N, Lys-C, and
chymotrypsin. Several coherent themes emerge by combining the results
obtained using all six proteases. First, the cleavage of Max, in the absence of
DNA and at low ionic strengths, was virtually complete after two hours of
digestion by any of the six proteases. Elevated ionic strengths slowed the V8
proteolysis considerably (Figure 4.8b) but had relatively less effect in slowing the
digestions of Max with the five other proteases. A second theme was that in the
presence of sDNA the rates of digestion of Max were greatly lowered —as
previously described for the V8 and subtilisin results. Over a two day period, all
of the proteases studied showed some degree of complete as well as partial
digestion of the Max-DNA complex. The extent of complete digestion
varied—V8, Lys-C and chymotrypsin showed the greatest whereas Asp-N
showed the least.
The data involving partial digestion are the most informative in
characterizing the Max-DNA structure. Results for six of the proteases are
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Figure 4.11 Summary

of proteolysis of the b/HLH/Z Max-DNA

complex

Results summarizing the partial proteolysis of b/HLH/Z M a x in the presence of
D N A by the endoproteases Glu-C, Asp-N, chymotrypsin, Lys-C, trypsin, and
subtilisin. Small arrowheads inside the diagrams point to the respective potential
proteolytic cleavage sites. The cleavage sites can be divided Into two types:
those that are cleaved by protease in the absence of D N A (indicated by the solid
arrowheads) and those that are not cleaved in the absence of D N A (indicated by
open arrowheads). The large arrows outside the diagrams point to sites of
proteolysis of the M a x - D N A complex, as measured by MALDI-MS, that result in
fragments which maintain DNA-binding.

Three levels of proteolysis are

represented: a solid arrow signifies a rapid and complete cleavage (minutes to
hours), an open arrow signifies a slower and nearly complete cleavage (hours to
2 days), and an arrow drawn in broken outline Indicates a very slow and
incomplete cleavage (2 days or more).

Proteolysis by Asp-N included the

non-specific cleavage between Ala105 and Arg106 which did not occur in the
absence of D N A . Proteolysis by subtilisin occurred sequentially over a two day
period through the C-terminal in the direction given by the horizontal arrow.
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summarized in Figure 4.11. The diagrams depicted in these figures show the
observed sites of cleavage which lead to fragments that maintain DNA binding.
The Lys-C and chymotrypsin results can serve as examples for elucidation.
Over a period of three days, Lys-C proteolysis of the Max-DNA complex leads to
complete as well as partial digestion (data not shown). Partial proteolysis results
in three high-mass peptides: 25-77, 25-104, and 25-113. These fragments
show significant resistance to digestion, suggesting that they remain bound to
DNA. These findings are summarized on the Lys-C diagram of Figure 4.11: the
solid arrow at the N-terminal signifies complete cleavage (within 12 hours) at Lys
24; the open arrows at the leucine zipper and C-terminal regions signify
incomplete cleavage (after one day) at Lys 77 and 104. In contrast, the
chymotrypsin digest of the Max-DNA complex did not produce any long-lived
partial proteolytic fragments. After one day of chymotrypsin treatment of Max,
only undigested protein and a modest amount of completely digested Max was
observed (data not shown). Thus, no arrows are drawn in the chymotrypsin
diagram depicted in Figure 4.11.

4.4.7 The Proteolytic Protection map
The current findings can be presented in the context of the X-ray crystal
structure of b/HLH/Z Max-DNA. Figure 4.12 shows a colored version of the
ribbon diagram (Ferre-D'Amare et al., 1993) shown earlier (Figure 4.3)
superimposed with results from the Max proteolysis experiments. Amino acid
residues that are targets of cleavage (by the six endoproteases used in the
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Figure 4.12 Proteolytic protection map of the b/HLH/Z Max-DNA

complex

The proteolytic protection m a p is a depiction of the combined results of analyses
by M A L D I - M S of a large number of proteolytic digestions performed on M a x (in
the presence of Max-specific D N A ) with the endoproteases V8, Lys-C, Asp-N,
chymotrypsin, trypsin and subtilisin. Using a color-coded measure of protection
against proteolysis, the figure w a s created by superimposing the M A L D I - M S
proteolysis results onto a ribbon diagram of the X-ray crystal structure of the
M a x - D N A complex (Ferre-D'Amare et al., 1993). The peptide backbone tracing
the two M a x monomers are outlined as white and pink ribbons. The N-termini
(residue 22) are at the bottom, the C-termini (residue 107) are at the top. The
coordinates of the last six residues (108-113) were not available because the
X-ray crystallographic electron density m a p indicated that these residues were
random coil (they would be colored red in the diagram). Amino acid residues
that are proteolytic targets have their sidechains highlighted as colored spheres
in a space-filling representation. (All highlighted sites were shown to rapidly
cleave in the absence of D N A ) . The three colors reflect a relative measure of
protection against partial proteolysis at the highlighted residue. Blue represents
the sidechains that dramatically resist proteolysis over a 2-4 day period. Green
indicates less protection where complete or partial proteolysis at these sites has
occurred over this time. Red represents the lowest level of protection, where
complete cleavage at these sites occurred in less than one day. Protection from
proteolytic cleavage at the 'blue' sites together with cleavage at either a 'green'
or 'red' site results in a truncated form of the protein which remains bound to
DNA.
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study) are depicted as colored spheres in a space-filling representation; for
clarity, other residues are omitted (see figure caption for complete description.)
The colors correspond to the three levels of protection against partial proteolysis
of the Max-DNA complex that allows for the maintenance of DNA binding. Blue
represents the greatest degree of protection, where no partial proteolysis was
observed over two to four days of digestion. Green indicates a lesser degree of
protection, where complete or partial proteolysis at these sites has occurred over
this time. Red represents the least amount of protection, where complete
cleavage at these residues has occurred in less than one day.

4.5 DISCUSSION

4.5.1 Max in the Absence of DNA
Under conditions of low salt (50 mM buffer, 15 mM KCl, 1 mM MgCy,
Max exhibits little resistance to digestion by six different endoproteases. The
rates of digestion of Max are similar to those usually observed for denatured
proteins or peptides. With the use of V8 protease, for example, the digestion
occurs rapidly and indiscriminately at all five glutamate residues of Max and is
nearly complete in one hour (Figure 4.5a-c). These findings demonstrate that at
low ionic strengths. Max has an open, flexible structure, one that has insufficient
higher-order folding and/or rigidity to resist rapid proteolytic digestion. Although
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these results do not allow us to conclude that the protein is in an oligomeric form
other than a monomer, they suggest that any self-association is weak at low
ionic strengths.
Elevation of the ionic strength has pronounced effects on the V8 digestion
of Max (Figure 4.8b), although the effects with the other proteases were less
dramatic. These distinctions may be related to the differences in the activities
and the modes of action of the proteases. At 150 mM KCl the rate of V8
proteolysis of Max drops by almost an order of magnitude compared to
observations under low ionic strengths. Two factors may account for this
reduction of proteolytic rates. Elevated chloride ion has previously been
observed to inhibit V8 activity (Sorensen et al., 1991) and is predicted to give an
approximate two-fold decrease in V8 activity in going from 15 mM to 150 mM
KCl. The second factor is based on the notion that elevated ionic strengths may
induce a structural change of the protein; evidence for this is suggested by the
observed changes in the pattern of cleavage by V8 at elevated salt levels. The
cleavage pattern indicates three regions of proteolytic protection that decrease in
the order four-helix bundle > leucine zipper » N-terminal region. By
extrapolating from the X-ray crystal structure of the Max-DNA complex, this order
of proteolytic protection appears to correlate to the extent of hydrophobic
interactions found within each region. The greatest number of hydrophobic
interactions are found within the four-helix bundle, less in the leucine zipper and
fewest in the N-terminal, which, in the absence of DNA, is expected to be a
random coil (Ferre-D'Amare et al., 1993). These correlations of proteolytic
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protection with hydrophobic interactions indicate that physiological salt levels
favor a dimeric form of Max. Because dimerization occurs mainly through
hydrophobic interactions found within the four-helix bundle and leucine zipper
domains, an elevation of the salt level is predicted to stabilize the dimer.

4.5.2 Max in the Presence of DNA
My findings are summarized as follows. (1) In the presence of DNA, both
complete and partial proteolysis of Max were observed, the extent of which was
protease dependent. The fragmentation patterns of partial proteolysis were the
most informative for the studies. (2) In the presence of DNA, striking changes
were observed in the rates and patterns of proteolysis of Max. The effective
rates of proteolysis were greatly reduced —by up to a hundred fold— compared
to those seen in the absence of DNA. The steep drop in rates indicates that in
the presence of DNA, Max undergoes structural changes which correlate to a

significant reduction of solvent accessibility and/or flexibility of the protein. (3)
With each of the proteases used, the patterns of proteolysis were dependent on
the nature of DNA present in solution. In the presence of sDNA, the N-terminal
of Max remains highly protected against proteolysis, whereas in the presence of
nsDNA the N-terminal is rapidly cleaved. This behavior is shown, for example, in
the V8 digestion of Max (compare Figures 4.6a-c and 4.7 with 4.8a). Similar
findings are also observed with the Lys-C and trypsin digestions of Max in the
presence of nsDNA (data not shown). I can infer from the proteolytic protection
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assay that M a x binds at its N-terminal to E-box D N A with high specificity and
affinity, strengthening the X-ray crystallographic findings and earlier biochemical
studies (Ferre-D'Amare et al., 1993 and references cited therein). Conversely, in
the presence of nsDNA, the N-terminal remains highly susceptible to proteolysis,
an indication that it is flexible and accessible to proteolytic attack This finding is
in agreement with circular dichroism measurements which suggest that the
N-terminal of b/HLH/Z proteins is a random coil in the presence of nsDNA (FerreD'Amare, 1994; Ferre-D'Amare et al., 1994). (4) The distinction between the
patterns of proteolysis of Max in the presence of sDNA and nsDNA supports an
'induced fit' model for DNA binding (Spolar and Record, Jr. 1994). For Max the
induced fit model predicts that site-specific DNA binding would proceed by a
random-coil-to-helix folding transition of the N-terminal of the protein. The
folding transition occurs only in the presence of DNA containing the cognate
E-box recognition site, as evidenced by the rapid cleavage of the N-terminal of
Max in the presence of nsDNA. (5) The results of the proteolytic protection
assay suggest that the binding of Max to E-box DNA is accompanied by an
extensive rigidification of the protein throughout its entire length. Proteolytic
susceptibility is greatest only towards the extreme N- and C-termini (summarized
in Figures 4.11 and 4.12). The MALDI-MS peptide mapping results indicate that
there are three distinct regions of proteolytic protection in the presence of Maxspecific DNA. These are the N-terminal, the central and the C-terminal regions.
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4.5.2.1 The N-terminal Region
The N-terminal DNA-binding region (residues 24-36) consistently
exhibited the greatest protection from proteolysis in the presence of sDNA. This
observation is in agreement with the finding that the N-terminal adopts a rigid
helical conformation that makes a large number of specific contacts with the
E-box consensus site (Ferre-D'Amare et al., 1993). The proteolytic protection
assay also addresses a specific structural question concerning Lys 24. X-ray
crystallography of the Max-DNA complex indicated that because of crystal
packing, the S-NH2 of Lys 24 was interacting with a neighboring DNA molecule
(Ferre-D'Amare et al., 1993). However, it could not be determined whether Lys
24 was making contact with its bound DNA in the absence of crystal packing.
The proteolysis results show that Lys 24 is rapidly cleaved by Endo Lys-C. The
resulting shortened protein (i.e., fragment 25-113) remains highly resistant to
further Lys-C cleavage, indicating that DNA binding is maintained. Thus, the
results have shown that Lys 24 is not required to preserve DNA binding. I did
not, however, determine whether Lys 24 was needed to establish DNA binding.

4.5.2.2 The Central Region
The second level of proteolytic protection is the region of Max that
correlates to the four-helix bundle. The results are consistent with the notion that
the four-helix bundle is a highly compact, globular domain. The three conserved
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aromatic residues of the bundle (Phe 43, Tyr 70, Tyr 74) were highly protected
against chymotrypsin cleavage, reflecting the inaccessibility of these residues to
proteolytic attack. All of the Lys, Arg, Glu and Asp residues of Helix I and II were
also highly protected against proteolytic cleavage. The eight-residue loop of the
bundle showed a remarkable resistance to cleavage at Glu 56 (by V8) and Lys
57 (by Endo Lys-C and trypsin), and especially towards cleavage by subtilisin, a
highly active protease with broad specificity. These results suggest that despite
its solvent accessibility, the loop maintains a rigid structure in solution, in
agreement with the X-ray crystallographic finding that the peptide backbone of
the loop is well defined in the electron density map of the Max-DNA complex
(Ferre-D'Amare et al., 1993).

4.5.2.3 The C-terminal Region
The lowest level of proteolytic protection of the Max-DNA complex was
associated with the C-terminal region. Three conclusions can be deduced from
the observed rates and patterns of proteolytic cleavage of this region. First, the
complex showed a high susceptibility to cleavage from residues 107-113 (by
subtilisin and trypsin), demonstrating the presence of a stretch of flexible
polypeptide at the C-terminal. This result is consistent with the X-ray
crystallographic finding that the C-terminal six residues were not visible in the
electron density map of the Max-DNA complex (Ferre-D'Amare et al., 1993).
Second, the observed proteolytic 'unzipping' of the complex is characteristic of a
leucine zipper motif. [A similar pattern of proteolysis was observed to occur in
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another b/HLH/Z protein, S R E B P l (sterol regulatory element binding protein 1);
discussed later]. The sequential and gradual cleavage of the zipper can be
understood in terms of its structure. The zipper consists of a coiled-coil
arrangement of two amphipathic helices, resulting in a rigid structure that is
stabilized by both hydrophobic and polar interactions between the two helices
(Landschuiz et al., 1988; O'Shea et al., 1989). The most accessible part of the
zipper is its C-terminus where the two helices can more readily unfold and yield
to proteolysis. Based on previous studies of leucine zipper domains, a strong
polar interaction is predicted to occur between Lys 89 of one helix and Asp 84 of
the other helix (and vice versa) (Baxevanis and Vinson, 1993). The results show
a high proteolytic protection of Lys 89 (against Lys-C and trypsin) and Asp 84
(against Asp-N), findings that may reflect the predicted interhelical electrostatic
interaction between these two sidechains. The 'stalling' of proteolysis at residue
77 (by subtilisin) or at residue 75 (by trypsin) demonstrates that the region
N-terminal to the zipper (the four-helix bundle) greatly resists proteolysis. This is
the first report of an 'unzipping and stalling' pattern of proteolysis of a leucine
zipper. A third conclusion regarding the C-terminal region concerns the role of
the leucine zipper on stabilization of the Max-DNA interaction. Partial or
complete removal of residues of the zipper by proteolysis does not eliminate
DNA binding. This result indicates that the four-helix bundle is a highly stable
structure that is sufficient to maintain DNA binding without the leucine zipper and
supports the notion that the leucine zipper may be more important in defining
dimerization specificity than it is in stabilizing the Max-DNA complex (Reddy et
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al., 1992). Finally, a note about the effects of higher-order oligomerization of
Max dimers. Tetramerization of other b/HLH/Z proteins has been observed and
is believed to occur through an interaction between the leucine zipper domains
of b/HLH/Z dimers (Ferre-D'Amare et al., 1994) and references cited therein).
The proteolysis results are inconclusive concerning the tetramerization of Max.

4.5.3 Evaluating the Proteolytic Protection Assay
Several factors that impact upon the proteolytic protection assay are
discussed below. These include specific vs. non-specific protein-DNA
interactions, dynamics of the Max-DNA complex, and the use of MALDI-MS in
proteolytic peptide mapping.

4.5.3.1 Specific vs. Non-specific Protein-DNA Interactions
The results of this study indicate that the interactions between Max and
sDNA lead to a significant protection against proteolysis of the Max dimer.
Interactions between protein and DNA are usually categorized as either specific
or non-specific (Record, Jr. et al., 1991). In the case of Max, there are highly
specific interactions between the DNA-binding region of the protein and the
oligonucleotide bases lining the major groove of the E-box recognition sequence
(Ferre-D'Amare et al., 1993). The dramatic increase in proteolytic protection of
Max upon binding to DNA is an indication that specific protein-DNA interactions
lead to a rigidification of the dimeric structure of the protein. There can also be
weaker, non-specific interactions that occur between positively charged groups
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of M a x and negatively charged phosphate groups of D N A . These non-specific
protein-DNA interactions could shield the protein against proteolysis,
complicating the simple correlation of proteolytic protection with structure. Since
non-specific protein-DNA interactions are known to weaken with increasing
cation concentrations (Record, Jr. et al., 1991), several proteolysis experiments
were performed at elevated ionic strengths. However, earlier experiments in this
study have shown that raising the ionic strengths also leads to a tightening of the
Max dimerization, masking any reduction in shielding that arises from
non-specific protein-DNA interactions. A compelling reason to suggest that the
shielding does not greatly influence the patterns of proteolytic protection derives
from experiments involving the proteolysis of Max carried out in the presence of
nsDNA. Despite the high potential for shielding to occur between nsDNA and
the highly basic N-terminal, this region of Max is rapidly and preferentially
cleaved by either V8 (refer to Figure 4.8a), Lys-C or trypsin. These findings
suggest that non-specific protein-DNA interactions do not inhibit proteolytic
activity in the basic N-terminal region, and by inference most likely across the
rest of the protein.

4.5.3.2 Dynamics of the Max-DNA Complex
If Max-DNA were a static complex, proteolytic fragments could only arise
from digestion of the intact complex and there would be no ambiguity as to the
origin of the fragments. However, protein-DNA complexes are known to be In
dynamic equilibrium with unbound protein and DNA, so that proteolysis can
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occur from both the bound and unbound protein —leading to ambiguities in the
interpretation of the data. This difficulty was minimized by maintaining an initial
50% molar excess of unbound DNA over Max-DNA complex in all of the
experiments. An excess of unbound DNA ensured that virtually all of the Max
molecules are complexed to DNA. (A simple estimation of the % protein bound
is given in Figure 4.13). At the same time, a 13-fold molar excess of total DNA
over protease was maintained. This ensured that upon dissociation of the
complex. Max is considerably more likely to encounter and reassociate with
unbound DNA than it is to encounter protease. The success of this approach
was confirmed by the long apparent lifetime (days) of the Max-DNA complex
observed in the proteolysis experiments.

4.5.3.3 MALDI-MS is Well Suited for the Proteolytic Protection Assay
This study has demonstrated that MALDI-MS has adequate speed and
mass accuracy to analyze hundreds of complex digest mixtures 'on the fly'. A
comparable task handled by methods such as SDS-PAGE, liquid
chromatography and peptide sequencing would be tedious and prohibitively
slow. As an alternative to the MALDI-MS technique, proteolytic digestions can
be analyzed by electrospray ionization mass spectrometry. For example, limited
proteolysis combined with ESI-MS was successfully applied to the analysis of
structural changes in various forms of calmodulins upon calcium binding
(Brockerhoff et al., 1992). A recent proteolysis study undertaken in the Chait lab
of the HIV-1 protein Nef complexed to SH3 protein also demonstrated the
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Under equilibrium conditions
{Max)2 + ^DA^^ (duplex)
Kn =

{{Max)2 • sDNA (duplex)}

[(Max)^][sDNA)]
[iMax)^*sDNA]

(4.1)

(4.2)

An estimate of the percentage of M a x dimer bound to D N A at equilibrium can be
calculated using the experimental initial concentrations of Max dimer and DNA
(15 i^iM and 22.5 iiiM, respectively) and assuming a KQ of approximately one
nanomolar (Sha et al., 1995).
Initial Concentrations

Equilibrium Concentrations

(Max), = \.50 xWU

{Max)2=\.50xWM-B

sDNA (duplex) = 2.25 x 10' M

sDNA (duplex) = 2.25 xWU-B

KD=1

B = cone, of the Max-DNA eomplex

X10-'M

1.50x10"^- 51(2.25x10'^- B

FromEq. 2,

KD=10-'M

=

Solving for B, B = \{ Max)'

% Bound ~

[(Max)^^^Bound
\^Max)'

Figure 4.13

Initial

B

Bound

= 1.4998 X 10-'M

-5

_ 1.4998 xl0--^M

x l O O % = 99.987%

1.500 x l O ' ^ M

Calculation of percent Max dimer bound to DNA.

Calculation of the percentage of Max dimer bound to Max-specific DNA (sDNA)
under solution equilibrium conditions. The association between M a x dimer and
s D N A is given by equation 4.1. The corresponding dissociation constant (KQ)
relating equilibrium concentrations is given by equation 4.2. The calculation
shows that under equilibrium conditions a very small percentage (0.013 % ) of
Max dimer is not bound to D N A .
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feasibility of utilizing ESI-MS (Lee et al., 1996).

However, the electrospray

technique requires that samples for peptide mapping be free of involatile buffers
and salts, necessitating thorough desalting. In addition, successful analysis of
complex mixtures by electrospray often requires chromatographic separation of
the mixture. In contrast, MALDI-MS is highly tolerant of buffers, salts and other
biochemical additives and complex mixtures can be directly analyzed from
digestion solutions.
Finally, a note regarding the quantitative aspects of the mass spectral
data. The proteolytic protection assay is based on correlating proteolytic
fragments to protein structure. The identities of the proteolytic fragments were
determined from their masses. The progress of the proteolytic digestions was
determined by a semi-quantitative evaluation of the relative heights of the
fragment ion peaks. Although accurate quantitation of peptides and proteins by
MALDI-MS can be difficult, dependence on absolute quantitation was lessened
by relying on a comparative analysis of the relative rates that proteolytic
fragments appear and disappear (as mass spectral ion peaks) during the course
of a digestion.

4.6 Conclusions of the Max Study
A simple biochemical method that combines enzymatic proteolysis and
MALDI mass spectrometry was developed to probe aspects of the solution
structures of DNA-binding proteins (Cohen et al, 1995). The method is based on
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the notion that structural information can be inferred from a determination of
protection against enzymatic proteolysis (as governed by solvent accessibility
and protein flexibility). The procedure was applied to a study of the transcription
factor Max. In the absence of DNA and at low ionic strengths. Max is rapidly
digested by each of six endoproteases selected for the study, results consistent
with an open and flexible structure of the protein. At physiological salt levels, the
rates of digestion are moderately slowed. This reduction in rates together with
the patterns of cleavage are consistent with homodimerization of Max through a
predominantly hydrophobic interface. In the presence of Max-specific DNA, the
protein becomes dramatically protected against proteolysis, exhibiting up to a
hundred-fold reduction in cleavage rates, compared to the rates observed in the
absence of DNA. The fragmentation patterns of proteolysis correlate well with
those expected of a stable dimer bound to DNA at its basic N-terminals, in good
agreement with the Max-DNA structure previously determined by X-ray
crystallography. Protection is greatest in the N-terminal and helix-loop-helix
regions of the protein, corresponding to the DNA-binding region and the globular
four-helix bundle domain, respectively. An intermediate level of protection is
found within the leucine zipper domain. The leucine zipper is distinguished by
undergoing a sequential proteolytic cleavage that starts from the C-terminal of
the zipper and terminates at the protease-resistant four-helix bundle. Proteolysis
also indicates a high affinity of Max for its target DNA which remains high even
when the leucine zipper is proteolyticaUy removed. Proteolytic protection is least
near the N- and C-termini indicating that these are the most flexible and
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accessible regions of the protein. The present biochemical results confirm and
extend the X-ray crystallographic findings of the Max-DNA complex.
In addition to the study of the helix-loop-helix protein Max and its complex
with DNA, the present method appears well suited for many other structural
biological applications. These include the precise characterization of the
boundaries of rigid protein domains (important for NMR and X-ray
crystallography; see next chapter), the determination of binding specificity of
DNA-binding proteins, and the characterization of conformational changes
induced in proteins by covalent modifications such as phosphorylation (see next
section).
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4.7 Proteolysis to Structurally Probe Other H L H Proteins

4.7.1 SREBPl, USF, and Hairy
SREBPl, USF, and Hairy were structurally probed using proteolysis and
mass spectrometry in a similar fashion as was done for Max. Each of the
three proteins possess interesting features. SREBPl has a non-palindromic
10 bp DNA recognition sequence (the SRE) instead of the canonical 6 bp
E-box sequence (see Materials section). The SREBPl loop length is seven
residues, compared with the Max loop length of eight. For USF, the
hydrophobic heptad repeat of the leucine zipper goes 'out-of register' in the
middle of the zipper; there is evidence that DNA-bound USF dimers form
tetramers that may promote DNA looping (Ferre-D'Amare et al., 1994); also,
USF has a longer loop than Max (12 vs. 8 residues). Finally, Hairy, a small
b/HLH protein, has a helix-breaking proline in the DNA-binding basic region.
Hairy has an eleven residue loop. My goal was to proteolyticaUy probe the
structures of these three HLH proteins. The results are given below.
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4.7.1.1 SREBPl-Sterol Regulatory Element Binding Protein 1
The b/HLH/Z SREBP1-SRE DNA complex yielded to subtilisin and endo
Lys-C digestions In a fashion resembling b/HLH/Z Max proteolysis using these
enzymes. I will present and discuss the subtilisin results; identical arguments
can be made for the trypsin digestions. With subtilisin, proteolysis of the
b/HLH/Z SREBPl-SRE DNA complex, occurred down the leucine zipper

(N-terminal direction), initially resulting in the rapid removal of the first seve
C-terminal residues (by -1 hr), then in a more gradual, sequential removal of

residues of the leucine zipper (in the N-terminal direction) so that by 1 day, the
digest stalled near the bottom of the zipper at residues 380 and 384. This
puts the maximum number of residues between the 'stalled' C-terminal and
the top of the four helix bundle (residue 374) at ten. For Max the number of
residues was also ten. Thus, inasmuch as 'gross' structural features can be
inferred from proteolysis, b/HLH/Z SREBPl and Max (bound to DNA) are very

similar (i.e., in terms of rigidity and solvent accessibility), especially in the H
and leucine zipper regions. The 'lifetimes' of the two complexes in solution
(based on the MALDI-MS signal of the subtilisin digest fragments) are also
comparable. However, any structural differences between the two proteinDNA complexes in their DNA-binding regions cannot be distinguished by
proteolysis. Thus although the DNA recognition elements differ in both
sequence and length (SRE vs. E-box), the proteolysis results strongly suggest
that the b/HLH/Z forms of SREBPl and Max (bound to DNA) are structurally
similar. (An early report of the crystal structure of b/HLH/Z SREBPl-SRE161

D N A complex (Antonio Parraga/Burely) indicates that the S R E B P 1 - S R E X-ray
structure closes resembles that of the b/HLH/Z Max-E-Box DNA complex.)

4.7.1.2 USF-Upstream Stimulatory Factor
The MALDI-MS mapping of the subtilisin digestion of b/HLH/Z USF
revealed rapid (5 min) cleavage of ~3-4 residues from the C-terminal of USF,
similar to the findings for Max (Figure 4.10a) and SREBPl, discussed
previously. However, for extended subtilisin digest times (>1 hr) the MALDIMS signal intensity from high mass fragments for the USF-DNA complex
rapidly diminished. By four hours of digest there were several groups of peaks
in the m/z 6000-8000 range, but they were too weak to obtain an accurate
mass for identification. I interpreted these findings as follows. USF protein
yields to subtilisin digestion more quickly than either Max or SREBPl. One
reason for the greater susceptibility to digestion may be related to the long
loop in USF. USF has four more residues in its loop than Max and five more
than SREBPl (see Figure 4.2). Unlike Max or SREBPl, the long loop in USF
may be 'extended' enough for suitable subtilisin attack, whereas the shorter
loops in Max and SREBPl are too rigid and/or inaccessible to the subtilisin
active site.

4.7.1.3 Hairy
The b/HLH protein Hairy was much more susceptible to proteolysis than
was b/HLH/Z Max (when bound to DNA). For example, endo Glu-C (V8)
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digest of either Hairy or M a x in the absence of D N A w a s essentially complete
in less than 15 minutes. In the presence of 14 mer E-box DNA, the digestion
rate of Hairy dropped by a factor of ~10, while for Max the reduction was
estimated to be a factor of -100. The greater susceptibility of Hairy (bound to
DNA) to proteolysis compared to Max may arise from several factors. The
equilibrium binding constant (K^) for b/HLH proteins is in the order of 10"^ M
whereas for b/HLH/Z proteins it is -10"^ M (Sha et al., 1995). Using these
estimations for Kp, the percent bound calculated by Eq. 4.2 (see Figure 4.13)
is 90% for Hairy and 99.99% for Max. Thus, there would be a greater
percentage of b/HLH than b/HLH/Z proteins in the unbound state (i.e., more
exposure to proteolytic degradation). In addition, Hairy has a longer loop than
Max (11 vs. 8 residues), a feature that may also contribute additional
susceptibility of Hairy to proteolysis.
The b/HLH Hairy proteolysis results raises an interesting issue since they
run counter to the earlier findings with b/HLH/Z Max. Slow proteolytic removal
(48 hr) of the leucine zipper of Max (see Max study) resulted in a stable,
proteolyticaUy resistant 'b/HLH' form of Max (e.g.. Max 12-77 in Figure 4.10c).
It is not clear why 'b/HLH' Max has what appears to be a much longer lifetime
than b/HLH Hairy. b/HLH Max may be intrinsically more stable than b/HLH
Hairy (smaller Kp). The longer loop in Hairy (11 residues) may also play a role
in increasing the susceptibility of proteolytic attack compared to Max which
has a shorter loop (8 residues).
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4.8 Proteolysis to Structurally Probe Phosphorylated M a x

Protein phosphorylation is a powerful m e a n s of exerting regulatory control
over eukaryotic cellular events. The ubiquitous phenomenon of
phosphorylation is observed from signal transduction to cell cycle
mechanisms. Nuclear proteins are frequently targets for phosphorylation by
specific cellular kinases. One example is the API family of transcription
factors, which includes the proto-oncoproteins Fos and Jun. These two
proteins are known to form homo- and heterodimers with each other.
Elevated expression of Fos and Jun in stimulated cells has been implicated in
the activation of transcription of growth-promoting genes. Fos and Jun have
multiple phosphorylation sites, each of which has been shown exert distinct
control over the DNA-binding and frans-activation activities of the two proteins
(Abate etal., 1993).
Max, like Fos and Jun, is a DNA binding protein whose activity depends
on oligomerization. Inspection of the N-terminal sequence of Max (Figure
4.14) reveals consensus sites for casein kinase II (CKII) phosphorylation
(Meisner and Czech, 1991; Berberich and Cole, 1992; Prendergast et al.,
1992). The 4-residue consensus sequence for CKII phosphorylation (of serine
or threonine) is S/TxxE/D, where x is any amino acid (Meisner and Czech,
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Figure 4.14 Casein kinase II consensus sites in HLH proteins.
Casein kinase II consensus sites for serine phosphorylation in regions
N-terminally adjacent to the b/HLH/Z domains of Max, M a x A C and M y c and to
the b/HLH domain of El2. The consensus sequence for CKII is S/TxxE/D.
Serine residues that fit the CKII consensus are enlarged and shaded in bold.
The N-termini of the basic DNA-binding regions are doubly underlined. T h e
9-residue alternatively spliced insert sequence in M a x is singly underlined.
The form of M a x investigated in this study is designated M a x A C (Max 2-12/22113) which does not include the insert.
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1991). Figure 4.14 shows the amino acid sequences immediately adjacent to
the N-terminal of the basic regions of the b/HLH/Z proteins Max, MaxAC and
Myc, and the b/HLH protein El2. Here, Max refers to the long form (i.e.,
includes the nine-amino acid alternatively spliced insert, underlined in Figure
4.14) that has three possible CKII sites. The shorter form, termed MaxAC
(excludes the insert) shows 2 CKII sites. Myc and El2 have one CKII site
each.
Interestingly, the CKII sites are flanked by a rather high number of acidic
residues in Max, MaxAC, and El2 but not Myc. In the Max N-terminal
sequence, 9 out of 23 (9/23*0.4) residues are acidic; for MaxAC the ratio is
7/13 (0.5), for El2, 10/23 (0.4) and for Myc, 3/23 (0.1). Upon phosphorylation
by CKII, the ratios increase further because of the introduction of an acidic
phosphate group. The presence of the acidic residues may, in part, assist
kinase targeting, binding and phosphorylation. The acidic residues may also
play a structural role affecting DNA binding of the HLH dimer complex. An
earlier study reported that El2 preferentially binds DNA as a heterodimer with
other b/HLH proteins, such as E47 and MyoD, rather than with itself as an El2
homodimer (Sun and Baltimore, 1991). In addition, unlike El2, E47 was
found to bind DNA as a homodimer. E47 has a lower number of acidic
residues in the region adjacent to the b/HLH domain compared to El2 (7 out
of 23 residues). The study showed that the 'acidic region' of El2 (residues
529-550) conferred heterodimerization specificity. Swapping the two
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N-terminal regions in El2 and E47 potentiated homodimerization of El2. It
was concluded that the high number of acidic residues adjacent to the (then
putative) DNA binding domain negatively influence DNA binding of El2
homodimers (Sun and Baltimore, 1991).
A comparable argument was offered for Max, where mutation of the two
CKII serine sites in MaxAC (Ser2 & 11) to non-polar residues enhanced DNA
binding (Prendergast et al., 1992) relative to the wild-type protein. In this
study, a model was proposed suggesting that phosphorylation may be
weakening DNA binding through electrostatic repulsion between phosphate
residues on the protein and the DNA backbone. It was also argued that DNAbinding could be compromised by an interaction between the highly negatively
charged acidic region and the positively charged DNA-binding (basic) region
(Sun and Baltimore, 1991; Prendergast et al., 1992).
The high resolution X-ray study of b/HLH/Z Max (Max 22-113)-DNA
complex provided a clue into the structure of the N-terminal acidic region.
Initial crystallization trials of Max were with MaxAC (Max 1-113, minus the
9-residue insert). No crystals of MaxAC were obtained. Dynamic light
scattering experiments indicated that solutions of MaxAC were polydisperse, a
finding that was attributed to extensive aggregation of the protein (FerreD'Amare and Burley, 1997). Dynamic light scattering determines whether the
protein is in solution as oligomers (i.e., monomer, dimer, etc.) of the same size
(monodisperse) or as randomly aggregated species (polydisperse). Removal
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of the N-terminal acidic region yielded a construct of the protein (i.e., b/HLH/Z
Max, residues 22-113) that was monodisperse and ultimately crystal I izable.
The dynamic light scattering results strongly suggest that the acidic N-terminal
of Max (bound to DNA) is unstructured (i.e., a random coil), a condition that
would favor aggregation at elevated protein concentrations. Thus, it is
probable that no high resolution structure of MaxAC (with its acidic N-terminal
region) will be attained, either by X-ray crystallography or NMR.
In lieu of a high-resolution structure, I decided to apply the
proteolysis/mass spectrometry protocols presented earlier in this chapter to
probe MaxAC. One of the questions that I addressed was whether proteolysis
can probe how phosphorylation of MaxAC effects its structure and DNA
binding.

4.8.1 Results
Phosphorylation of MaxAC by CKII was straightfonA/ard, taking ~2 hr to
complete. MALDI-MS was useful for monitoring the progress of the
phosphorylation. The molecular mass of the intact protein following treatment
by CKII increased by 160 Da from the unmodified MaxAC consistent with the
addition of two phosphate groups to the protein. Peptide mapping using both
MALDI- and ESI-MS confirmed that Ser2 and Serll were completely
phosphorylated (data not shown). (Hereinafter, the doubly phosphorylated
protein will be referred to as MaxAC(+)P, whereas unphosphorylated protein
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will be referred to as MaxAC.) It is worth noting that N-terminal peptides
derived from the N-terminal of MaxAC are very acidic (see Fig. 4.14). Acidic
peptides are notoriously difficult to analyze by MALDI (Juhasz and Biemann,
1994), even by negative-ion MALDI-MS. I found that acidic peptides that
contained at least two strong basic residues (i.e., the V8 fragment MaxAC232) were observed in both positive- and negative-ion MALDI using 4HCCA or
DHB matrices dissolved in water/acetonitrile (data not shown).

4.8.1.1 Proteolysis of MaxAC and MaxAC(+)P
Four proteases were employed to probe MaxAC: endo Lys-C, Glu-C (V8),
Asp-N, and subtilisin. (1) Proteolysis performed in the absence of DNA
showed that MaxAC or MaxAC(+)P was rapidly cleaved by all four enzymes, in
a similar fashion to b/HLH/Z Max (see Fig. 4.5) (data not shown). (2) In the
presence of non-specific DNA, the basic region of MaxAC was quickly (< 1 hr)
cleaved by any of the four proteases, whereas MaxAC(+)P was cleaved
rapidly by three of the four enzymes (see Figure 4.15). (3) In the presence of
E-box DNA, the digest rates and patterns dramatically changed. Also, distinct
differences in the patterns and rates of proteolysis between MaxAC and
MaxAC(+)P were observed for some of the enzymes. A summary of these
results is shown in Figure 4.16 and discussed below for each enzyme.
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Figure 4.15 MaxAC + nsDNA proteolysis summary.
TOP: Linear representation of MaxAC (Max 2-12/22-113, not to scale).
N-terminal length is exaggerated. CKII phosphorylation sites (Ser 2 & 11)
are marked (P). B O T T O M 4 D I A G R A M S : Summary of MALDI-MS analyses
of Lys-C, V8, Asp-N, and subtilisin digests in the presence of non-specific
DNA. Vertical arrows designate sites (numbered) that are partially or
completely cleaved in M a x A C (hollow arrows drawn above each diagram)
and MaxAC(+)P (solid arrows drawn below each diagram). Large arrows
denote extensive cleavage whereas smaller arrows indicate less as
measured by MALDI-MS at the given times of digestion [times are s a m e for
both M a x A C and MaxAC(+)P]. Stars placed in the sequence indicate
protease target residues for Lys-C, V 8 & Asp-N proteases.
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TOP: Linear representation of MaxAC (Max 2-12/22-113, not to scale).
N-terminal length is exaggerated. Casein Kinase II phosphorylation
sites (Ser 2 & 11) are marked (P).
BOTTOM 4 DIAGRAMS: Summary of MALDI-MS analyses of Lys-C,
V8, Asp-N, and subtilisin digests of M a x A C and MaxAC(+)P performed
in the presence of E-box (Max-specific) DNA. Horizontal arrows
denote direction of digestion from either the N- or C-termini. See
Figure 4.15 caption for full description of all other symbols & terms.
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4.8.1.2 Lys-C Digestion of MaxAC
In the presence of nsDNA, both MaxAC and MaxAC(+)P were rapidly
(1 min) cleaved at Lys24. In the presence of E-box DNA, there was no
significant difference between the patterns and rates of Lys-C digest of
MaxAC or MaxAC(+)P. Cleavage by Lys-C initially occurred mainly at Lys104
(15 min) then gradually at Lys24 (1 hr), yielding the fragments 2-104 and 25104. Interestingly, this pattern of digestion is reversed for the Lys-C
proteolysis of b/HLH/Z Max —cleavage at Lys24 was the initial dominant site
for Lys-C attack, whereas cleavage at Lys104 occurred much more slowly
(data not shown).

4.8.1.3 Glu-C (V8) Digestion of MaxAC
V8 digests of MaxAC and MaxAC(+)P in the presence of nsDNA were
dominated by cleavage at Glu32, a conserved residue in the DNA-binding
region. In comparison, V8 digestion performed in the presence of E-box DNA

showed significant differences in the patterns and rates of proteolysis between
MaxAC and MaxAC(+)P. Cleavages at GlulO and Glu103 were prevalent for
MaxAC, yielding the fragments 2-103 and 11-113 (Ihr) and 11-103 (3 hr). By
contrast, although cleavage at Glu103 was present, cleavage at GlulO was
conspicuously absent for MaxAC(+P). GlulO is adjacent to phosphoserinell
in MaxAC(+)P.
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Careful inspection of the V 8 digest data for the MaxAC(+)P-DNA complex
revealed proteolytic fragmentation at Glu32 (15 min). The resulting peptide
fragment. Max 32-113, gave a weak but persistent MALDI-MS signal over a
hour digest period. (Unphosphorylated Max did not show any significant
cleavage at Glu32.) At 24 hr of V8 digest of MaxAC, the N-terminal was
entirely cleaved, and the C-terminal was partially cleaved, leaving the highmass fragments 11-103 and 11-96. This situation was very similar to the 2
day V8 digest of b/HLH/Z Max (see Figure 4.7). In contrast, at 24 hr of V8
digest of MaxAC(+)P, the protein was completely digested (no MALDI-MS
peaks >6 kDa were observed).

4.7.1.4 Asp-N Digestion of MaxAC
As in the Lys-C proteolysis, Asp-N cleavage of MaxAC and MaxAC(+)P
essentially paralleled each other in both the patterns and rates of digestion.
With either form of Max and in the presence of non-specific DNA, cleavage
occurred rapidly (minutes) at Asp23 (Figure 4.15). In the presence of E-box
DNA (Figure 4.16), proteolytic cleavage was much slower (hours) and
sequential, starting at residue Asp5 and going through the N-terminal in a
'PacMan'-like fashion from Asp5 to 6 to 12 and 'stalling' at Asp23. By one day
of Asp-N digestion, the fragment 24-103 dominated for MaxAC and
MaxAC(+)P. Even after 4 days of incubation with Asp-N, the fragment 24-103
remained intense and there were the first hints of cleavage at Asp 84. The
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only difference worth highlighting between the Asp-N digests of M a x A C and
MaxAC(+)P was that phosphorylation of Serll greatly reduced Asp-N
hydrolysis of the phosphoSer11-Asp12 bond.

4.7.1.5 Subtilisin Digestion of MaxAC
Phosphorylation of MaxAC had significant impact on the subtilisin
proteolysis, both in the patterns and rates of digestion. In the presence of
non-specific DNA (Figure 4.15) subtilisin digestion of MaxAC occurred rapidly
(minutes), first at Asn29 in the basic DNA-binding region, then at Ser108 in
the C-terminal to leave the fragment 30-108, a polypeptide that is incapable of
binding DNA. By one hour, the digestion of the whole protein was complete.
For MaxAC(+)P, digestion of the N-terminal was substantially less than for
unphosphorylated Max. By one hour the dominant fragment was 2-108. It is
unclear how phosphorylation of Ser2 and Serl 1 would interfere with subtilisin
cleavage of Asn29 (the target for unphosphorylated protein), particularly if the
protein is not bound to DNA (i.e., nsDNA). Even at one hour, the 2-98
fragment remained, and complete digestion required >4 hr.
In the presence of E-box DNA, subtilisin digestion of MaxAC resulted in
the fragment 11-108 (1 hr), which essentially is the b/HLH/Z domain of Max
(Figure 4.16). Like b/HLH/Z Max, any further subtilisin activity appeared as a
sequential cleavage of the C-terminal residues (1-9 hr). In contrast, digestion
of MaxAC(+)P left the fragment 2-108 (1 hr), and no evidence for cleavage at
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GlulO. Because GlulO is adjacent to phosphorylated Serll, subtilisin does
not cleave peptide bonds adjacent to plhosphorylated serines, as was
observed for V8 and Asp-N. Over a longer period (1-4 hr), the phosphorylated
N-terminal of MaxAC slowly yielded to subtilisin cleavage at Glu8. By 9 hr
phosphorylated Max was completely digested.

4.8.2 Discussion

There are several features that the proteolysis data reveals about MaxAC
and the effects of N-terminal phosphorylation.

4.8.2.1 Differences Between MaxAC vs. b/HLH/Z Max
The heightened protection of Lys24 against Lys-C digest of MaxAC may
reflect an increase in the rigidity of the long polypeptide chain (Max 2-12/2224, 14 residues) emerging, in the N-terminal direction, from the major groove
of the E-box recognition sequence in MaxAC vs. the much shorter chain (Max
22-24, 3 residues) for b/HLH/Z Max. Because Lys24 in b/HLH/Z Max is
situated just three amino acids away from the N-terminal residue of b/HLH/Z
Max (i.e., Ala22), the peptide chain around Lys24 may be more flexible and
accessible by Lys-C in b/HLH/Z Max than in MaxAC. In comparing Lys-C
proteolysis of MaxAC and MaxAC(+)P, phosphorylation of MaxAC did not
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change the pattern of Lys-C digestion, probably because cleavage at Lys24,
in removing the acidic N-terminal, resulted in identical forms of the protein
(Max 25-104).

4.8.2.2 The N-terminal Region
In the presence of E-box DNA, additional protection against proteolysis of
the N-terminal was observed with Asp-N protease in both MaxAC and
MaxAC(+)P (Figure 4.16), compared to the digests performed in the absence
of DNA. The gradual sequential cleavage through the N-terminal up to Asp23
(immediately adjacent to the DNA) suggests that the N-terminal acidic region
is perhaps conformationally restricted or inflexible and/or the protease is
sterically hindered against direct cleavage at Asp23 (as was the case for
Asp-N cleavage in the presence of nsDNA; see Figure 4.15).

4.8.2.3 Effects of Substrate Phosphorylation on Protease Activity.
For three of the proteases it was shown that phosphorylation severely
reduced (Asp-N) or completely abolished (V8 and subtilisin) hydrolysis of
peptide bonds that shared the phosphorylated residue. It appears that the
additional negative charge and/or bulk of the phosphate group significantly
interferes with enzyme-substrate binding.
Phosphorylation inhibition of proteolysis was an intriguing finding. It is
interesting to ask whether such inhibition could be used in nature for In vivo
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control of protein processing

For example, could a specific substrate be

targeted for proteolytic attack following substrate dephosphorylation (by a
phosphatase)? In this scenario, phosphorylation would act to inhibit protein
processing. Although little has been published concerning the effects of
phosphorylation and proteolysis, I found one paper that investigated the
change in specificity of trypsin and a trypsin-like protease responding to
substrate phosphorylation (Benore-Parsons et al., 1989). The study employed
reverse-phase HPLC and radiolabeled peptides to perform the analysis.
Using the heptapeptide substrate Leu-Arg-Arg-Ala-Ser-Leu-Gly, the authors
showed that phosphorylation of Ser5 in the peptide (by pyruvate kinase)
altered the kinetics and patterns of proteolysis. Both enzymes cleave
between Arg3 and Ala4 on the unphosphorylated peptide. Phosphorylation of
Ser5 dramatically reduced the rate of cleavage by trypsin (by almost 50-fold)
and it redirected the site of proteolysis by the trypsin-like enzyme from Arg3 to
Arg2. The authors discussed a possible influence of substrate phosphorylation
on selectively influencing cellular protein processing and turnover events
(Benore-Parsons et al., 1989).

4.8.2.4 Lifetime of the MaxAC-DNA complex.
Some of the proteolysis data suggest that phosphorylation of MaxAC
reduces the 'lifetime' of the MaxAC(+)P-DNA complex. The V8 digest is
considered first. Phosphorylation of Serll prevented V8 cleavage at Glu 10
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(Figure 4.16). The N-terminal of MaxAC(+)P w a s thus left 'intact'. Discounting
other loss mechanisms, the 'disappearance' of MaxAC(+)P from the digest
solution can only occur by proteolysis in the DNA-binding or HLH regions of
the protein. The study of the b/HLH/Z Max-DNA complex (presented earlier in
this chapter) clearly indicated that access to either the DNA-binding or HLH
regions by protease requires the dissociation of the protein-DNA complex. For
MaxAC(+)P, indirect evidence for such dissociation is seen in the V8 digest of
the MaxAC(+)P-DNA complex. V8 fragmentation at Glu32 (in the DNA-binding
region), observed for MaxAC(+)P, but not MaxAC, suggests that the proteinDNA complex is dissociating, permitting V8 hydrolysis at Glu32. Additional
evidence for dissociation of MaxAC(+)P-DNA is provided by the 24 hr V8
digest data. For MaxAC, at 24 hr of V8 digest, the N-terminal was entirely
removed and the C-terminal was partially cleaved, leaving the high-mass
fragments 11-103 and 11-96. This situation essentially mirrors the 2 day V8
digest of b/HLH/Z Max (see Figure 4.7). In contrast, at 24 hr of V8 digest of
MaxAC(+)P, the protein was completely digested. The subtilisin results also
support the notion that Max phosphorylation increases the dissociation of the
protein-DNA complex. At 9 hours of subtilisin digest of MaxAC, the b/HLH/Z
protease-resistant domain remained. In contrast, after 9 hours of V8
hydrolysis, the MaxAC(+)P-DNA complex was completely digested. From this
data, I hypothesize that the MaxAC(+)P-DNA complex has a shorter 'lifetime'
than the MaxAC-DNA complex.
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The effects of phosphorylation on the association and dissociation rates of
Max was shown in a recent study by Luscher (Bousset et al., 1993).
Employing electrophoretic mobility shift assay gels, the authors demonstrate
the effects of N-terminal phosphorylation. Using the gel shift assays, they
showed that phosphorylation of MaxAC completely abolished DNA binding.
This finding was in general agreement with other studies which also
suggested that phosphorylation of Max by CKII substantially reduced or
abolished DNA binding (Berberich and Cole, 1992; Prendergast et al., 1992;
Bousset et al., 1993; Koskinen et al., 1994). From competitive binding
assays, Luscher reached their principal findings of the study —that
phosphorylation of Max by CKII increased both the 'on' (association) and 'off
(dissociation) rates of DNA binding. The changes in the rates were found to
be similar. They correlated these results to the fact that steady state binding
was unaffected by phosphorylation. Similar changes in ko^ and koff (the
association and dissociation rate constants of the Max-DNA complex) would in
effect 'cancel out' leaving Kp (the binding constant, =koff/kon) essentially
unchanged.
The main result of Luscher—that the on and off rates of MaxAC increase
upon phosphorylation— is in agreement with the proteolysis results described
above. The proteolysis data suggested a reduced lifetime of the
MaxAC(+)P-DNA complex compared to the MaxAC-DNA complex. However,
it remains unclear why the MaxAC(+)P-DNA complex is not observed by gel
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shift assays given that the proteolysis data strongly suggests that
phosphorylated Max binds DNA and forms a proteolytic-resistant complex.
The reasons for not observing the gel-shift complex may be related to the
DNA-protein binding kinetics (i.e., the on and off rates) of the complex through
the gel. A high dissociation rate may drastically reduce the number of intact
complexes in the gel so that few or none are detected.

4.8.3 Conclusions
The HLH family of DNA-binding proteins has served as a good model to
study protein structure by limited proteolysis and mass spectrometry. Used
carefully, proteolysis can usefully probe protein structure. Important to the
success of discerning protein structure by proteolysis is the use of MALDI-MS,
where a large number of digestions, performed under various conditions, can
be examined with high mass accuracy, ease and speed.
A particularly attractive use of the methods described in this chapter
would be the exploration of the effects of substrate length and conformational
flexibility on protease activity. A great deal of work has been done in the past
30 years on protease specificity, but not nearly as much on the understanding
other factors such as substrate polypeptide flexibility. This lifetime of effort,
the way, was achieved almost exclusively using non-MS methods. I believe
MS will open up many avenues for further exploration.
The proteolysis study of Max has already revealed some intriguing
findings regarding the proteases themselves. For example, it was shown for
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the b/HLH/Z M a x - D N A complex, that Lys-C cleaved at Lys24 (the third residue

from the N-terminal) but that trypsin (or subtilisin) did not cleave at this residue
and nor did Asp-N after Asp23 (the second residue from the N-terminal).
However, Asp-N successfully cleaved at Asp23 in the MaxAC-DNA complex,
probably because in MaxAC, Asp23 is positioned 14 residues from the
N-terminal. Thus Asp-N, subtilisin and trypsin seem to require more than two
N-terminal residues flanking the target amino acid whereas Lys-C can cleave
very short substrates. Systematic studies of digestions combined with the
potential use of synthetic polypeptide substrates would shed light on the
substrate length specificities and conformational flexibility requirements as
well as information regarding the size of the protease active site. Availability
of high resolution structures of substrate proteins and the proteases
themselves will be very useful to correlate and interpret the experimental data.
Finally, the ability to rapidly and precisely define protein folding domains is
a distinct benefit derived from the proteolysis/mass spectrometric study of
Max. This application —domain elucidation— will be presented in the next
(and last) chapter.
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Chapter 5 — Domain Elucidation by Mass Spectrometry

The success of the proteolysis/mass spectrometry study of Max
(discussed in Chapter 4) established a direct and powerful application —protein
domain elucidation (Cohen, 1996). This chapter describes the utility of domain

elucidation in the structural investigation of three proteins —Mef 2C, leptin, an
TAFs 42/62.

5.1 Materials
5.1.1 Proteins
Sequences of recombinant proteins are given in Figure 5.1. Mef 2C: Mef
2C was from Lei Zhong (Stephen K. Burley Lab, Rockefeller University). The
protein construct consisted of Mef 2C 2-105 + the 8-residue C-terminal His-Tag
LEHHHHHH (112 residues; calc. mass 13,134 Da). The protein concentration
was 300 \iU in -100 mM KCl, HEPES buffer, DTT & 10 % glycerol. Leptin:
Various forms of recombinant leptin (Obi) were from Ketan Gajiwala (Burley
Lab) and Jeffrey Halaas (Jeffrey Friedman Lab, Rockefeller). The leptins
included human —bOblv (wild type seq. 22-167, 146 residues, 16,024 Da, with
disulfide) expressed in yeast; hObIa (Amgen) (22-167 + N-term. Met, 147
residues, 16,156 Da, with intact disulfide linkage) expressed in E. Coll; hObIb
(22-167 + 4-residue N-terminal GSHM from HIS Tag, 150 residues, 16,437 Da,
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with disulfide); AhObI (22-53/62-167 (54-61 deletion), 142 residues, 15,555 Da,
with disulfide); and mouse leptin —mObIa (Amgen preparation) (22-167, 147
residues, 16,136 Da, with disulfide) and mobib (22-167 + 4-residue N-terminal
GSHM from HIS Tag, 150 residues, 16,417 Da, with disulfide) expressed from

E.Coli. The leptin samples were usually in KCl and buffer solution (no glycerol
and stored at -70°C.

TAFS 42/62: Various constructs were obtained from Xiaoling Xie (Burley Lab).

Drosophila TAF||42 (p42) "original construct" (wild type seq. 2-100, 99 residues
11,297 Da; and a C55S mutant, 11,281 Da); "new construct 1" (NCI) (2-95, 94
residues, C55S, 10,732 Da), NC2 (11-95 + N-term. Met, 86 residues, 9,935 Da

and a C55S mutant 9,919 Da.) dTAF|,62 (p62) 'original construct' (wild type seq
1-91 + N-term. GlySer from thrombin cleavage, 93 residues, 10,240 Da) and
NCI (1-82 + N-term. Gly, 83 residues, 9,072 Da). The samples were typically
0.6-8 mg/mL (as a heterodimer complex TAF42/62), stored in aqueous solutions
of -20 mM buffer (pH 6), 50 mM KCl, 5 mM MgCl2, 10 mM DTT (for wild-type
constructs), 1 mM PMSF (serine protease inhibitor) and 10 % glycerol at - 20°C.

5.1.2 Other materials
Buffers, MALDI matrices and matrix solutions are described in Chapter 2.
Centricon desalting devices were from Amicon (Beverly, MA).
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Mef-2C
Human Mef-2C (2-105 + 8-residue +
C-terminal His tag LEHHHHHH)
112 residues, 13,134 Da

hObIb
Leptin 22-167
+N-term. GHSM+disulfide
150 residues, 16,437 Da

1
10
20
I
1
1
mGRKKIQITRIMDERNRQVT
FTKRKFGLMKKAYELSVLCD
CEIALIIFNSTNKLFQYAST
DMDKVLLKYTEYNEPHESRT
NSDIVETLRKKGLNGCDSPD
PDADDLEHHHHHH

(21)
30
40
I
I
I
GHSMVPIQKVQDDTKTLIKT
IVTRINDISHTQSVSSKQKV
TGLDFIPGLHPILTLSKMDQ
TLAVYQQILTSMPSRNVIQI
SNDLENLRDLLHVLAFSKSC
HLPWASGLETLDSLGGVLEA
SGYSTEWALSRLQGSLQDM
LWQLDLSPGC

hOblv
Leptin 22-167+disulfide
146 residues, 16,024 Da

21
30
40
1
I
1
aVPIQKVQDDTKTLIKTIVT
RINDISHTQSVSSKQKVTGL
DFIPGLHPILTLS KMDQTLA
VYQQILTSMPSRNVIQISND
LENLRDLLHVLAFSKSCHLP
WASGLETLDSLGGVLEASGY
STEWALSRLQGSLQDMLWQ
LDLSPGC
hObIa (Amgen)
Leptin 22-167+N-term Met+disulfide
147 residues, 16,156 Da

21
30
40
1
1
I
MVPIQKVQDDTKTLIKTIVT
RINDISHTQSVSSKQKVTGL
DFIPGLHPILTLSKMDQTLA
VYQQILTSMPSRNVIQISND
LENLRDLLHVLAFSKSCHLP
WASGLETLDSLGGVLEASGY
STEWALSRLQGSLQDMLWQ
LDLSPGC

AhOb1 (54-61 deleted)
Leptin 22-53/62-167
+ N-terminal STDP +disulfide
142 residues, 15,555 Da
(11)

I

(20)

1

30

1

STDPVPIQKVQDD
TKTLIKTIVTRINDISHTQS
VSSkqkvtgldFIPGLHPIL
TLS KMDQTLAVYQQILTSMP
SRNVIQISNDLENLRDLLHV
LAFSKSCHLPWASGLETLDS
LGGVLEASGYSTEWALSRL
QGSLQDMLWQLDLSPGC

TAF42 (original construct)
dTAF„42 2-100
99 residues, 11,297 Da

mOb1a (Amgen)
mouse leptin 22-167
+ N-terminal Met + disulfide
147 residues, 16,134 Da

1 10 20

(21)
30
40
1
1
I
MVPIQKVQDDTKTLIKTIVT
RINDISHTQSVSAKQRVTGL
DFIPGLHPILSLSKMDQTLA
VYQQVLTSLPSQNVLQIAND
LENLRDLLHLLAFSKSCSLP
QTSGLQKPESLDGVLEASLY
STEWALSRLQGSLQDILQQ
LDVSPEC

1

I

I

mSAEKSDKAKISAQIKHVPK
DAQVIMSILKELNVQEYEPR
WNQLLEFTFRYVTCILDDA
KVYANHARKKTIDLDDVRLA
TEVTLDKSFTGPLERHVLAK
TAF42 (original construct) C/S

dTAF„42 2-100; C55S
99 residues, 11,281 Da
1 10 20
1
1
1
mSAEKSDKAKISAQIKHVPK
DAQVIMSILKELNVQEYEPR
WNQLLEFTFRYVTSILDDA
KVYANHARKKTIDLDDVRLA
TEVTLDKS FTGPLERHVLAK

mOb1b
mouse leptin 22-167
+ N-terminal G S H M + disulfide
147 residues, 16,417 Da
(11) (20) 30

TKTLIKTIVTRINDISHTQS
VSAKQRVTGLDFIPGLHPIL
SLSKMDQTLAVYQQVLTSLP
SQNVLQIANDLENLRDLLHL
LAFSKSCSLPQTSGLQKPES
LDGVLEASLYSTEWALSRL
QGSLQDILQQLDVSPEC

TAF42 NCI
dTAF„42 2-95 C55S
94 residues, 10,732 Da
1 10 20

I

1

1

mSAEKSDKAKISAQIKHVPK
DAQVIMSILKELNVQEYEPR
WNQLLEFTFRYVTSILDDA
KVYANHARKKTIDLDDVRLA
TEVTLDKSFTGPLER
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TAF42 NC2
dTAF,, 42 11-95 + N-term. Met.
86 residues, 9,935 Da

TAF62 (Original Construct)
dTAF,, 62 1-91+ N-term GlySer
93 residues, 10,240 Da

1

1

10

20

10

20

MsaeksdkaklSAQIKHVPK
DAQVIMSILKELNVQEYEPR
W N Q L L E FTFRYVTCILDDA
KVYANHARKKTIDLDDVRLA
TEVTLDKSFTGPLER

GSMLYGSSISAESMKVIAES
IGVGSLSDDAAKELAEDVSI
KLKRIVQDAAKFMNHAKRQK
LSVRDIDMSLKVRNVEPQYG
FVAKDFIPFRFAS

TAF42 NC2 (C/S)
dTAF,, 42 11-95 C55S + N-term.
Met. 86 residues, 9,919 Da

TAF62 NCI
dTAF,, 62 1-82+N-term Gly
83 residues, 9,072 Da

1

10

20

1

MsaeksdkaklSAQIKHVPK
DAQVIMSILKELNVQEYEPR
WNQLLEFTFRYVTSILDDA
KVYANHARKKTIDLDDVRLA
TEVTLDKSFTGPLER

Figure 5.1

10

20

GMLYGSSISAESMKVIAESI
GVGSLSDDAAKELAEDVSIK
LKRIVQDAAKFMNHAKRQKL
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Protein constructs for domain elucidation studies.

Numbering systems are based on the wild-type sequences with insertions and
deletions as indicated. Lower case letters designate residues that are omitted in
the constructs. Underlined residues are not in the wild-type sequence. Histidine
Tag in Mef2C is underlined. Calculated average masses are shown. The pair of
Cys residues in leptin (in bold) are disulfide linked. C y s to Ser mutations in
T A F 4 2 are bold.
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5.2 M e t h o d s
5.2.1 Proteolysis and Cyanogen Bromide Digestion
Proteolytic digestion and MALDI-MS peptide mapping were carried out as
described in Chapter 2. Cyanogen bromide (CNBr) digests of leptin were
performed in either 50-70% formic acid or 0.1 N HCl. A small crystal of CNBr
was added to the acidified protein solutions to commence the digestion,
performed in the dark and in the hood. Aliquots (~1 )nL) were sampled at 1, 2, 5,
15 min and 1 hr. of digestion and added to matrix solution (4HCCA/FWI; see
Chapter 2). Longer digest times were not necessary, and when carried out in
formic acid resulted in peptide formylation. Alternatively, CNBr digests were
performed directly in the matrix solution from which samples were taken and
deposited on the MALDI probe tip for matrix crystallization (IN THE HOOD!).

5.2.2 Electrospray Ionization Mass Spectrometry (ESI-MS)
ESI-MS was performed on a Finnigan TSQ-700 triple quadrupole mass
spectrometer with the assistance of Urooj A. Mirza. ESI-MS on protein samples
was carried out in one of three ways—denaturing direct infusion, denaturing
on-line desalting, and non-denaturing conditions.

5.2.2.1. Denaturing Conditions/Direct Infusion
Proteins that were in solutions having low involatile salt concentration (i.e.,
below 1 mM in final the ESI solution) were directly infused into the mass
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spectrometer via a syringe p u m p (Harvard Apparatus). For infusion, proteins
were dissolved in water:methanol:acetic acid (1:1:2.5%) to make 20-50 ^iL of a
10-20 fiM protein solution. The infusion flow rate was 3 f^L/min. The
electrospray conditions were 4.5 kV spray voltage, ~3 [lA current, 175-200°C
stainless steel transport capillary temperature, ~100 V skimmer voltage and 1.21.3 kV multiplier. The mass spectrometer was typically set to scan m/z
600-2000. The raw m/z spectra were converted to mass data using the Finnigan
deconvolution software.

5.2.2.2 Denaturing Conditions/On-line Desalting Cartridge
If protein samples contained salts and additives, the samples were loaded
onto an on-line protein desalting trap cartridge (Michrom BioResources, Inc.,
Pleasanton, CA). Initially, the cartridge was flushed clean with 100 |aL injections
of 1:1 water/ACN or water/methanol followed by flushing with pure water.
Protein samples were then loaded onto the cartridge from solutions containing
little or no organic solvents. From the same direction as protein loading, the
cartridge was flushed with pure water or 0.05 % acetic acid solution. The
number of washings depended on the salt level in the original protein sample. In
a direction opposite to that for protein loading, the protein was eluted off the
cartridge into the ESI source with a solution of 70% ACN/30% water (acidified
with 2.5% acetic acid) infused via the Harvard syringe pump at a rate of 6|LiL/min.
(All other instrument conditions are as described for direct infusion.) After about
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six minutes of elution, protein signal appeared and remained steady for a few
minutes for data collection.

5.2.2.3 Non-Denaturing ESI-MS
Non-denaturing mode was used to study non-covalent interactions
between TAF42 and TAF62 in solution. Protein samples were extensively
treated to remove salts and additives via the Centricon (see below). Traces of
salts and additives severely compromised the electrospray process. Low
concentrations (< lOmM) of a volatile buffer, such as ammonium acetate, are
usually tolerable. If a buffer is included it should be of the highest purity. In the
study of the TAFs, it was determined that pure water (no buffer) gave the best
electrospray results. Appropriately prepared protein solutions were directly
infused Into the ESI source of the mass spectrometer as described above.
Typical concentrations of proteins used in the non-covalent studies ranged from
50-100 |iM, infusion flow rate of 3fiL/min, capillary temperature of 150-180°C,
and a skimmer potential of 130-150 V. The mass spectrometer was normally
scanned in the range m/z 2000-3800. Adjustments made in the capillary
temperature and the skimmer voltage affected the probability of observing noncovalent interactions. After each adjustment of capillary temperature, 10-15
minutes was allowed to reach thermal equilibrium. Observing non-covalent
interactions with ESI-MS is a more an art than science and requires patience and
experimenting.
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5.2.3 Centricon Desalting
Protein samples for ESI-MS non-covalent studies were in solutions
essentially free of involatile salts, buffers and other additives (e.g. glycerol). The
Centricon 10 concentrator (10 kDa molecular weight cutoff) (Amicon; see
Materials) was used to desalt/clean the TAF42/62 samples. The Amicon
Instruction booklet details information on handling and assembling the Centricon
tubes. The Centricon desalting usually takes a whole day (up to 10 hr). (1) A
fresh supply of Centricon tubes was always used (shelf-life is a few months). (2)
The Centricon membrane contains glycerol & antibacterial agents that must be
thoroughly removed by first hand rinsing with MilliQ water and then centrifuging
TWICE with 2 mL of water through the Centricon using the Beckman GS-6R
refrigerated Centrifuge, set to 4°C at -6000 rpm (-5500 g relative centrifugal
force) for one hour. A second Centricon tube filled with an equivalent volume of
water was always to balance the centrifuge. (3) For desalting, 1 mL of water
was first added to the prepared Centricon tube followed by the protein sample
(typically 10 nmol of protein sample, thawed from -20°C storage) and then
enough water to almost fill the tube (~2 mL total). The tube was centrifuged for
-1 hr at 6000 rpm and 4°C. The tube was refilled with fresh water and the
centrifuging/washing cycle was repeated 7 times. After the final wash, the tube
was inverted and spun at 2500 rpm for 3 minutes to collect about 40 }iL of
desalted sample. The samples were either immediately used for ESI-MS or
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stored at 4°C. T A F 42/62 w a s vulnerable to adventitious proteolysis and needed
to be used within a day or two after desalting.

5.3 Introduction

Protein crystallographers continually seek improved strategies to grow
crystals that will diffract to high resolution. In order to obtain high-resolution
structures it is important to have the assurance of working with compact, well
defined proteins. This generally accepted notion presumes that restricting the
degrees of conformational motion in a protein increases the chances that it will
crystallize into well-ordered lattices (Joachimiak and Sigler, 1991). A precisely
defined compact 'folding domain' also results in a protein with reduced
tendencies towards aggregation.
A hallmark of large, multi-functional proteins is their modularity. The
constituent modules are often described as being organized as 'beads on a
string'. The modules represent autonomously folded polypeptide structures,
frequently referred to as domains, where a domain is generally from 50-150
amino acid residues in length. Protein domains are linked together usually by
flexible, unstructured polypeptide chains. Figure 5.2 depicts the situation in
cartoon form. A protein with three folding domains is shown. Conformational
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Figure 5.2 Domain elucidation
TOP: Hypothetical three-domain protein. Folding domains are shaded red,
blue and green. Interdomain linkages are denoted as thin colored lines.
Limited proteolysis in solution would cleave within the polypeptide linkages
(arrows) releasing the individual folding domains.
BOTTOM: Single protein domain that has polypeptide chains extending
beyond compact folding region as a random coil at the N- and C-termini.
Limited proteolysis would trim off these flexible chains (arrows) leaving a
more compact folding domain.

flexibility about the interdomain linkages would reduce packing efficiency within a
crystal of the three-domain protein. Limited proteolysis of the protein in solution
would cleave within the interdomain linkages, releasing the individual domains.
Alternatively, recombinant forms of individual domains, whose boundaries are
not well defined, may have polypeptide extending from the N- and/or C-termini, a
situation that may give rise to poor crystal packing or aggregation instead of
crystallization. The classical biochemical method to identify protein domains is
limited proteolysis combined with SDS-PAGE, HPLC and N-terminal sequencing.
However, the poor mass accuracies of SDS-PAGE (no better than 5%) and the
expense and time requirements of N-terminal sequencing (days-weeks) is
unappealing in the need for speedily attaining a well defined folding domain for
high resolution structural studies.
In Chapter 4, limited proteolysis combined with MALDI-MS provided
precise details of the domain boundaries of Max and related proteins. The
proteolysis study of MaxAC serves as a good example of domain elucidation
using MALDI-MS. Figure 5.3 summarizes the results for the proteolysis of
MaxAC (Max 2-12/22-113). In the absence of DNA, proteolysis of the protein
with any of six enzymes occurred rapidly (< 1 hr) and throughout the length of
the protein. Upon binding to Max-specific DNA, a protease-resistant folding
domain (Max 25-108) become defined by about one hour of digestion. This
domain (Max 25-108) was slightly more compact than the original b/HLH/Z
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Figure 5.3 Domain elucidation of MaxAC
The protein MaxAC was probed by proteolysis in the absence (TOP), and
presence ( B O T T O M ) of Max-specific DNA. The three colors code for relative
rates of proteolysis as measured by MALDI-MS: red is most rapid (minuteshours), green is intermediate (hours-days), blue are regions where little or no
proteolysis occurred. Horizontal arrow denotes direction of gradual,
sequential proteolysis observed in the C-terminal region in the presence of
DNA. T w o protease-resistant folding domains become defined upon binding
to DNA: 25-108 (b/HLH/Z Max) and 25-75 (b/HLH Max).
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construct (Max 22-113) used in the X-ray crystallographic study of Max.

A

gradual proteolytic cleavage through the leucine zipper (over a "-48 h period)
resulted in a 51-residue protease-resistant structure (Max 25-75). This structure
represents a b/HLH (zipperless) form of the protein. Strong resistance to any
further proteolysis demonstrated the remarkable globular-like characteristics of
the four-helix bundle (Ferre-D'Amare et al., 1993). In retrospect, knowledge of
the more compact, protease-resistant forms of Max may have benefited the MaxDNA crystallization study, especially since the original long form of Max (i.e.
MaxAC) failed to produce crystals (Ferre-D'Amare and Burley, 1997).
The utility of limited proteolysis and MALDI-MS analysis for domain
elucidation can also be seen from a recent investigation of the domain
organization of the E. Coli RNA polymerase a subunit (Blatter et al., 1994). In
this study, SDS-PAGE of a number of different proteolytic digests showed that
the a subunit was comprised of two domains connected by a short flexible linker.
MALDI-MS was used to determine the exact N- and C-terminal residues of the
proteolytically-released domains as well as the length of the linker chain. The
authors used this information in developing a model for the role of the a subunit
in transcription activation. More recently, limited trypsin digestion, MALDI-MS,
and amino acid sequencing were used to determine the domain organization of
the E. Coli RNA polymerase a^° subunit (Severinova et al., 1996).
The combination of proteolysis and mass spectrometry can provide
information about the compact folding domains of proteins with unprecedented
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accuracy and speed. Armed with a knowledge of the precise boundaries of
protein folding domains, protein constructs can be redesigned that are 'well
behaved' for NMR studies and exhibit elevated propensities towards yielding
high resolution diffraction-quality crystals for X-ray crystallography. Three
proteins with unknown structures will be discussed to demonstrate the utility of
the proteolysis/mass spectrometry domain elucidation strategies.

5.4 Results — Domain Elucidation of Proteins of Unknown Structures
5.4.1 Mef-2C
Myocyte enhancer factor-2C (Mef2C) is a eukaryotic tissue-restricted
transcription factor that is a member of the MADS box DNA-binding protein
family (Martin et al., 1993). The MADS box is a 58-residue domain that is
conserved in a diverse range of proteins. In Mef2C the MADS box spans
residues 1-58 (see Figure 5.4). The MADS box represents a novel DNA-binding
domain whose structure was not available (at least at the time of the thesis
study). Previous mutagenesis experiments localized the DNA-binding region of
the MADS box to residues 1-30 (Martin et al., 1993). Mef2C also has a second
region called the Mef2 domain, positioned immediately C-terminal to the MADS
box (residues 60-88, see Figure 5.4) that is believed to confer frans-activation
activity.
A high-resolution X-ray crystallography investigation was begun on the
Mef2C protein (Lei Zhong/Burley). For the study, the initial construct of Mef2C
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Figure 5.4 Mef 2C domain elucidation
TOP: Representation of Mef2C (2-105 -i- 8-residue His-Tag) containing
the DNA-binding M A D S box and the M E F 2 domains. Stippled region
at C-terminal denotes the His-Tag. B O T T O M : Summary of the MALDIM S peptide mapping of the limited proteolysis of Mef2C. The solid
colored lines designate proteolytic resistant regions observed in the
absence (blue) and presence (red) of DNA.
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w a s based on sequence homology alignment with other proteins of the Mef2
family. A Histidine Tag was included at the C-terminal end of the protein to
assist in protein isolation and purification following recombinant expression.
Although normally positioned at the N-termini of proteins, the His Tag was placed
at the C-terminal to avoid disrupting the highly conserved N-terminal DNAbinding region. Although sequence alignment is a useful guide for designing
protein constructs, the application of limited proteolysis and mass spectrometry
was used here to more accurately define the folding domain(s) of the Mef2C
protein.
Subtilisin and trypsin digests were peri'ormed on the Mef2C protein in the
absence and presence of DNA. The MALDI-MS peptide mapping results are
summarized in Fig. 5.4. The data strongly indicated that residues 1-10 of Mef2C
play a critical role in DNA binding since these residues are highly protected from
proteolysis in the presence, but not absence of Mef-specific DNA. The
proteolysis data also suggested that the C-terminal domain boundary of Mef2C
when bound to DNA was at residues 79 or 90-92. Because the entire Mef2
homology domain spans residues 60-88, residue 91 was selected as the domain
boundary. Thus the design of a new construct of Mef2C was based on
combining the proteolysis data and sequence homology information.
The domain elucidation of Mef2C by MALDI-MS took less than 2 days to
complete. Expression of a new construct would require a few weeks to prepare.
However, during this time a group in Switzerland released an X-ray structure of a
MADS box protein bound to DNA (Pellegrini et al., 1995), essentially scooping
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the Mef2C project. It is nevertheless instructive to consider s o m e of the relevant
findings of the MADS box X-ray crystallography. The protein in the published
X-ray structure was serum response factor (SRF). The crystallographers used a
92-residue construct of SRF that contained the MADS box and solved the
structure to 3.2 A resolution. Interestingly, the SRF-DNA structure showed that
the N-terminal 11 residues of the MADS domain made specific contacts with the
minor groove of the DNA (Pellegrini et al., 1995). The minor groove interactions
provide a rationale for the proteolytic protection of the N-terminal residues that I
observed in the Mef2C-DNA complex (Figure 5.4). The crystallographers that
solved the SRF-DNA complex also predicted that the N-terminal residues of the
MADS box would be unstructured in the absence of DNA. The proteolysis data
on Mef2C (without DNA) are consistent with the prediction of an unstructured
N-terminal. Finally, I speculate on whether more precisely defined protein
boundaries of the SRF construct (i.e., domain elucidation) would have improved
the X-ray diffraction data? The SRF construct included an extra nine residues
extending beyond the N-terminal of the MADS box domain that showed little or
no electron density in the X-ray data (Pellegrini et al., 1995). Was inclusion of
these extra residues in the SRF construct detrimental to the crystal packing and
the diffraction quality? The Mef2C proteolysis data suggests that the extra
N-terminal residues in SRF were dispensable. It is possible that an optimized
construct could have yielded an X-ray structure with resolutions better than that
obtained (3.2 A).
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5.4.2 Leptin
The leptin protein was introduced and discussed in Chapter 3, particularly
in regards to characterizing the endogenous human form of leptin for posttranslational modifications. Additional mass spectrometric research was also
undertaken on leptin and is presented here.
Leptin was under intense investigated by several laboratories at
Rockefeller. Physiological studies of injections of recombinant leptin into mice
were undertaken in the Friedman laboratory. At the same time, a high resolution
X-ray structural study was being carried out by Ketan Gajiwala in the Burley
laboratory. Thus, there was a strong need to examine recombinant leptin to
determine correctness of expression, purity levels, and the oxidation state of the
two cysteine residues present in the protein. In addition, domain elucidation by
proteolysis/mass spectrometry of leptin would benefit the structural studies.
Over a one year period, about a dozen different batches of leptin (human
and mouse forms) expressed from various sources (bacteria and yeast) were
analyzed by MS. ESI-MS was used principally to measure the masses of the
intact protein (via the desalting cartridge, see Methods) (data not shown).
MALDI-MS was also used to measure the protein mass. Although MALDI- and
ESI-MS mass accuracies are similar (0.01% at 16 kDa), attaining these
accuracies by MALDI-MS requires internal calibration and repetitive
measurements. In contrast, ESI-MS consistently provided 'spot-on' masses with
single injections of sample.
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M A L D I - M S w a s more useful than ESI-MS to monitor the purity levels of
recombinant leptin samples. This has been my general experience in dealing
with samples containing low levels (few percent) of 'impurities.' From the MALDI
analyses of leptin, it became apparent that the protein was unstable in solution.
Many of the recombinant leptin samples that I received consistently showed
degradation products (see below).
Ultimately, a preparation of recombinant mouse leptin (from Amgen) was
found to be exceptionally pure by MALDI-MS (Figure 5.5a). Using the Amgen
protein as a control, I performed a simple experiment to monitor the stability of
the protein in solution. The results, shown in Figure 5.5, indicate that the protein
is susceptible to partial degradation when stored at +4°C over a long period (5
months) (Figure 5.5d). Little or no degradation was seen at lower temperatures
(Figure 5.5b,c). Although the MALDI-MS data is not strictly quantitative, I
estimated -1-2% degradation in the sample stored at 4°C. Trace proteases,
perhaps left over from the protein isolation procedures may explain the
degradation products. The stability experiment suggested that long-term storage
of the protein is best at done -70°C (Figure 5.5b.) Such information is useful for
the crystallization trials since they are carried out at 4-25°C for periods of weeks
to months.
Careful inspection of the MALDI-MS data (Figure 5.5d) indicates that
protein 'self-degradation' is occurring In the N-terminal portion of recombinant
mouse leptin, specifically in the stretch of residues 51-60, with the dominant
cleavage between residues 57/58. Similar results were obtained in preparations
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Figure 5.5 Long-term stability of recombinant mouse leptin in solution.
M A L D I - M S of recombinant mouse leptin (mObI/Amgen) that w a s stored at three
different temperatures for five months.
(a) Spectrum obtained from a fresh preparation of protein before storage. The
multiple charge states (1+ - 4+) indicate presence of a single component (leptin).

(b) Blow-up of the region m/z 3200-4800 (containing the 4+ ion of intact protein)
of the spectrum in panel a. Protein degradation products for leptin would appear
in this region if they were present, as will be seen in the succeeding panels. For
the fresh sample of leptin, there is no indication of protein degradation. The
leptin sample w a s divided and stored at three different temperatures.

(c-e) MALDI mass spectra, collected on the leptin samples after five months of
storage at (c) -70, (d) -20, and (e) 4°C. Degradation is most noticeable In the
sample that w a s stored at 4°C. The strong peak arising from degradation at
Val57 (i.e. fragment 22-57) observed in the spectrum in panel (e) has caused the
relative intensity of the +4 ion (from the intact protein) to drop considerably.
However, the signal-to-noise of the 4+ ion has not changed much from the other
spectra (b-d). The mass accuracy of M A L D I - M S enables an unambiguous
Identification the peaks, indicating that the region of mouse leptin containing
residues 51-60 is susceptible to degradation.

(f) Summary of mouse leptin 'self degradation. Partial sequence of the mouse
leptin containing the residues susceptible to degradation as determined by
M A L D I - M S of the recombinant protein (leptin 22-167) shown in panels a-e.
Arrows point to observed cleavage sites —^small arrows designate minor
amounts of cleavage, the large arrow designates the site (Val57-Thr58) of
greatest degradation.
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of the h u m a n form of leptin, whose residues 50-60 were susceptible to 'self
degradation (Figure 5.6a). To further probe the structure of leptin, subtilisin and
trypsin limited digests were performed on the leptin samples. The digests
revealed that the most susceptible sites for proteolysis were between residues
54-61 for human leptin, in agreement with the 'self degradation findings.
The facile 'self degradation of leptin suggested that residues 54-61 in
human leptin were located within a flexible loop. A deletion mutant of leptin
(AhObI) that omitted residues 54-61 was designed. The mutant was
substantially more resistant (>100 fold) than the wild-type protein to trypsin
proteolysis, especially at the N-terminal (data not shown) —^supporting the idea
that the region 54-61 is unstructured. Unfortunately, crystallization trials of
AhObI were unsuccessful.
A methylated form of human leptin (obtained through reductive
methylation of the free amino groups of the recombinant protein) was also
examined by MALDI-MS. Methylation may stabilize the protein and increase the
chances for its crystallization. Besides MS, no other methods are available to
analyze methylated proteins and accurately map all the sites of modification,
which was successfully carried out on methylated leptin (data not shown).
Unfortunately, methylation was not the 'magic bullet' that would yield protein
crystals. Ketan Gajiwala has spent considerable effort (>1 yr.) on leptin
crystallization trials, and has only recently obtained crystals that diffract, albeit to
low resolution, by modifying the protein refolding strategies.
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Figure 5.6 Characterization of recombinant human leptin
(a) Linear representation of recombinant human leptin (hObI 22-167). Arrows
indicate sites of 'self degradation as measured by MALDI-MS.

The three

methionine residues of leptin are noted. These are the target residues for CNBr
digest. Cyanogen bromide digests indicate the presence of a disulfide linkage
between Cysl 17 and Cys 167 (see below).

(b) MALDI-MS of cyanogen bromide digest of recombinant human leptin,
expressed in yeast. The digestion was performed in 0.1 N HCl for one hour.
Three of the major peaks can be identified —^22-75 and 90-167 (2 peaks)— as
CNBr products that m a p to leptin. The two peaks that correlate to fragment
90-167 are marked peak 1 and 2. CNBr cleavage of leptin at Met89 yields a
product that produces peak 1. If there were no disulfide, subsequent cleavage of
90-167 at Met157 would result in 90-157, a peptide that was not observed by
MALDI (the second product, 158-167 has no basic groups and was also not
observed). If a disulfide linkage were present between Cysl 17 and Cys167,
CNBr cleavage of the 90-167 fragment at Met157 yields the fragment ion (peak
2) whose mass differs from peak 1 by the CNBr hydrolysis of the Met157-Leu158
bond. The pair of peaks labeled with an asterisk could not be identified and
were presumed to be an artifact of the CNBr digest.
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A further use of M S associated with leptin characterization w a s the
identification of the C-terminal intramolecular disulfide bond. Cyanogen bromide
digests provided strong evidence for the presence of a disulfide linkage in
recombinant human leptin (Figure 5.6b) (Halaas et al., 1995). The key to the
disulfide bond identification was the presence of Met157, positioned between the
two cysteine residues (Cysl 17 &167) (See Figure 5.6a). CNBr cleavage
produced several products —fragments 22-75 and a pair of peaks that
correspond to 90-167 (Figure 5.5b, peaks 1 & 2). CNBr cleavage of leptin at Met
89 leaves fragment 90-167 (peak 1). Subsequent cleavage of the 90-167
peptide at Met157 would result in two fragments —90-157 & 158-167. However,
a disulfide between Cysl 17 and Cysl67 leaves the two fragments (90-157 and
158-167) covalently connected through the disulfide linkage, resulting in peak 2.
Trypsin digest of the leptin also provide results that support the CNBr findings of
the presence of an intramolecular disulfide bond (data not shown).

5.4.3 TAFs 42/62
The TAF proteins are factors associated with the TATA box-binding
protein (TBP) (Goodrich and Tjian, 1994; Burley and Roeder, 1996). For RNA
polymerase class II promoters, TBP and the TAFs (more specifically TAF|,s)
represent subunits of the general transcription factor TFIID. TFIID is critical for
recruiting proteins in the assembly of the eukaryotic transcriptional machinery
and plays a pivotal regulatory role in gene expression. Although, the TAFs are
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Figure 5,7 Sequence alignments
ofdTAF42&62
witii tiie tiistones 1-13 & 1-14.
The histone-like portions of Drosophila T A F 4 2 and T A F 6 2 are
aligned with chicken histones H 3 and H4. Annino acid identities
are denoted with ( | ), and sinnilarities with ( : ). T A F numbering
systems are above the sequences.
Secondary structural
assigments (a-helices, loops) are based on the TAF42/62 and
histone core crystal structures (Xie et al, 1996).
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not essential for basal level transcription, they appear to be important for
activator-dependent transcription, at least for in vitro assays. The TAFs are
believed to mediate interactions between the basal transcriptional machinery
(bound to the TATA box through TBP) and transcription and regulatory factors
(bound to distal sites on the DNA). A large number of TAFs have been cloned in
yeast, Drosophila and human (Burley and Roeder, 1996) that display remarkable
cross-species sequence homologies for a given TAF protein.
Using biochemical methods, interactions have also been mapped
between many of the TAF proteins (Burley and Roeder, 1996). Two of these
interactions were mapped to the subunits Drosophila TAF||42 and TAF||62
(Kokubo et al., 1994). Both subunits have homologous yeast and human forms.
Immunoprecipitation experiments indicate that TAF42 and TAF62 interact
strongly (Kokubo et al., 1994). More striking is the resemblance (at the
sequence level) of TAF42 and TAF62 for the non-linker histone proteins H3 and
H4 (Figure 5.7). Like histones H3 and H4, TAF42 and TAF62 strongly associate
in solution, forming a tight heterodimer (TAF42/TAF62) with a --lO'® M equilibrium
dissociation constant. Such a tight association facilitated the co-expression and
purification of the TAF42/62 complex. There is also strong evidence pointing to
the existence of the heterotetrameric complex (TAF42/TAF62)2, a species that
would be analogous to the core histone (H3/H4)2 complex. Ultracentrifugation
experiments have shown an equilibrium dissociation constant of TAF
dimer/tetramer complex to be -10-^ M (Xie et al., 1996). Also, biochemical
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studies have revealed a third T A F (TAFSOa in Drosophila) interaction with the
TAF42/62 tetramer suggesting the existence of a histone octamer-like TAF
complex (Hoffmann et al., 1996).
I undertook two studies of the TAF42/62 complex. (1) An investigation of
the non-covalent interactions between the proteins by ESI-MS, and (2) domain
elucidation of the TAF42/62 complex by MALDI-MS.

5.4.3.1 ESI-MS of Non-covalent Interactions between TAF42 and TAF62
As discussed in Chapter 1, under appropriate solution conditions, ESI-MS
can probe the interactions between proteins in solution. Figure 5.8a shows the
ESI-MS of the TAF42/62 complex under denaturing conditions (i.e., sprayed from
an acidified methanolic solution). The proteins constructs used in this
experiment were the TAF42 and TAF62 sequences that spanned the histonesimilarity regions (TAF42/62 original constructs; see Materials and Figure 5.7).
The spectrum shows two "envelops" of ion peaks —one from TAF42, the other
from TFA62— that represent distributions of a highly multiply-charged protein
species. Under acidic denaturing conditions (pH --2.5), the protein is maximally
unfolded in solution, exposing acidic and basic residues for protonation that
results in a broad distribution of positive charge states for each protein. Figure
5.8b shows a deconvolution of the ESI mass spectrum of Figure 5.8a.
Deconvolution mathematically 'combines' the multiple-charged peaks of each
protein species into a single peak for each protein (Mann et al., 1989). The two
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Figure 5,8 ESI-MS of dTAF 42/62 under denaturing conditions

(a) Raw data labeled with multiple protonation charge states of
dTAF42 (1-100)(shadowed #s) and dTAF62 (1-91)(italisized #s), and
(b) deconvoluted data of (a) labeled with the measured masses of
the TAFs. Expected masses: TAF62, 10,240 Da; TAF42, 11,297 Da.
Peaks marked with asterisk are M S fragment ions from TAF42.
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major peaks shown in the deconvoluted spectrum have masses that correlate to
the TAF42 and TAF62 constructs.
Figure 5.9a shows ESI mass spectra of the TAF42/62 complex
electrosprayed under non-denaturing conditions. Comparison with the spectra
obtained under denaturing conditions (Figure 5.8a) reveals several important
differences. (1) Protein ions with higher m/z values were measured under nondenaturing conditions (Figure 5.9a). No peaks were observed in this high m/z
range under denaturing conditions (data not shown). The peaks in the higher
m/z range in the non-denaturing conditions (Figure 5.9a) arise from protein with
low charge states. Approaching neutral pH, the protein is expected to be in its
native, folded state (i.e., TAF42/62 heterodimeric and tetrameric complexes). A
more compact structure due to protein folding as well as non-covalent
interactions between the subunits would likely reduce the protonation of basic
groups due to the 'burial' of protein residues at the interaction interface. It would
be energetically highly unfavorable to 'bury' a residue with a net charge,
especially into a hydrophobic region such as a globular domain. (2) A set of
peaks that correlate to the TAF monomers is observed under denaturing (Figure
5.8a) and non-denaturing (Figure 5.9a) conditions. (3) A set of peaks whose
mass correlates to the heterodimeric complex of TAF42/62 is observed under
non-denaturing conditions (Figure 5.9a). There is no evidence for homodimers
or any form of tetramers. No dimeric peaks were observed under the acidic
denaturing conditions. (4) By adjusting the capillary temperature and skimmer
voltage, the intensity of the heterodimer peaks (for the non-denaturing solution)
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were m a d e to completely dominate (at reduced temperatures and voltages) or to
completely disappear (at elevated temperatures and voltages) (data not shown).
The dissociation of the complex at elevated capillary temperatures and skimmer
voltages confirmed that the heterodimer TAF42/62 complex measured under
non-denaturing solution conditions was non-covalent and that the specificity of
interaction (i.e. heterodimerization) is maintained into the gas phase.
Further attempts were made to observe the tetramer complex
(TAF42/TAF62)2 by ESI-MS. The most 'gentle' ESI conditions (i.e. low capillary
temperature and skimmer voltage) are required to observe dimer-dimer noncovalent interactions which are expected to be much weaker than monomermonomer interactions. Under extremely gentle conditions, there were only weak
indications of a tetrameric species. As mentioned before, the dimer/tetramer
equilibrium dissociation constant was determined by ultracentrifugation to be
~10"^ M —three orders of magnitude weaker than the monomer/dimer
dissociation constant. Even the 'gentlest' ESI-MS conditions were probably still
too harsh to maintain the interactions of a moderately-weak tetrameric complex
into the gas phase.

5.4.3.2 Domain Elucidation of the TAF42/62 Complex for
High-Resolution Studies
Xiaoling Xie set out to crystallize the TAF42/62 complex in order to
address the possibility that a pair of TAFs has a histone-like topology. [A low
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resolution crystal structure of the core histone octamer w a s available for
comparison (Arents et al., 1991).] The first job was selecting initial constructs for
crystallization. The task was simplified through the histone TAF42/62-H3/H4
similarity alignments. However, because strong sequence homology was
lacking, the exact lengths of the helices and loops in the TAFs were not clear.
To accommodate the 'boundary' uncertainties, the original TAF constructs
Included 8-20 additional residues extending beyond the histone-like portions at
the N- and C-termini (except for the N-terminal of TAF62). Throughout the
crystallization project, MALDI- and ESI-MS was used to check the identity and
purity levels of the recombinant TAF proteins.
After four months of protein expression, isolation and co-purification the
TAF42/62 constructs were shown to be monodisperse and tetrameric by
dynamic light scattering methods (Xie/Burley). High monodispersion usually
means little or no protein aggregation, an important condition for a successful
crystallization (Ferre-D'Amare and Burley, 1997). The TAF proteins readily
crystallized, but the crystals were small and diffracted weakly to 4-5 A. Flexible
portions of the protein were suspected to be reducing the packing efficiency into
the protein crystal lattice, compromising the quality of the X-ray diffraction.
Additional evidence came from MALDI-MS which showed that recombinant
TAF42/62 is susceptible to substantial degradation in solution. The MALDI data
revealed a complex mixture of degradation products whose identities correlated
to proteolytic cleavage at the protein termini (data not shown).
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Limited proteolysis w a s applied to the protein complex to better elucidate
its folding domains. Separate digests were performed using endo Asp-N, Glu-C,
trypsin, chymotrypsin and subtilisin. MALDI-MS was used to map the digests.
Figure 5.10 summarizes the proteolysis results. The digest data made clear that
three of four termini were proteolyticaUy susceptible, whereas the N-terminal of
TAF62 was highly resistant to digestion.
The proteolysis data provided a rational basis for redesigning constructs
of the TAF proteins. Several new constructs were designed, and ultimately the
most 'compact' ones —dTAF42 (11-95) and dTAF62 (1-82) (see Figure 5.10)—
yielded positive results. From five to nine residues were 'trimmed' from three of
the four termini of the original constructs; the TAF62 N-terminal was left
unchanged. In less than two months after redesigning the constructs,
recombinant protein was available for crystallization trials. The trials promptly
produced large crystals that diffracted to better than 1.4 A resolution (Xie et al.,
1996). The TAF42/62 structure solved to 2 A resolution is shown in Figure
5.11a. For comparison, the H3/H4 heterodimer structure [extracted from the low
resolution histone-core octamer structure (Arents et al., 1991)] is also depicted
(Figure 5.11b). The folds are very similar. The TAF42/62 structure represents
the first high-resolution TAF structure as well as the first high-resolution view of
the histone fold, showing that the tetrameric (dTAF42/dTAF62)2 complex (not
shown) strongly resembles the (H3/H4)2 heterotetrameric core of the histone
octamer (Xie etal., 1996).
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Figure 5.10 Domain elucidation of the dTAF42/62 complex.
The linear diagrams outlined in black depict the protein constructs
{dTAF42 (1-100) and d T A F 6 2 (1-91)} initially designed for crystallization
based on histone H 3 and H 4 sequence similarities (Fig. 5.7). M A L D I - M S
mapped the proteolyticaUy susceptible sites. Red arrows denote sites of
rapid (min-hr) and green arrows denote sites of slow (hr-1 day)
proteolysis. Solid blue lines designate the n e w constructs used for high
resolution X-ray crystallography. The a-helical regions, determined from
the crystal structure, are labeled.
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dTAF42

H3

Figure 5.11 The dTAF42/62 and histone H3/H4 structures.
X-ray crystallographic structures of the histone-like regions of
dTAF42/dTAF62 complex (LEFT), solved to 2.0A resolution, showing the
binary heterodimeric complex between dTAF42(11-95) (red) and dTAF62
(1-91) (blue), the 'minimal folding domains' of the proteins as determined by
limited proteolysis and mass spectrometry; and (RIGHT) the corresponding
view of the complex between histones H 3 (red) and H 4 (blue) for
comparison. The ribbons outline the polypeptide backbones of each protein
(Xie etal., 1996).
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5.4.4 Domain

Elucidation by Mass Spectrometry-Additional Applications

Domain elucidation by mass spectrometry has proven to be an
indispensable tool for high resolution studies (described above). Subsequent
X-ray crystallographic projects have also benefited from domain elucidation
including the HIV I Nef/SH3 protein complex (undertaken in the Chait and
Kuryian Labs) (Lee et al., 1996) and two structural studies (in progress) of
protein-RNA complexes: the Novel protein-RNA complex (Lewis/Burley) and the
eukaryotic initiation factor 4E (elF-4E; the small cap-binding protein)
(Marcotrigiano/Burley). In the HIV I Nef/SH3 study, MALDI- and ESI-MS were
used to map the limited digests. Both mass spectrometric methods yielded
similar information concerning the compact folding domain of the Nef-SH3
complex (U. A. Mirza, personal communication).

5.5 Conclusions —Mass Spectrometry as a Tool for Protein
X-ray Crystallography

Figure 5.12 outlines an overall strategy of applying mass spectrometry to
high-resolution protein X-ray crystallography. A comparable diagram could also
be drawn for multidimensional NMR spectroscopy. MS can facilitate the route to
a high resolution structure (Chait, 1994) at almost every stage of crystallography.
Figure 5.12 summarizes these stages. (1) Protein expression,
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Figure 5.12 Protein X-ray crystallography & mass spectrometry
The four stages of protein X-ray crystallography where m a s s spectrometry
has played an important facilitating role leading to a high resolution structure.

218

isolation and purification (discussed in this chapter). (2) Protein crystallization
trials. Protein crystals can be directly analyzed by MALDI-MS (an example is
given at the end of Chapter 2). (3) Domain elucidation (presented in this
chapter). (4) Phase determination. Heavy atom derivatives (e.g.,
selenomethionine or mercury derivatized proteins) can be assayed by MALDI- or
ESI-MS. These are extremely useful measurements since there are no other
simple analytical methods available to assay heavy atom incorporation. (For
example, this was particularly useful in the TAF 42/62 project). In summary,
mass spectrometry has developed into an invaluable tool that should be included
in the arsenal of strategies used for attaining high resolution X-ray
crystallographic and NMR structures.
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